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ABSTRACT 
 
Role of intracellular cysteines in ENaC function 
Armelle TAKEDA, Department of Pharmacology and Toxicology (CH) and Biomedical 
Research Centre Bichat-Beaujon (F). 
Thesis performed in co-supervision between the Faculty of Biology and Medicine of the 
University of Lausanne, Switzerland and the Doctoral Institute of Physiology and 
Physiopathology of the University Pierre & Marie Curie of Paris, France. 
 
The epithelial sodium channel (ENaC) regulates the sodium reabsorption in the collecting 
duct principal cells of the nephron. ENaC is mainly regulated by hormones such as aldosterone 
and vasopressin, but also by serine proteases, Na+ and divalent cations. The crystallization of an 
ENaC/Deg member, the Acid Sensing Ion Channel, has been recently published but the pore-
lining residues constitution of ENaC internal pore remains unclear. It has been reported that 
mutation αS589C of the selectivity filter on the αENaC subunit, a three residues G/SxS 
sequence, renders the channel permeant to divalent cations and sensitive to extracellular Cd2+. 
We have shown in the first part of my work that the side chain of αSer589 residue is not 
pointing toward the pore lumen, permitting the Cd2+ to permeate through the ion pore and to 
coordinate with a native cysteine, γCys546, located in the second transmembrane domain of the 
γENaC subunit. In a second part, we were interested in the sulfhydryl-reagent intracellular 
inhibition of ENaC-mediated Na+ current. Kellenberger et al. have shown that ENaC is rapidly 
and reversibly inhibited by internal sulfhydryl reagents underlying the involvement of 
intracellular cysteines in the internal regulation of ENaC. We set up a new approach comprising 
a Substituted Cysteine Analysis Method (SCAM) using intracellular MTSEA-biotin perfusion 
coupled to functional and biochemical assays. We were thus able to correlate the cysteine-
modification of ENaC by methanethiosulfonate (MTS) and its effect on sodium current. This 
allowed us to determine the amino acids that are accessible to intracellular MTS and the one 
important for the inhibition of the channel. 
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RESUME 
 
Rôle des cysteines intracellulaires dans la fonction d'ENaC  
Armelle TAKEDA, Département de Pharmacologie et de Toxicologie (CH) et Centre de 
Recherche Biomédical Centre Bichat-Beaujon (F). 
Thèse effectuée en co-tutelle entre la Faculté de Biologie et de Médecine de l'Université de 
Lausanne, Suisse et l'Ecole Doctorale de Physiologie et de Physiopathologie de l'Université 
Pierre & Marie Curie de Paris, France. 
 
Le canal épithélial sodique ENaC est responsable de la réabsorption du sodium dans les 
cellules principales du tubule collecteur rénal. Ce canal est essentiellement régulé par voie 
hormonale via l'aldostérone et la vasopressine mais également par des sérines protéases, le Na+ 
lui-même et certains cations divalents. La cristallisation du canal sodique sensible au pH acide, 
ASIC, un autre membre de la famille ENaC/Deg, a été publiée mais les acides aminés 
constituant le pore interne d'ENaC restent indéterminés. Il a été montré que la mutation αS589C 
du filtre de sélectivité de la sous-unité αENaC permet le passage de cations divalents et 
l'inhibition du canal par le Cd2+ extracellulaire. Dans un premier temps, nous avons montré que 
la chaine latérale de la αSer589 n'est pas orientée vers l'intérieur du pore, permettant au Cd2+ de 
traverser le canal et d'interagir avec une cysteine native du second domaine transmembranaire 
de la sous-unité γENaC, la γCys546. Dans un second temps, nous nous sommes intéressés au 
mécanisme d'inhibition d'ENaC par les réactifs sulfhydryl internes. Kellenberger et al. ont 
montré l'implication de cystéines intracellulaires dans la régulation interne d'ENaC par les 
réactifs sulfhydryl. Nous avons mis en place une nouvelle approche couplant la méthode 
d'analyse par substitution de cystéines (SCAM) avec des perfusions intracellulaires de MTSEA-
biotine. Ainsi, nous pouvons mettre en corrélation les modifications des cystéines d'ENaC par 
les réactifs methanethiosulfonates (MTS) avec leur effet sur le courant sodique, et donc mettre 
en évidence les acides aminés accessibles aux MTS intracellulaires et ceux qui sont importants 
dans la fonction du canal. 
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RESUME DESTINE A UN LARGE PUBLIC 
 
Rôle des cysteines intracellulaires dans la fonction d'ENaC  
Armelle TAKEDA, Département de Pharmacologie et de Toxicologie (CH) et Centre de 
Recherche Biomédical Centre Bichat-Beaujon (F). 
 
La cellule, unité fonctionnelle du corps humain, est délimitée par une membrane 
plasmique servant de barrière biologique entre le milieu extracellulaire et le milieu 
intracellulaire. Cette membrane est imperméable aux nutriments indispensables au 
fonctionnement de la cellule et donc du corps. Mais la survie de la cellule dépend, entre autres, 
du maintien de la teneur en ions dans chacun des milieux intracellulaire et extracellulaire et les 
ions doivent pouvoir être réabsorbés ou sécrétés selon les besoins de la cellule. Ainsi, la cellule 
synthétise des protéines qui s'insèrent dans la membrane et forment un canal laissant passer 
spécifiquement, dans un sens ou dans l'autre, certains ions. L'ion sodium (Na+), présent dans la 
plupart des aliments et dans le sel, est spécifiquement absorbé dans les cellules du rein grâce à 
un canal à Na+ épithélial appelé ENaC. Dans le cas d'ENaC, les ions Na+ sont réabsorbés de 
l'urine primaire vers l'intérieur de la cellule. Ils passent ensuite, grâce à un autre canal, de 
l'intérieur de la cellule vers le sang. C'est entre autres par cette réabsorption de Na+ que se fait la 
régulation et le maintien de la concentration sodique du plasma sanguin. Le rôle crucial d'ENaC 
dans le maintien de l'équilibre sodique dans le corps sous-entend une haute régulation de ce 
canal dans les cellules. Certains cas de canal ENaC hyperactif ont déjà été rapportés comme 
dans des maladies telles que l'hypertension et la mucoviscidose. Pour parer à ces 
dysfonctionnements, il est essentiel de connaitre les mécanismes et fonctionnements de ce genre 
de protéines. Ainsi, nous nous sommes intéressés aux mécanismes qui régissent l'activité de ce 
canal. Comment ENaC peut-il être aussi sélectif aux ions Na+ sans laisser passer les autres ions? 
Par quels mécanismes et interactions avec les autres protéines ENaC peut-il être activé ou 
désactivé? Une protéine est une macromolécule biologique composée d'une chaîne d'acides 
aminés. Parmi les 22 acides aminés présents chez l'homme, la cystéine présente un groupe 
particulier, le groupe sulfhydryl, capable de former une liaison spécifique et stable avec un autre 
groupe sulfhydryl. Ces liaisons sont souvent impliquées dans la structure tridimensionnelle de la 
protéine. Nous avons utilisé cette caractéristique afin d'étudier l'accessibilité et le rôle des 
cystéines présentes dans ENaC et donc, établir la structure du canal et la corréler avec sa 
fonction. 
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INTRODUCTION 
 
The Epithelial Sodium Channel (ENaC) belongs to the ENaC/Degenerin gene family 
discovered in the beginning of the 1990s. Two genes, deg-1 and mec-4, were first discovered in 
Caenorhabditis elegans. Chalfie et al. have shown that gain-of-function of these two degenerin 
ion channel genes results in a toxic gene product. This causes the degeneration of several 
neurons (23) and renders mutants incapable of mechanosensation. Then, the sequence of the 
ENaC α subunit was isolated from epithelial cells of rat distal colon and identified by functional 
expression in Xenopus laevis oocytes (19), quickly followed by the two other β and γ ENaC 
subunits (20). Sequence alignment of ENaC α, β and γ subunits with mec-4 and deg-1 had 
underlined a high sequence homology, presuming that proteins product by these three genes are 
members of the same cation channel family. To this new family, numerous additional genes 
appeared to share sequence homology. Neuronal degenerin from human and rat brain were 
cloned and described as amiloride-sensitive cation channels for which phylogenetic analysis 
indicated that they were equally divergent from all other members of the ENaC/DEG family. 
These genes are expressed predominantly in the peripheral and central nervous system and thus, 
their encoding protein were called mammalian degenerins (MDEG) or brain Na+ channels 
(BNaC1, BNaC2) (42). After the discovery of their activation by rapid extracellular 
acidification (128), their name was changed to Acid-Sensing Ion Channel (ASIC). In parallel, it 
had been shown that in the nervous tissue of the snail Helix aspersa, the FMRFamide-gated 
sodium channel (FaNaC) could be blocked by amiloride. This protein shares a low sequence 
identity with ENaC subunits and degenerins but displays the same overall structural 
organization (79), forming its own subfamily within the ENaC/DEG family. It has also been 
shown that the gene dGNaC1 is expressed specifically in the gonads and early embryo in 
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Drosophila melanogaster and thus, seems to be implicated in gametogenesis and early 
embryogenesis in drosophila. 
Studies of sequence alignment between all the members of ENaC/Deg family led to a 
potential phylogenetic tree proposed in Figure 1 (70). Related sequences are organized into 
subfamilies. We can distinguish seven branches, with three main subfamilies of genes encoding 
for: (i) the four ENaC subunits (α, β, γ and δ); (ii) the four ASIC subunits (+ splice variants); 
and (iii) the C. elegans degenerins (DEG, DEL, MEC and UNC). The amino sequence identity 
between the different ENaC/Deg subfamilies is 15-20 %. Within subfamilies, identities are 30 
% for ENaC subunits and 45-60 % for the four ASIC genes (1 to 4). Between species, identities 
of amino sequences are 85 % between human and rat orthologs of ENaC, almost 100 % 
between human and rat orthologs of ASIC1, 2 and 4 and 85 % for ASIC3 (70). Although 
functionally different, members of ENaC/Deg family share the same structure and functional 
domains that are involved in the control of the channel activity and in the formation of the pore. 
 
 
 
 
 
 
 
 
 
Figure 1: Phylogenetic tree of the ENaC/Deg family. Kellenberger and Schild, Physiol. 
Rev., 2002 
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I/ ENaC 
I-1) Localization of ENaC 
ENaC is located at the apical membrane of polarized cells in different tissues, i.e. the 
kidney, the lung, the skin, salivary glands and the tongue. It mediates the Na+ transport across 
the membrane to permit its vectorial transcellular transport. This electrogenic Na+ absorption is 
necessary to maintain the composition and the volume of the fluid on either side of the 
epithelium. For example, in the kidney, this active transepithelial transport is essential for the 
maintenance of blood Na+ and K+ levels and their homeostasis. In the lung, it permits to 
maintain the volume of the luminal fluid. 
I-1-i) The kidney 
The kidney is a natural filter that maintains the homeostatic balance in the body by 
excreting metabolites and organic wastes in urine along with water (Figure 2). It regulates the 
blood pressure by regulating the plasma concentration of ions such as Na+ and K+, and the 
levels of compounds like glucose and bicarbonate. The nephron is the renal functional unit. 
Millions of nephrons join together in collecting ducts to pour out the secreted urine in the ureter 
(Figure 2A). 
 
 
 
 
Figure 2: (A) Schematic representation of the kidney (http://health.nytimes.com) (B) 
Schematic representation of a nephron (http://www.ivy-rose.co.uk) 
  19
 
The glomerulus is a network of blood capillaries that filter the blood thanks to the high 
permeability of its capillaries to water and electrolytes. The filtrate flows along the nephron 
(Figure 2B) and water and small molecules are reabsorbed from the filtrate into the blood. At 
the basolateral membrane of proximal convoluted tubule (PCT) cells, the Na+,K+-ATPase 
actively pump Na+ out of the cell into the blood leading to a strong electrochemical gradient in 
the cell. This gradient provides a potential to allow isoosmotic Na+ reabsorption (65 % of 
filtered sodium) from the lumen to the cell. In the loop of Henle, water is reabsorbed into the 
hyperosmotic medullary interstitium leading to the concentration of urine. Approximately 25 % 
of filtered sodium is reabsorbed in the thick-walled ascending limb (TAL) via the Na+,K+,2Cl- 
cotransporter (NKCC2), organized in parallel with the apical K+ channel ROMK. Then, in the 
distal convoluted tubule (DCT), about 10 % of sodium is reabsorbed by the Na+,Cl- 
cotransporter. The collecting ducts connect the nephrons to the ureter. In humans, the system 
accounts for 4-5 % of the kidney's reabsorption of sodium and 5 % of the kidney's reabsorption 
of water. The cortical collecting ducts (CCD) cells are largely impermeable to water without the 
presence of antidiuretic hormone (or vasopressin), and are sensitive to aldosterone which 
stimulates active sodium reabsorption. They are composed of two types of cells: (i) the principal 
cells, mediating the sodium-potassium balance, and (ii) the intercalated cells (α and β), 
participating in the acid-base homeostasis. In the principal cells of CCD (Figure 3), sodium is 
reabsorbed from urine by ENaC which colocalizes with the K+ channel ROMK. Sodium is then 
driven to blood via the basolateral Na+,K+-ATPase pump. This absorption is regulated by the 
expression of ENaC at the surface of the apical membrane. 
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Figure 3: Transepithelial ion transport in a principal cell of the cortical collecting duct. R, 
mineralocorticoid receptor; AIT, aldosterone-induced transcripts; ARP, aldosterone-repressed 
protein. from Kellenberger & Schild, Physiol. Rev., 2002 (70) 
 
I-1-ii) The lung 
On the apical surface of the airway epithelium (Figure 4A), there is a glycocalyx, a 
network of polysaccharides that coats the apical cell surface, and a film of liquid, the periciliary 
liquid (PCL) layer through which cilia beat freely. This is overlaid by a mucus layer, a gel 
generated by the high molecular weight mucins, which entraps particles to be transported by 
coordinated ciliary movement. Altogether, PCL and mucus layers form the Airway Surface 
Liquid (ASL). The PCL is likely a polyanionic gel layer that allows the cilia to beat. During 
their strokes, the tips of the cilia contact the underside of the mucous blanket. They propel 
mucous with entrapped particles to the mouth where everything can be expectorated. This 
allows the surface of the airways to be kept clean. The viscoelasticity of the mucus is 
determined by the mucins themselves, their interaction with "sticker" proteins and by the 
hydration of the layer. This hydration is mediated by a balance between Na+ absorption via 
ENaC, and Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR) 
(Figure 4B). The hydration of the mucus is the most important variable in controlling the 
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efficiency of mucus clearance (15). CFTR belongs to the ABC (ATP-binding cassette) family 
transporter ATPases and is the only ion channel of the family. It has been shown that CFTR 
inhibits ENaC activity (122) and stabilizes ENaC at the plasma membrane (82). Moreover, a 
direct physical association of CFTR and ENaC has been assessed with the fluorescence 
resonance energy transfer technique (FRET) (8). 
 
 
 
 
 
 
Figure 4: Schematic representation of lung cells. (A) The airway surface liquid (ASL) is 
partitioned into three open compartments, a glycocalyx, a pericilary liquid (PCL) layer and a 
mucus layer. from http://www.med.unc.edu/cystfib/Staff/paradiso.htm (B) Regulation of the 
volume of PCL by active ion transport. from Boucher, Eur. Respir. J, 2004 (14). 
 
I-2) Biophysical properties of ENaC 
ENaC discriminates among cations based on their size. Small cations such as sodium, 
lithium and protons are permeant whereas larger cations like potassium or ammonium are not 
(Li+ > Na+ >> K+). Moreover, ENaC is not permeable to divalent cations. In CCD and Xenopus 
laevis oocytes expressing αβγ ENaC, 140 mM of extracellular Na+ leads to a unitary 
conductance (g) of 5 pS and 150 mM of extracellular Li+, to a g(Li+) of 10 pS. Calculation of 
the concentration for half-maximal conductance (Km) shows that the apparent affinity is higher 
for Na+ than for Li+, with Km(Na+) of 20-50 mM and Km(Li+) of 90 mM in CCD and 120 mM in 
Xenopus laevis oocytes. This lower affinity and higher conductance of Li+ is explained by a 
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higher dissociation rate of Li+ from its binding site in the channel pore compared with Na+. The 
single-channel conductance changes with the subunit composition of ENaC. In oocytes 
expressing αβ ENaC, the single-channel conductance is 4-5 pS at 150 mM Na+ or Li+. With αγ 
ENaC, the Na+ conductance is still 4-5 pS but Li+ conductance is 9-10 pS, as with αβγ ENaC 
(70). Measurement of the voltage-dependence of the conductance through ENaC has been 
accounted for in large part by the concentration gradient for Na+ across the apical cell 
membrane. ENaC is characterized by a slow kinetic of the gating, i.e. long spontaneous open 
and closed times in the range of 0.5-5 seconds at room temperature. In rat CCD, at 37 °C, the 
gating of the cloned rat ENaC speeds up (hundreds of milliseconds in duration) (43). 
 
I-3) Regulations of ENaC 
The main role of ENaC in polarized epithelial cells is to allow the vectorial transcellular 
transport of Na+ in order to maintain the composition and the volume of the fluid on either side 
of the epithelium. The entry of Na+ through ENaC at the apical membrane induces a favourable 
electrochemical gradient that allows the secretion of K+ in the tubule lumen. ENaC represents 
the rate-limiting step in this process and is regulated by different factors. As other proteins, 
ENaC follows general process of protein biosynthesis and degradation. Biosynthesis of ENaC 
subunits is under the control of aldosterone, as explained below, and degradation occurs via the 
ubiquitination of the subunits. Ubiquitination is a posttranslational modification involving the 
ligation of ubiquitin polypeptides and plays an essential role in many kinds of cellular function. 
The process of ubiquitination consists of 3 main steps (Figure 5): (i) the ubiquitin is activated by 
ATP and then transferred to the E1 ubiquitin-activating enzyme where it binds to E1 sulfhydryl 
group via a thioester linkage releasing a molecule of AMP; (ii) the ubiquitin is transferred from 
E1 to the cysteine residue of E2 ubiquitin-conjugating enzyme; (iii) the E3 ubiquitin-protein 
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ligase interacts with both E2 and the substrate and allows the transfer of ubiquitin to a lysine 
residue present on the substrate. Substrate can be monoubiquitinated or polyubiquitinated 
leading to different signals for protein recycling or degradation. A target protein must be 
labelled with at least four ubiquitin monomers (in the form of a polyubiquitin chain) before it is 
recognized by the proteasome, where unneeded or damaged proteins are degraded by 
proteolysis. The E3 ubiquitin ligase of ENaC has been shown to be the Neural Precursor cells-
expressed developmentally down-regulated 4, Nedd4-2 (125). Nedd4-2 interacts specifically 
with ENaC subunits via its PY motif but mechanisms of Nedd4-2-mediated regulation of ENaC 
will be detailed later (cf. 'Liddle syndrome' and 'PY motif'). USP2-45 has been recently 
identified as the deubiquitinating enzyme that increases ENaC activity in Xenopus oocytes (35), 
i.e. the antagonist enzyme of Nedd4-2. 
 
 
 
 
Figure 5: The ubiquitination system. from http://upload.wikimedia.org/wikipedia/commons/ 
7/7f/Ubiquitylation.png 
 
I-3-i) Hormonal regulation 
I-3-i-a) Aldosterone 
Aldosterone is a hormone synthesized in the cortex of the adrenal glands in response to 
the renin-angiotensin system that regulates blood pressure by controlling the extracellular fluid 
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volume of the body. The renin-angiotensin system is itself activated by a decrease in renal blood 
pressure or decrease in dietary Na+ (98). In the principal cells of the cortical collecting duct 
(CCD), aldosterone regulates the Na+ reabsorption by its binding to the mineralocorticoid 
receptor (MR) (Figure 6) (121). The activated complex MR/aldosterone is translocated to the 
nucleus where it binds to the MR/GR responsive element within the promoter of aldosterone-
induced transcripts. It has been recently shown by surface biotinylation of renal cells in rat 
kidney and by membrane fractionation that increasing the levels of aldosterone in the animals, 
by feeding a low-Na+ diet or infusing them directly with hormone, increased the expression of 
ENaC subunits at the surface by two- to fivefold (41). Among the synthesis of αENaC, α1 and 
β1 Na+,K+-ATPase subunits during the late phase of aldosterone-response (> 3 hours) (85; 86), 
aldosterone increases ENaC activity by increasing the number of channels at the cell surface in 
two different ways: (i) stimulation of pathway increasing channel insertion at the cell surface, 
(ii) inhibition of pathway removing channel expressed at the cell surface. During the early phase 
(45 min to 3 hours), aldosterone induces the synthesis of several proteins that mediate the cell 
surface expression of ENaC (100). 
 
 
 
 
 
Figure 6: Model for the regulation of ENaC surface expression. Effect of aldosterone and 
vasopressin on Sgk1, K-Ras, GILZ, 14-3-3, Nedd4-2 and USP2-45 regulations. from Verrey et 
al., Kidney Int., 2008 (125). 
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The Serum and Glucocorticoid regulated Kinase isoform 1 (Sgk1) plays a role in 
preventing apoptosis and promoting cell proliferation (88). It has been identified as a primary 
aldosterone-induced transcript in amphibian and mammalian renal epithelia (25; 90). Sgk1 
knock-out (Sgk1-/-) mice studies did not present an abnormal phenotype at standard NaCl intake, 
with an aldosterone-mediated increase of the amiloride-sensitive sodium current similar in wild-
type (WT) and Sgk1-/- mice (36; 87; 133). In contrast, in a low salt diet, Sgk1-/- revealed a 
significant urinary salt wasting despite increases in plasma aldosterone levels, suggesting that 
lack of Sgk1 prevented the upregulation of ENaC. However, Fejes-Tóth et al. have shown that 
the change in salt wasting should be due to a significant decrease in the Na+,Cl+-cotransporter 
(NCC) which mediates sodium transport in early distal tubules. In vitro, the stimulatory effect 
of aldosterone on ENaC has been related to Sgk1 (80). First, a direct interaction between Sgk1 
and ENaC has been suggested in inside-out membrane patches of Xenopus laevis oocytes where 
deletion of the αENaC C-terminus significantly reduced the stimulatory effect of Sgk1 (32). 
Second, the phosphorylation by Sgk1 of the ubiquitine ligase Nedd4-2, involved in the 
internalisation of ENaC from the cell surface for recycling or degradation (cf. 'Liddle syndrome' 
and 'PY motif'), has been shown to increase the cell surface expression of ENaC (30; 117). K-
Ras2 is a small G protein that stimulates the ENaC activity via its effector protein PI3-kinase 
and likely also via direct effects of its phospholipid product, the phosphatidylinositol 3,4,5-
triphosphate (PIP3) on ENaC function (119). The glucocorticoid-induced leucine zipper 
(GILZ) is a leucine zipper protein whose expression is augmented by dexamethasone. It 
prevents the activation of Raf, another downstream effector of Ras, and thereby prevents the 
inhibitory action of Erk1/2 on ENaC. Erk-mediated inhibition involved ENaC phosphorylation 
that stimulates Nedd4-2 interaction with ENaC. Thus, GILZ stimulates the release of ENaC 
from the inhibition mediated by Nedd4-2 (10). 14-3-3 protein has been shown to potentially 
participate in the inhibition of Nedd4-2 mediated by Sgk1 (125). 
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I-3-i-b) Vasopressin 
Vasopressin (VP), or antidiuretic hormone (ADH), regulates the water conservation in the 
body by increasing the permeability to water in the last portion of the nephron (7). VP is stored 
in the neurohypophysis and released after changes in the osmotic pressure, detected by 
baroreceptor in the hypothalamus. In the kidney, VP targets the principal cells of the CCD 
where it acts via two specific receptors: the V2 receptor (V2R) located in the basolateral 
membrane with cyclic adenosyl monophosphate (cAMP) as second messenger, and the V1a 
receptor (V1aR) located in the apical membrane with Ca2+ as second messenger (1) (Figure 7). 
The antidiuretic action of VP occurs via V2R, leading to an increase of water and urea 
permeability and sodium transport. The V2R-induced increase of cAMP leads to the insertion in 
the apical membrane of preformed vesicles containing AQP2 and an increase of the apical 
membrane Na+ conductance achieved through ENaC (7). Altogether, water and sodium 
reabsorption lead to the concentration of the luminal fluid in the CCD and thus, to an increase of 
the urine osmolality. The hydroosmotic effect of basolateral VP can be inhibited by a luminal 
action of VP mediated by V1aR. Apical VP stimulates prostaglandin (PGs) synthesis via an 
increase of intracellular Ca2+ (16). 
 
 
 
 
 
Figure 7: Effect of vasopressin on mammalian CCD cells. Representation of V2R and V1aR 
effects on AQP2 and ENaC. V2R induces the activation of both channels by an increase of 
intracellular cAMP. This can be attenuated by the combined action of VP from the luminal side 
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on V1aR which induces an increase of Ca2+ and thus of prostaglandins (PGs). The antidiuretic 
action of VP can be reinforced with non-steroid anti-inflammatory drugs (NSAID) by inhibiting 
the PGs. from Bankir, Cardiovasc. Res., 2001 (7) 
 
I-3-ii) Proteolytic activation of ENaC 
Although aldosterone and vasopressin play a key role in the regulation of ENaC, there are 
also others factors that regulate ENaC. The first evidence of proteolytic activation was the 
activation of ENaC by extracellular addition of the serine protease trypsin (27). Membrane-
bound serine proteases had been identified that act as channel activating proteases (CAP) 
(127). The first, CAP-1 in the mouse model or prostasine in human, is a 
glycophosphatidylinositol-anchored protein (24). The two others are mCAP-2, the mouse 
homolog of the human transmembrane serine protease TMPRSS4, and mCAP-3, or matriptase 
(126). Each of them is able to increase the sodium current 6 to 10 fold in Xenopus laevis 
oocytes by increasing ENaC open probability. It has also been shown that co-expression of 
mCAP1, 2 or 3 with Sgk1 leads to a synergistic activation of ENaC (126). Other proteases also 
activate ENaC like the ubiquitous subtilisin-like proprotein convertase furin, cleaving both the 
α and γ subunits (58), and the neutrophil and pancreatic elastase, cleaving at two different sites, 
both distal to the furin cleavage site on the γ subunit (51). 
The activation of ENaC involves the furin-dependant cleavage of the extracellular loop at 
two sites within the α subunit and at a single site within the γ subunit (60). This cleavage 
permits the release of two inhibitory domains, one of 26 amino acids located between the two 
sites on the α subunit (22), and a second one of 43 amino acids between the furin and prostasine 
cleavage sites on the γ subunit (17). It has been shown that the furin-mediated cleavage of the α 
subunit affected the basal sodium current, whereas cleavage of the γ subunit affected the overall 
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expression levels (52). Complete activation was obtained with the combined action of trypsin 
cleaving the γ subunit (31; 91). Further studies suggested that the proteolytic processing of the γ 
subunit has a dominant role in activating the channel (21). The β subunit does not undergo any 
proteolytic cleavage but seems to play an important role in ENaC activation via furin-
independent activation. The proteolysis of α and γ subunits occurs within the trans-Golgi 
network but both cleaved and uncleaved channels are expressed at the cell membrane (59). 
 
 
 
 
 
Figure 8: Schematic representation of proteolytic regulation of ENaC. Convertases and 
ENaC are expected to cotraffic along the same trans-Golgi path, potentially partially proteolized 
ENaC heteromers to be delivered to the cell surface. At the cell surface, channel-activating 
serine proteases (SP) become activated and, if appropriately colocalized, can complete 
proteolytic activation. from Rossier and Stutts, Annu. Rev. Physiol., 2008 (101) 
Cleaved ENaC is used to exhibit long open and closed states. A population of amiloride-
sensitive channels presenting a long closed time and short open times was predicted to be the 
non-cleaved pool of expressed channels which are able to be activated by extracellular proteases 
(18). It has to be noticed that more than the proteases, inhibitors of proteases play also a role in 
the regulation of ENaC. For example, the protease nexin 1 (PN-1) is an endogenous serine 
protease inhibitor (serpin) that inhibits prostasine as other proteases and, in this way, regulates 
the expression of selected proteases. In the lungs, the air surface liquid volume is highly 
regulated by the balance of proteases and protease inhibitors that modulate ENaC activity (89). 
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I-3-iii) Ion regulation of ENaC 
I-3-iii-a) Na+ self- & feedback inhibitions 
The activity of ENaC is strongly regulated by sodium itself via two distinct phenomena: 
self-inhibition and feedback inhibition. Self-inhibition is the quick return of inward sodium 
current to a lower steady state value after the rapid increase of extracellular sodium 
concentration. This model proposes that external sodium has an inhibitory effect on ENaC 
activity, thereby protecting the cell from Na+ overload. Mechanisms remain unclear but Palmer 
et al (94) proposed that self-inhibition likely induces a decrease in the open probability of 
ENaC. Bize and Horisberger (11) have recently demonstrated by outward sodium current 
measurements that self-inhibition and saturation of the conduction site play a significant role in 
the inhibition of ENaC by extracellular Na+. Using ENaC chimera, Babini et al. (6) showed the 
involvement of the proximal part of the extracellular loop in the Na+ self-inhibition. Moreover, 
two histidine and several cysteine residues have been proposed as crucial structural 
determinants for the Na+ self-inhibition (106; 110). Recently, αGly481 and γMet438 in mouse 
ENaC subunits have been identified as functional determinants of Na+ self-inhibition and of 
ENaC gating (83). Self-inhibition can be prevented by extracellular proteases (26), such as furin 
(107), or by extracellular Zn2+ (113) or protons (28). The feedback inhibition displays a slow 
time course (time constant 10-20 min) due to the increase of intracellular sodium concentration. 
The inhibition occurs via a reduction of the ENaC open probability, limiting the sodium entry 
when concentration of intracellular Na+ ions is high (3). Kellenberger et al. (65) have shown 
that the Liddle mutations of the PY motif on the β and γ subunits, involved in the Nedd-4 
regulation of ENaC, lead to a mutant channel less sensitive to inhibition by intracellular Na+. It 
has been recently shown that intracellular Na+ regulates ENaC cleavage by altering the 
accessibility of ENaC cleavage sites to proteases (72). 
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I-3-iii-b) intracellular pH 
Maintenance of cell pH depends on the gradient of Na+ from outside to inside the cell. 
Thus, elevation of intracellular Na+ due to a stimulation of Na+ entry can lead to the 
acidification of the intracellular medium. Cell pH is therefore a candidate to mediate feedback 
inhibition. Indeed, it has been shown in frog skin that the sodium permeability is highly 
sensitive to cytoplasmic pH (53). However, the role of pH in mediating control over Na+ 
channels may differ from tissue to tissue (43). 
I-3-iii-c) redox regulation 
It has been shown that nitric oxide (NO) inhibits ENaC activity in lung alveolar type 2 
cells (54) and that in human lung carcinoma cells, the H2O2-mediated oxidative stress 
suppresses the dexamethasone-dependent αENaC transcriptional activation (130). These results 
suggested that the oxygen-sensitive regulation of ENaC is potentially a key mechanism for 
regulation of epithelial Na+ transport during hypoxia. It has been shown recently that ENaC is 
inhibited in mouse CCD cells by application of intracellular heme mimicking hypoxia 
conditions (131). This inhibition occurs via a decrease in ENaC open probability with no 
change in the unitary current amplitude. When hemeoxygenase is active, i.e. when hemes are 
catabolised, activity of ENaC is stimulated (131). It has thus been proposed that hemeoxygenase 
permits the oxygen-sensitive regulation of ENaC. The site on ENaC by which heme should 
exert its inhibition has not been determined. Furthermore, no known binding site has been found 
on ENaC but histidine, methionine and cysteine residues are known to provide sites of 
interaction with heme iron. Study of protein sequences alignment underlined the presence of 
intracellularly accessible cysteines in the N- and C-termini of α, β and γENaC subunits. 
Especially in the N-terminus, five cysteine residues are conserved among species and flanked a 
highly conserved HG motif that plays a role in ENaC gating. Cysteine-substitution and 
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modification experiments have shown that ENaC is inhibited by intracellular thiol reagents and 
thiol oxidation (64). This suggests the involvement of intracellular cysteines of ENaC in the 
thiol-mediated inhibition and, above all, suggests the possibility that changes in intracellular 
redox potential modulate ENaC activity and transepithelial sodium transport. The mechanisms 
of the thiol-mediated inhibition of ENaC will be investigated in this work. 
 
I-4) Physiopathology involving ENaC 
I-4-i) Pseudohypoaldosteronism type 1 
Pseudohypoaldosteronism type 1 (PHA1) is an inheritable disorder characterized by 
severe neonatal salt-wasting, metabolic acidosis, hyperkalemia, dehydration and elevated 
plasma aldosterone and renin activities. We distinguish two distinct clinical features (50): (i) the 
autosomal dominant form, linked to the mineralocorticoid receptor; (ii) the recessive systemic 
form, linked to ENaC. This latter is due to frameshift or missense mutations that lead to a loss 
of channel function. Several mutations have been identified in human ENaC subunits, for 
example: (i) the missense mutation βG37S, in the highly conserved domain HG, located in the 
N-terminus of the β subunit. Homologous mutations into α and γ subunits also significantly 
reduce the ENaC sodium current (44); (ii) 2 frameshifts (1449delC and 729delA) and 1 
missense mutation resulting in the substitution of serine 562 for leucine in the alpha subunit 
(αS562L) (103); (iii) the mutation αR508Stop leading to a truncated α subunit missing the 
second transmembrane and C-terminus domains (12); (iv) the mutation αR492Stop leading also 
to a truncated form of the α subunit (13). 
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I-4-ii) Liddle syndrome 
This syndrome took the name of the endocrinologist Grant W. Liddle that described the 
first time in 1963 patients presenting 'A familial renal disorder simulating primary 
aldosteronism but with negligible aldosterone secretion' (77). This autosomal dominant 
Mendelian hypertension is characterized by severe hypertension, hypokalemia, suppressed 
plasma renin activity and low urinary level of aldosterone. Mineralocorticoid antagonist such as 
spironolactone has no effect but a specific blocker of ENaC, trimaterene, normalized blood 
pressure and hypokalemia. The linkage of the Liddle syndrome with the β subunit of ENaC has 
underlined a premature stop codon in the C-terminus of the β subunit (115). This leads to the 
deletion of almost all the C-terminus of the β subunit, particularly the PY motif, involved in the 
Nedd4-2 ubiquitin ligase regulation (cf. 'Regulation of ENaC' & 'PY motif'). Alteration of 
internalisation of ENaC results in an increase of its surface expression and thus, an increase in 
sodium reabsorption (39). The conserved sensitivity of ENaC Liddle mutant to aldosterone and 
vasopressin contribute to the increase of Na+ absorption (5). Several other mutations, on the rat 
β and γ subunits, have been described: (i) the βR564Stop mutation identified from the first 
Liddle patients (104); (ii) the γW574Stop that deletes the last 76 amino acids of the γENaC C-
terminus (48); (iii) the βP616L, a de novo missense mutation of the β subunit (49). Mutations in 
the extracellular loop (the insertion of a single nucleotide in the exon 13 of βENaC leading to a 
frameshift abrogating the PY motif, and γN530S) had been identified from a patient with Liddle 
syndrome and associated with an increased ENaC activity (56). 
The first evidence in vivo of the constitutive hyperactivity of ENaC in CCD from mice 
harbouring Liddle mutation was provided with mice expressing the mutated form of βENaC 
found by Liddle (9; 97). Another model of Liddle mice was obtained with mice deficient in the 
ubiquitin ligase Nedd4-2 (114). These mice express hypertension via ENaC hyperactivity since: 
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(i) the three ENaC subunits are highly expressed in kidney, in contrast with other Na+ 
transporters; (ii) the down-regulation of ENaC function is impaired; and (iii) the salt-sensitive 
hypertension is substantially reduced in presence of amiloride. 
 
I-4-iii) Cystic fibrosis lung disease 
Ninety percent of cystic fibrosis (CF) cases are due to a deletion at position Phe508 in the 
CFTR protein. CF disease evolves from small-airway obstruction, airway inflammation and 
intermittent infection into chronic bacterial infection, bronchiectasis and ultimately death. 
Phe508 mutation prevents the achievement of the native global conformation and leads to a 
misfolding and failure of translocation of CFTR to the apical membrane (14). Mice deficient in 
CFTR do not have a spontaneous pulmonary disease phenotype but overexpression of ENaC in 
mice inducing ASL depletion, increased mucus concentration, delayed mucus transport and 
mucus adhesion to airway surfaces (84). It has been shown that the ASL volume modulates the 
activity of ENaC by modification of the serine proteases-protease inhibitors balance and that 
alterations of this balance leads to an excessive Na+ absorption like in CF (89). Altogether, these 
observations suggest that airway surface hydration is the most important variable in controlling 
the efficiency of mucus clearance. Pharmaceutical companies are looking to develop new 
treatments for diseases such as CF, like derivative of amiloride, the specific inhibitor of ENaC, 
that is 60-100 fold more potent than amiloride (57). 
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II/ ASIC 
Four Acid-Sensing Ion Channels, or ASIC, genes have been identified (ASIC 1 to 4) and 
three of them have splice variants: ASIC1 a/b, ASIC2 a/b, ASIC3 a/b/c. ASIC are ligand-gated 
ion channels activated by protons with different pH sensitivity and kinetics depending of the 
subunit composition of the multimer. 
II-1) Localization of ASIC 
ASIC is expressed at the membrane of epithelial cells in the central and peripheral 
nervous systems. ASIC1a, ASIC2a and ASIC2b each show a widespread distribution pattern in 
brain. Highest levels of expression, and coexpression with ASIC4, are found in the 
hippocampus (involved in short term memory, navigation), the cerebellum (sensory reception, 
coordination, motor control), in the pyramidal neurones of the neo- (sensory perception) and 
allocortical (olfaction) regions, the main olfactory bulb (olfaction), the habenula (olfaction) and 
the basolateral amygdaloid nuclei (memory, emotional reaction). The strongest expression of 
ASIC4 is in the pituitary gland (70). In the peripheral nervous system, ASIC localize to neurons 
innerving skin, heart, gut and muscle. They have also been detected in the eye, ear, taste buds 
and bone. In cutaneous neurons, ASICs, especially ASIC3, have been detected in large, medium 
and small dorsal root ganglion (DRG) neurons (132). 
 
II-2) Biophysical properties of ASIC 
In contrary to ENaC that is constitutively active, ASIC is gated by extracellular protons 
and thus sensitive to extracellular pH. They are low conductance channels that mainly conduct 
Na+ (g(Na+) of 10-15 pS) (78). Homomeric ASIC1a channels respond to low external pH by 
mediating a fast and transient inward current with a threshold pH of 6.9 and the pH for half-
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maximal activation (pH0.5) at 6.2. In addition, ASIC1a is permeable to Ca2+ and K+ (Na+ > Ca2+ 
> K+) and desensitizes rapidly (inactivation time = 1.4 sec). ASIC1b responds with a similar 
transient current compared with ASIC1a and a pH0.5 of 5.9. Homomeric ASIC2a channels have 
low sensitivity to protons with a pH0.5 of 4.4. ASIC 3 are highly sensitive to protons and have a 
pH0.5 of 6.7 (134). ASIC2b and ASIC4 do not form homomeric channels. However, they 
associate with other subunits to form heteromeric ASIC with distinct properties that we will not 
detail here. Typical inward sodium currents obtained with homomeric ASIC1a, ASIC1b, 
ASIC2a and ASIC3 are presented in figure 9. 
 
 
 
Figure 9: Acid-evoked currents in heterologous cells (Cos-7) expressing the indicated 
ASIC subunits. from Wemmie et al., Trends in Neurosciences, 2006 (132) 
II-3) Modulation of ASIC 
ASIC activity can be modulated by interacting proteins. Physiological relevance of these 
interactions remains unclear but they have been described either in vitro or in vivo by 
immunofluorescence. ASIC subunits contain a PDZ binding motif at their C-terminal part and 
interact with several PDZ-containing proteins. For example, PICK1 (Protein interacting with C-
kinase 1) colocalizes with ASIC in the nervous system and associates with ASIC1 and ASIC2. 
In vitro, it participates at the protein kinase C (PKC)-mediated up regulation of ASIC2a and 
ASIC3. During inflammation, ASIC3 is up-regulated by activators of the PKC pathway released 
(78) such as NHERF-1, Na/H exchange regulatory factor-1, which associates with ASIC3 and 
increases its surface expression. Most of these proteins colocalize with ASIC3 in DRG neurons 
suggesting their association in vivo. ASIC also interact with non-PDZ proteins. An association 
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of CaMKII, calcium/calmodulin-dependent protein kinase II, and ASIC1a has been described in 
brain, which is enhanced by ischemia and leads to an increase of ASIC1a current by CaMKII 
phosphorylation (78). The Figure 10 shows proteins interacting with ASIC. Peripheral 
inflammation also increases the ASIC transcript levels in DRG and spinal cord. Synaptically 
released protons could activate ASICs in the postsynaptic and, possibly, the presynaptic 
membrane (insert, Figure10). 
FMRF-amide is a neuropeptide known to lead to a potentiation of the H+-gated currents 
by increasing the peak amplitude and/or slowing inactivation of ASIC1 and ASIC3 but not 
ASIC2a. FMRF-amide is not present itself in mammals, but FMRF-amide-related proteins 
(NPFF, NPAF, NPSF) are largely expressed in the central nervous system. However, 
modulation of ASIC requires FMRF-amide addition at pH 7.4, i.e. when the channel is closed, 
raising questions about how these peptides could affect ASIC in vivo (78). 
 
 
 
 
 
 
Figure 10: ASICs in primary afferent nociceptors and spinal cord neurons. Interacting 
proteins and extracellular modulators are shown. AA, Arachidonic Acid; NGF, Nerve Growth 
Factor; PKC, Protein Kinase C;SP, Substance P; CGRP, Calcitonin gene-related peptide; 5-HT, 
Serotonin. From Lingueglia, JBC, 2007 (78) 
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II-4) Pharmacology of ASIC 
II-4-i) PcTX1 
The Psalmotoxin 1, or PcTX1, is the most specific blocker of ASIC1a. It has been isolated 
from the venom of South American tarantula Psalmopoeus Cambridge. PcTX1 is a peptide of 
40 amino acids cross-linked by three disulfide bridges. It inhibits ASIC1a mediated sodium 
current in nanomolar concentrations (IC50 < 1nM). PcTX1 acts as a gating modifier by binding 
on cysteine-rich domains I and II (CRDI and CRDII; cf. below, 'Cysteine-Rich Domain') of the 
extracellular loop. It shifts the channel from its resting state towards the inactivated state 
through an increase of its apparent affinity for protons. This shift is Ca2+-dependent, where 
increasing extracellular Ca2+ results in a decrease of the PcTX1 inhibition (134). 
II-4-ii) APETx2 
APETx2 is a 42 amino acids peptide toxin isolated from sea anemone Anthopleura 
elegantissima. It specifically inhibits homomeric ASIC3 (IC50 = 63 nM in rat and 175 nM in 
human) and ASIC3 containing channels (ASIC3/1a, IC50 = 2 μM; ASIC3/1b, IC50 = 900 nM; 
ASIC3/2b, IC50 = 117 nM). Others channels are not sensitive to APETx2. The mode of action 
remains unknown (134). 
II-4-iii) Non-specific blockers of ASIC 
Amiloride is a diuretic agent that specifically blocks ENaC in the nanomolar range. It is a 
non specific blocker of ASIC with an IC50 of 10-50 μM (compared with 0.1-1 μM for ENaC). 
As for ENaC, amiloride binds in the pre-TM2 region and inhibits the current by direct blockage 
of the channel (cf. below 'Amiloride binding site'). A-317567 is a non-selective blocker of 
ASIC1a-like, ASIC2a-like and ASIC3-like currents in rat DRG neurons with IC50 of 2-30 μM. 
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Finally, non-steroid anti-inflammatory drugs (NSAIDs) are known to inhibit ASIC at 
therapeutic doses for analgesic effects. For example, Ibuprofen inhibits ASIC1a with an IC50 of 
350 μM, and Aspirin, ASIC3 containing channels with IC50 of 260 μM (134). 
 
 
 
 
 
 
Table 1: Properties of ASIC channels. n/a, non applicable. from Lingueglia, JBC, 2007 (78) 
 
II-5) Physiopathology linked to ASIC 
II-4-i) Pain 
The suggestion of the involvement of ASIC in visceral pain came with the observation 
that ASIC3 is expressed in cardiac afferents, likely mediating the pain of ischemia angina (123). 
In addition, ASIC affects the response to gut distension. ASIC might be also involved in pain at 
several locations. They are expressed in nerves innervating joints and bones suggesting that they 
sense the acidosis induced by chronic inflammatory arthritides and cancer metastases. 
Moreover, ASIC in muscle afferents may detect the lactic acidosis due to severe or intense 
exercise. Altogether, these observations suggest that ASIC should be a good target for the 
treatment of pain. But mouse data showed that disrupting ASIC might increase sensitivity to 
  39
painful stimuli. Explanations are unclear but might include variability in genetic background 
and species, differences in testing paradigms and environmental variability (132). 
 
II-5-ii) Ischemic stroke 
During ischemia, increased anaerobic glycolysis because of reduced oxygen supply leads 
to lactic acid accumulation. Accumulation of lactic acid, along with increased H+ release from 
ATP hydrolysis, causes a decrease in brain pH, or acidosis. During brain ischemia, extracellular 
pH falls to 6.5 or lower. Because of its permeability to Ca2+ and it sensitivity to pH, the 
activation of ASIC1a plays a role in the pathology of acidosis-mediated and ischemic brain 
injury. It is also known that N-methyl-D-aspartic acid (NMDA) receptors and subsequent Ca2+ 
toxicity are involved in ischemic brain injury. Compared to ASIC1a or NMDA blockade alone, 
co-application of NMDA and ASIC1a blockade produces additional neuroprotection. Therefore, 
Ca2+-permeable ASIC1a represents a novel pharmacological target for ischemic brain injury 
(134). 
II-5-iii) Other diseases 
ASIC1a is located at synapses and particularly abundant in the amygdala (emotional 
reaction), and modulation of synaptic physiology is likely to have behavioural consequences. 
Loss of ASIC1a has pronounced effects on fear-related behaviour. Moreover, analysis of mice 
overexpressing ASIC1a suggests that human gain-of-function mutations might be prone to 
fearful behaviour and supersensitive to acidosis. Therefore, manipulating ASIC1a function 
pharmacology might provide a novel strategy for reducing fear and anxiety in patients (132). 
Moreover, a significant drop of brain pH during intense neuronal excitation or seizure activity 
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suggests that ASIC1a activation might play a role in the generation and maintenance of 
epileptic seizure (134). 
 
III/ Structure of ENaC/Deg members 
III-1) Generality on sodium channels 
Besides the ENaC/Deg gene family, ion channels are commonly defined as an assembly 
of proteins inserted in the plasma membrane that form aqueous pores through which ions can 
flow down their electrochemical gradient. They are classified by the nature of their gating: (i) 
those activated by a change in membrane potential are called voltage-gated channels and (ii) 
those activated by an external chemical ligand, called ligand-gated channels. Voltage-gated 
sodium channels are responsible for action potential creation and propagation. The pore-
forming α subunits consist of four homologous repeat domains (I-IV) each comprising six 
transmembrane segments (S1-S6) for a total of 24 transmembrane segments (Figure 11A). They 
co-assemble with auxiliary β subunits, each spanning the membrane once and both α and β 
subunits are highly glycosylated. Ligand-gated channels open in response to specific ligand 
molecules binding to the extracellular domain of the receptor protein. Ligand binding causes a 
conformational change in the structure of the channel protein. The pore is formed by a 
pentameric arrangement of subunits, which are in turn composed of a large extracellular domain 
(which contains the ligand binding site) and four transmembrane domains (Figure 11B). 
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Figure 11: Structure of typical voltage-gated and ligand-gated channels. (A) Structure of a 
typical voltage-gated ion channel composed of (a) α subunit (comprising four subunits I to IV) 
that forms the aqueous pore (b), assembled with an auxiliary β subunit. (B) Structure of the 
ligand-gated neuronal nicotinic acetylcholine receptor (nAChR). The receptor is pentameric (b) 
with each subunit containing a ligand binding site and four transmembrane domains. from 
Cambridge University Press 
 
III-2) Structure of an ion channel 
The first ion channel to be crystallized was the K+ channel from Streptomyces lividans, the 
KcsA K+ channel (34). Bacterial K+ channel sequence is similar to that of other vertebrate and 
invertebrate voltage-dependent K+ channels allowing thus the determination of the general 
structure of all the potassium channels. As predicted by functional experiments, the K+ channel 
is a tetramer presenting a closed gate on the intracellular side. It is composed of four identical 
subunits that form an inverted teepee with the selectivity filter of the pore in its outer end, and a 
10 Å diameter cavity in the centre of the channel with an ion in it (Figure 12A). The lining of 
the selectivity filter is composed of five amino acids which turn their main chain carbonyls 
toward the pore axis and their side chains outward. The inner half of the pore is predominantly 
lined by a side chain of hydrophobic amino acids. It has been observed by electron density maps 
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that two K+ ions occupy the short selectivity filter, almost completely dehydrated (Figure 12B). 
Internal to the selectivity filter, floating in the centre of the 10 Å diameter cavity, is a third K+ 
ion, likely surrounded by water molecules (4). This ion is stabilized by two mechanisms: (i) the 
hydrophobic membrane interior of the large aqueous cavity, and (ii) the partial negative charge 
of the oriented helices toward the cavity. 
 
 
 
 
 
Figure 12: The KcsA K+ channel. (A) Representation of the tetramer as an integral membrane 
protein. Aromatic amino acids on the membrane-facing surface are displayed in black. (B) K+ 
ions in the cavity, in the middle of the membrane. From Doyle et al., Science, 1998 (34) 
 
III-3) Structure of the epithelial sodium channel 
III-3-i) A tetramer or a trimer? 
ENaC/Deg members share the same channel architecture thought for a long time to be a 
tetramer but finally described as a trimer in the recent crystallization of chicken ASIC1 (61). 
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III-3-i-a) Evidence for a tetrameric channel 
Several studies have shown that FaNaCh (29) and ENaC (37), belonging to the same 
ENaC/Deg family, were associated in tetrameric complexes. Firsov et al. (37) have shown by 
quantitative analysis of cell surface expression of ENaC that in a functional channel, the number 
of α subunits is higher than β or γ subunits. Then functional analysis of differential sensitivities 
to Zn2+, conferred by point mutations in the three ENaC subunits, have allowed the assessment 
of the two α, one β and one γ stoichiometry as a functional tetrameric conformation for ENaC. 
This subunit stoichiometry was confirmed by biophysical assays using amiloride-binding site 
mutated ENaC channels that display significant differences in sensitivity to external MTSEA 
from the wild-type channel (73). Moreover, a sucrose gradient analysis (33) demonstrated a 
tetrameric subunit stoichiometry in agreement with the studies above, at least in the intracellular 
pool of proteins. Recently, single-channel current measurements were performed in Xenopus 
laevis oocytes expressing individual mutations that alter the channel conductance (2). In the 
case of mutation on the α subunit, coexpression of wild-type and mutated subunits resulted in 
the appearance of channels with an additional single-channel conductance between those of 
wild-type and mutant channels. This intermediate single channel conductance suggested the 
presence of two α subunits in the channel. This was not observed for the mutation in β and γ 
subunits confirming the number of each subunit to one per channel. Altogether, these results 
confirmed the tetrameric functional structure of ENaC and the stoichiometry 2α, 1β and 1γ. 
However, with a combination of different techniques, the group of D. Stockand suggested 
that for maximal ENaC activity, each subunit is required and that ENaC at the membrane 
contains preferentially equal numbers of each type of subunit (118). He therefore suggests a 
trimer (1α, 1β and 1γ), a hexamer (2α, 2β and 2γ) or a nonamer (3α, 3β and 3γ) as the 
functional arrangement of ENaC. 
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III-3-i-b) Crystallization of a trimeric truncated chicken ASIC 
The crystallization of the chicken form of ASIC 1 (cASIC1) has led to a re-evaluation of 
ENaC/Deg channels structure (61). As predicted by the amino sequence of the subunits, each 
subunit has intracellular N- and C-termini, two transmembrane domains and a large 
extracellular loop. The crystallization of cASIC1 has been performed on a deleted channel, 
missing the N- and the C-termini and leading to a non-functional channel, called cΔASIC1. 
Transmembrane domains are α helix coupled to β strands in the large extracellular domains but 
no continuous pore along the three-fold axis of molecular symmetry is visible for the passage of 
ions (Figure 13B). Ions may access the ion pore by way of fenestrations near the extracellular 
membrane surface (Figure 13A). The extracellular domain resembles a forearm with 'wrist', 
'thumb', 'finger', 'knuckle', 'β-ball' and 'palm' depending of the α helixes and β sheets 
configuration as described in the Figure 13C. The 'thumb' domain presents five disulfide bridges 
forming a straight line from the conserved residue Trp288, in the 'wrist' junction, to the interface 
'thumb' / 'finger'. Concerning the transmembrane domains of each subunit, they adopt different 
conformation with a bent TM2 (Figure 13C) for two of the three subunits and a straight TM2 
for the third one (Figure 13A). This asymmetry remains unclear. The proton binding-site was 
identified in the extracellular domain as multiple close acidic residue pairs, far from the channel 
region. Its effect on channel gating seems to involve movement of the disulfide-rich 'thumb' 
domain depending of proton binding / unbinding. This suggests that the movement is 
transmitted to transmembrane domains by way of primarily non-covalent interactions, mediated 
by residues at the base of the 'thumb' like the conserved Trp288. 
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Figure 13: Trimer assembly of cΔASIC1. (A) Stereoview of the homotrimeric structure 
viewed parallel to the membrane plane. Each subunit is in a different colour. (B) View of the 
homotrimeric structure parallel to the molecular three-fold axis from the extracellular side of the 
membrane. (C) Domain organization of a single subunit, locations of disulfide bridges (labelled 
1-7). From Jasti et al., Nature, 2007 (61) 
 
The pore is defined primarily by residues from the TM2 (Figure 14A), with a negative 
electrostatic potential that likely contributes to cation selectivity (Figure 14B), although TM1 
also lines portions of the pore, especially in the extracellular vestibule. The degenerin site 
(Figure 14C, Gly432 ('d')) was located at the interface between TM2 and TM1 of adjacent 
subunits, indicating that introduction of a large residue into this interface may perturb the 
gating. 
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Figure 14: Structure and key residues in the transmembrane domains of cΔASIC1. (A) 
View of the homotrimeric structure parallel to the membrane plane. Oxygen atoms are red, 
nitrogen atoms are blue and numbering indicates residues in TM2 relative to the degenerin ('d') 
position. (B) Surface potential representation of the TM region sliced through the pore along the 
plane of membrane bilayer to show the negative potential along the pore. Contours are from -8 
(red) to +8 kT (blue). (C) View from the extracellular side, along the pore axis, showing the 
location of Gly432 ('d'). From Jasti et al., Nature, 2007 (61) 
 
The three-dimensional structure was obtained from a non-functional truncated form of 
cASIC1, missing the N- and C-termini. These parts of the channel are important in the function 
and structure of the channel as illustrated by physiopathology linked to intracellular deletion of 
ENaC subunit such as the PHA1 and the Liddle syndrome (cf. 'Physiopathology of ENaC'). 
Thus, we cannot exclude that the absence of the intracellular part leads to invalid observations 
and interpretations for a functional channel. 
 
III-3-ii) Structure of the subunit 
The αENaC subunit is a 79 kDa protein composed of 698 amino acids; the βENaC, a 72 
kDa protein of 638 amino acids; the γENaC, a 74 kDa protein of 650 amino acids and the 
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hASIC1a subunit, a 60 kDa protein with 528 amino acids. As we have seen above, each subunit 
has intracellular N- and C-termini, two transmembrane (TM) domains and a large extracellular 
loop. We will see below the main sites and domains present in ENaC and ASIC subunits. 
 
III-3-ii-a) HG domain 
Study of the PHA-1 (cf. 'Pseudohypoaldosteronism type 1') has permitted the 
identification of a missense mutation βG37S in the N-terminus of the human βENaC subunit 
leading to a loss of the channel function (44). Amino acids sequence alignments show a high 
conservation of this residue between human and rat ENaC (hαG70, hβG37, hγG40, rαG95, 
rβG37 and rγG40). This residue is also conserved in human and chicken ASIC1 (hA1a-G29 and 
cA1a-G30). It has been shown that the mutation rβG37S, as the homologous mutations in α 
(rαG95S) and γ (rγG40S) subunits, decreases the channel open probability underlining the 
potential involvement of this glycine residue in the gating of ENaC. Complementary studies 
showed on the rat α subunit that a conserved pre-TM1 segment, from T92 to C101, determine 
the open probability of ENaC and are involved in the channel gating kinetic. Three amino acids, 
the rat αH94, αG95 and αR98, are the most important in maintaining proper channel gating 
(45). These three amino acids are flanked by two cysteine residues conserved in two or three 
ENaC subunits: (i) rαC88, rβC30, rγC33; (ii) rαC101, rβC43. 
 
III-3-ii-b) Cysteine-Rich Domains (CRD) 
Two CRDs, CRD1 and CRD2, are present in the extracellular loop of ENaC/Deg 
channels. They are likely involved in the formation of disulfide bonds, thus in the formation of 
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mature channels (70). Mutation C133Y in the CRD1 of human αENaC has been shown to cause 
PHA-1 as seen above. Firsov et al. (38) have shown that mutation of two cysteines in CRD1 of 
the α, β and γ subunits (αC158, βC98 and γC100; αC332, βC270 and γC284) and two other 
cysteines in CRD2 of the α and β subunits (αC458 and βC399; αC472 and βC413) prevents the 
normal transport of assembled channels from intracellular compartments to the plasma 
membrane leading to a decrease in the number of ENaC expressed at the cell surface. Recently, 
it has been shown that half of the cysteines in the extracellular loop of α and γ subunits likely 
form intrasubunit disulfide bonds. This establishes the tertiary structure that ensures a proper 
Na+ self-inhibition (110). In ASIC1a, CRDs are also binding site for its specific blocker PcTX1 
(cf. 'PcTX1' in ASIC part). 
 
III-3-ii-c) Degenerin site 
The Degenerin site is a common site of all the ENaC/Deg members localized in the 
extracellular loop, closed to the TM2 (αS576, βS518 and γS530 in rENaC, G432 in cA1 and 
G433 in hA1a). Mutation of this site in C. elegans degenerins leads to the constitutive activation 
of the channel and then to neuronal cell swelling and degeneration. The substitution of the 
corresponding Gly into ASIC1 and ASIC2 also causes constitutive channel activity (129). 
Mutation of the corresponding Ser in the three human α, β and γ ENaC subunits induces an 
increase of the sodium current. Moreover, modification of adjacent residues has shown that the 
current increases by conformational change in the outer vestibule of ENaC (116). Modification 
of the rβS518 has been shown to alter the gating kinetics of the channel by destabilizing the 
closed state resulting in shorter closings and by slowing the closing of the channel (67). 
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III-3-ii-d) Amiloride binding site 
Amiloride is as a potassium-sparing diuretic. In the nanomolar range, it is the specific 
blocker of ENaC with a 100 fold lower affinity for ASIC and the other members of ENaC/Deg 
family (70). The IC50, i.e. the concentration of amiloride needed for the half inhibition of ENaC, 
is closed to 0.1 μM (43). Affinity of channels for amiloride depends on the extracellular pH, the 
transmembrane voltage and Na+ concentration. Indeed, amiloride is a weak base that can only 
block ENaC when charged positively underlining the importance of the extracellular pH. Then, 
the voltage dependence of channel block is explained by the binding of the cationic form of 
amiloride to its binding site, located within the transmembrane electric field. Moreover, the 
interaction between Na+ and amiloride is competitive, suggesting overlapping binding sites 
within the external ion permeation pathway (92). Finally, site-directed mutagenesis experiments 
have proposed that residues αS583, βG525 and γG537 form the amiloride binding site in the 
three rat ENaC subunits (105) and the residue G440 in hASIC1a. 
Evidence of the effect of amiloride on aldosterone-stimulated Na+ current was provided 
by patch-clamp experiments in A6 (47) and then in rat CCD cells (93). In rat CCD, the on-rate 
of amiloride is estimated of about 60 μM-1.sec-1 and the off-rate of 4 sec-1 whereas in the toad 
bladder, the amiloride on-rate is about 20 μM-1.sec-1 and the off-rate is about 2-3 sec-1. 
Concerning the KD, i.e. the constant of dissociation, the estimation in CCD cells coincides with 
macroscopic results that is 7.10-8 M (93). Later studies showed that mutation of the amiloride 
binding site on α and β subunits led to an increase in the dissociation rate of amiloride with 
little change in the association rate. They also demonstrate that benzamil, a derivative of 
amiloride, and triamterene, another ENaC blocker, share a common receptor with amiloride 
(66). 
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III-3-ii-e) Selectivity filter 
ENaC/Deg channels are permeable to monovalent small cations such as H+, Li+ and Na+ 
but not for larger cations like K+ and NH4+. This ion discrimination shows that the selectivity 
filter constitutes the narrowest part of the pore and that ions tightly interact with amino acids 
that line the pore (63; 68; 69; 108). The selectivity filter is a three amino acid sequence G/SxS 
preceding the second transmembrane domain in ENaC and ASIC (G587, S588 and S589 in rat 
αENaC). In addition to these residues, two residues within the TM2, αGlu595 and αAsp602, 
have been showed to have a role in conferring ion selectivity (111). Mutation of residue αS589 
in the selectivity filter allows the passage of larger ions such as K+, Rb+, Cs+, NH4+ and divalent 
cations. The larger the substituting amino acid is, the higher is the channel permeability to 
larger cations suggesting that introduction of large amino acids in the selectivity filter induces 
an enlargement of the outer pore allowing passage of larger ions. It has been thus proposed that 
the main chain of the G/SxS residues line the pore lumen, rather than their side chain (63). 
However, a discrepant study has been published proposing that mutated channel αS589Cβγ is 
sensitive to external Cd2+ block because of the sulfhydryl group accessibility at position α589 to 
Cd2+. They concluded that wild-type αSer589 hydroxyl groups face the lumen pore and 
contribute to cation selectivity and coordination of permeating cations (112). These results have 
led to open debate and investigations presented as the first part of this work (124). 
III-3-ii-f) PY motif 
The PY motif is a proline rich motif (PPPxPxxL) located in the C-terminus part of αβγ 
ENaC subunits and absent in ASIC. Presence of a proline-rich motif in proteins often indicates 
their involvement in protein-protein interactions because proline residues are breaker of regular 
secondary structures such as α helixes and β sheets, often rendering the proline-rich motif on 
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the surface of protein. Modular domains currently known to recognize proline-rich domains 
include SH3 and WW domains (76). The protein binding the PY motif has been identified as 
the human ubiquitin-protein ligase Nedd4. Moreover, studies have shown that Nedd4 binds to 
the PY motif via its WW domains 2, 3 and 4 (predominantly WW3) and that, when co-
expressed in Xenopus oocytes, it down-regulates ENaC activity (81). Complementary studies 
have shown that the interaction specifically occurs between the PY motif of the WW3 domain 
of the isoform 2 of Nedd4 (40; 55). Ex vivo, ENaC is ubiquitinated on lysine residues located in 
the N-terminus of the α and γ subunits (but not on the β subunit) (120). 
Mutation of the PY motif causes Liddle syndrome (cf. 'Liddle syndrome') by increasing 
the cell surface expression and the open probability (39). Nedd4-2 regulates the Na+ transport 
by controlling the relative expression of cleaved and uncleaved ENaC at the cell-surface (71), 
by rapidly removing cleaved ENaC from the cell surface (62). A recent study reports that 
Nedd4-2 multi-ubiquitinylates the surface-expressed pool of ENaC and underlines the role of 
the ubiquitin-proteasome pathway in the regulation of Na+ transport in the collecting duct (99). 
 
 
 
 
 
Figure 15: Localization of the main sites and domains conserved among ENaC and ASIC 
subunits. The N- and C-termini, HG domain and PY motif (PPPxYxxL) are intracellular. 
Cysteine Rich Domains (CRD) 1 & 2 are extracellular. 
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III-3-iii) The internal pore 
Three-dimensional crystal structure of the KcsA K+ channel provided insights regarding 
the possible structure of an ionic internal pore but ENaC shares no homology with K+ channels 
(34). Investigations on the study of the internal pore in the ENaC/Deg members consist of 
introduction of cysteines and the study of their accessibility by sulfhydryl reagents. In FaNaC, 
the ion pore is described as a large aqueous cavity, with a charge selectivity filter in the outer 
vestibule and the gate close to the interior (96). In ENaC, it has been proposed that the external 
entry of the pore has been formed by an α helix followed by an extended region that forms the 
selectivity filter (109). Consequently, it has been suggested the participation of the pore region 
in ENaC gating. The same group has then proposed, with the identification of β subunit residues 
lining the pore, that the three ENaC subunits have an asymmetric organization (75). More 
recently, we have shown in hASIC1a that three residues, Ala22, Ile33 and Phe34, participate in 
the internal pore (95). 
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AIM 
Before the release of the three-dimensional structure of the chicken ASIC 1, the ion 
permeation pathway and the molecular mechanism of ion permeation through ENaC/Deg 
channels were unknown. The first part of my work aimed at the understanding of the pore 
structure (more specifically of the internal pore located downstream the selectivity filter) that 
opens to the cytosolic side and at the contribution of the two transmembrane domains (TM1 & 
TM2). Today the three-dimensional structure of ASIC provides valuable information on the 
internal pore structure. Nevertheless, our data need to be interpreted in the context of the ASIC1 
structure to better understand structure-function relationships of members of the ENaC/ASIC 
ion channel family. In the second part of my work, we have addressed specific aspects of the 
cytosolic part of ENaC and ASIC channels that is involved in the modulation of channel 
activity. We were wondering if the channel inhibition by MTSET results from direct 
interactions of intracellular ligand with the N-terminal part of ENaC / ASIC and what are the 
accessible target sites in the N-terminal part for specific ENaC / ASIC inhibition. 
 
I/ Cadmium trapping in an Epithelial Sodium Channel Pore Mutant 
The selectivity filter of ENaC is formed by three residues G/SxS present in the three 
ENaC subunits. Mutation of one of the residues on the αENaC subunit, αSer589, changes the 
ion selectivity allowing the passage of divalent ions such as Cd2+ ions. A study, based on the 
external Cd2+-mediated inhibition of the mutated αS589Cβγ channel, proposed that this 
inhibition is the consequence of the interaction of Cd2+ ions with the sulfhydryl group of the 
substituted Cys at position α589. Thus, it was suggested by the authors that the side chain of the 
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wild-type αSer589 faces the pore lumen (112). We could show that the backbone of the 
selectivity filter residues line the internal pore and that the Cd2+-mediated inhibition of the 
mutated αS589Cβγ channel is due to the interaction of Cd2+ with a native cysteine located in the 
TM2 of the γENaC subunit rather than with the substituted cysteine α589. These results have 
been published in the Journal of Biological Chemistry, vol. 282, N° 44, pp. 31928-31936, Nov. 
2007. The crystallization of chicken ASIC few months after our publication tends to confirm 
our selectivity filter residue orientation. 
 
II/ The internal accessibility of the cysteine to sulfhydryl reagents 
ENaC has been shown to be inhibited by intracellular methanethiosulfonates (MTS) (64). 
This study revealed multiple cysteine residues in the N- and C-termini of ENaC subunits 
responsible for this thiol-mediated inhibition. We have investigated the mechanisms of this 
inhibition and the identification of the intracellular cysteines target by the MTS. In this part of 
my work, we set up a new approach based on the Substitution Cysteine Analysis Method 
(SCAM) coupled to intracellular perfusion of MTSEA-biotin in Xenopus laevis oocytes. 
Generated currents are measured by cut-open voltage-clamp before and after intracellular 
perfusion of MTSEA-biotin. Then proteins biotinylated by MTSEA-biotin are isolated with 
pull-down assay, thanks to the specific interaction between biotin and streptavidin beads. 
Biotinylated proteins are finally separated by SDS-PAGE and analyzed by western-blot with 
specific antibodies. In this way, we want to identify the cysteine accessible to intracellular MTS 
reagents and correlate them with cysteines involved in the function of the channel. 
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Materials and Methods 
 
Biotinylated reagents. We used two sulfhydryl reagents and an amino-reactive reagent. 
• N-Biotinylaminoethyl methanethiosulfonate (MTSEA-biotin) was purchased from 
Toronto Research Chemicals Inc. (Canada). This compound reacts specifically with the 
sulfhydryl group of cysteine residues to form a disulfide bridge, DTT-sensitive. 
• EZ-Link® Maleimide-PEO2-Biotin came from Pierce Biotechnology (USA). This 
compound with a spacer arm of 29.1 Å reacts specifically with the sulfhydryl group of 
cysteine to form a DTT-insensitive thioether bond. 
• EZ-Link® Sulfo-NHS-SS-Biotin (Sulfosuccinimidyl 2-(biotinamido)-ethyl-1, 3-
dithiopropionate) came from Pierce Biotechnology (USA). This thiol-cleavable compound 
with a spacer arm of 24.3 Å reacts with primary amine-containing molecules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Biotinylated reagents structure and reaction. (A-ii) MTSEA-biotin and (B) 
Maleimide-PEO2-Biotin reacts with sulfhydryl groups of protein resulting in the biotinylation 
of the protein. (C) Sulfo-NHS-SS-Biotin reacts with the amine group of protein. 
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Cross-linkers 
• dithio-bis-maleimidoethane (DTME), from Pierce Protein Research Product, Part of 
Thermo Fischer Scientific, IL, USA. Maleimide ends form stable thioether linkages with 
sulfhydryl groups on proteins and peptides at pH 6.5-7.5. Between the maleimide ends is a 
spacer arm of 13.26 Å. The internal disulfide bridge can be cleaved with DTT. 
• bis(maleimido)ethane (BMOE), from Pierce Protein Research Product, Part of Thermo 
Fischer Scientific, IL, USA. BMOE is a homobifunctional maleimide cross-linker that forms 
stable thio-ether linkages between sulfhydryl groups at pH 6.5-7.5. The spacer arm of 8.0 Å 
cannot be cleaved by DTT. 
• sodium tetrathionate (NaTT), from Sigma-Aldrich Chemie GmbH, Buchs, Switzerland, an 
oxidizing reagent promoting the formation of disulfide bridges. 
 
Antibodies. 
• Polyclonal antibody anti-αENaC targets an epitope located in the N-terminus part of the α 
subunit and was kindly provided by the group of Bernard Rossier, Department of 
Pharmacology and Toxicology of Lausanne, CH. 
• Polyclonal antibody anti-βENaC targets an epitope located in the C-terminus part of the β 
subunit and was kindly provided by Johannes Loffing, Institute of Anatomy of Zurich, CH. 
• Polyclonal antibody anti-γENaC targets an epitope located in the N-terminus part of the γ 
subunit and was kindly provided by Johannes Loffing, Institute of Anatomy of Zurich, CH. 
• Polyclonal antibody anti-hASIC1 targets a C-terminus epitope of the hASIC1 subunit was 
from Alomone labs of Jerusalem, Israel. 
• Monoclonal antibody anti-Actin, from Sigma-Aldrich Chemie GmbH, Buchs, 
Switzerland. 
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Site-directed Mutagenesis. The coding sequences of rat α, β and γENaC are cloned in 
the pSD5 vector and the coding sequence of human ASIC1a, in the pSDEasy vector. Both 
plasmids pSD5 and pSDEasy contain the SP6 promoter for the in vitro transcription (SP6), a 
polyA tail for the stabilization of the cRNA (pA), an origin of replication for bacteria 
amplification (Ori) and a gene coding for the ampicillin resistance (Ampi-R) (Figure 17). 
 
 
 
 
 
 
 
 
Figure 17: α, β, and γENaC genes are cloned in the pSD5 vector and human ASIC1a 
gene is cloned in the pSDEasy vector. Coding sequences of ENaC, ASIC1a and ampicillin 
resistance (Ampi-R) are in red arrow, SP6 is the promoter controlling ENaC and ASIC1a 
expression, pA is the polyA tail which will be synthesized at the 3’ end of the cRNA and Ori 
is the origin of replication of the vector. PvuII and FspI are the unique restriction sites used 
for the linearization of the plasmids before the in vitro transcription of, respectively, αENaC 
and hA1a. 
 
ENaC and hASIC1a mutants were obtained by site-directed mutagenesis using 
Stratagene’s QuickChange® protocol (Figure 18). The mutagenesis was carried out by PCR 
DNA amplification in a solution containing: 10 ng/μl template DNA, 20 mM dNTP, 100 
ng/μl of each the forward and the reverse oligonucleotide primers carrying the intended 
mutations, 2.5 U of Pfu Polymerase (Promega) and its 1X reaction buffer. The double 
stranded template DNA was denatured at 95 °C and annealed to the oligonucleotide primers. 
  58
The Pfu Polymerase extended the DNA strands from the mutagenic primers at 68 °C. The 
methylated DNA template was then specifically digested with the enzyme DpnI (1 h, 37 °C) 
leaving intact the mutated, non-methylated PCR product which was subsequently amplified in 
E. Coli DH5α cells. 
 
 
 
 
 
 
 
Figure 18: QuikChange® Site-Directed Mutagenesis Protocol. 
 
In the design of the oligonucleotide primers, along with the desired mutations, I 
introduced a silent mutation resulting in the removal of a restriction site. This allowed us to 
identify by enzymatic digestion the plasmid containing the desired mutation. After selection 
of the positive clones, we controlled the presence of the mutations by sequencing (Synergene 
Biotech GmbH). The region containing the desired mutations was subcloned into the wild-
type backbone in order to prevent undesirable mutations or into a previously modified 
sequence to combine several mutations together. 
 
In vitro cRNA transcription. 1 μg of wild-type or mutant α, β, γENaC, or hA1a cDNA-
encoding vectors was linearized with an enzyme having a unique restriction site located after 
the polyA tail, i.e. PvuII (α and γ subunits), BglII (β subunit) or FspI (hA1a). After 
purification of the linearized plasmid with the QIAQuick Gel Extraction Kit (Qiagen), 
complementary RNAs of each α, β, γ ENaC or hA1a subunits were synthesized in vitro for 1 
h at 40 °C in a solution containing: 5 mM 5' RNA 7-methylguanosine cap (Promega), that 
protects RNA from RNases, 5 mM A/C/UTP, 1 mM GTP (Pharmacia Biotech), 400 ng/μl 
  59
BSA (Promega), 52 U RNAse Inhibitor (Promega), 100 mM DTT (Promega), 30 U SP6 RNA 
Polymerase (Promega) and its reaction buffer 1X. At the end of the transcription, DNA was 
removed by 1 h incubation with 10 U RNase-free DNase (Promega). RNAs were then 
purified with the RNEasy® kit of Qiagen and kept at -70 °C. 
 
Expression in Xenopus laevis Oocytes. Healthy stage V and VI Xenopus laevis oocytes 
were pressure-injected with either 100 nl of a solution containing equal amounts of α, β and γ 
ENaC subunits RNAs or 100 nl of hA1a subunit cRNA at a total concentration of 100 ng/μl. 
For standard experiments, oocytes were kept at 19°C in a low-Na+ modified Barth’s saline 
(MBS) solution: (in mM) 10 NaCl, 0.82 MgSO4, 0.41 CaCl2, 0.33 Ca(NO3)2, 80 NMDG, 2 
KCl and 5 HEPES, pH 7.2. MBS solution was supplemented with antibiotics: 10 μg/ml 
penicillin and 5 μg/ml streptomycin. 
 
Two-Electrode Voltage Clamp. Electrophysiological measurements were made 16-30 
hours after injection. Sodium currents were recorded using the two-electrode voltage-clamp 
(TEV) technique (model TEV-200; Dagan Corp.). TEV measurements were carried out by 
placing the oocyte in a bath perfused with different solutions and impaled with two electrodes 
(Figure 19). One electrode measures the membrane potential (Vm) and the second one injects 
the current necessary to maintain the desired potential that would otherwise be modified by 
the channel activity. The two electrodes are realized using micropipettes containing a 1 M 
KCl solution. All electrophysiological experiments were performed at room temperature (22-
25 °C). For ENaC, the holding potential was -100 mV. Oocytes were maintained in a 
recording chamber continuously perfused with a standard bath solution containing in mM, 
120 NaCl, 2.5 KCl, 1.8 CaCl2-2H2O and 10 HEPES-NaOH, pH 7.2. The amiloride-sensitive 
currents, defined as the difference in currents measured before and after addition of 10 μM 
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amiloride (Sigma-Aldrich) in the bath, were considered as ENaC-mediated macroscopic INa+. 
For hASIC1a sodium current measurements, we used a holding potential at -80 mV. The 
control solution at physiological pH contains in mM, 120 NaCl, 2 MgCl2, 10 HEPES*H+, 
adjusted at pH 7.4 with N-Methyl-D-Glucosamine (NMDG). The acidic solution for the 
activation of hA1a contains in mM, 120 NaCl, 2 MgCl2, 10 MES and pH 6.0 is adjusted with 
NMDG. For each oocyte expressing hA1a, three to four activations were performed at 40 
seconds intervals. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Two-Electrode Voltage Clamp (TEV) set-up. 
 
Cut-Open. The cut-open technique allows the recording of macroscopic currents while 
both the inside and the outside of the oocyte are continuously perfused. Xenopus oocytes are 
placed in an experimental holder divided in three chambers (Figure 20). The superior pole of 
the oocyte is in contact with the upper chamber and perfused with the extracellular solution. 
The lower pole is impaled by a microperfusion pipette used as well as microelectrode. The 
external (upper) and the internal (lower) compartments are electrically isolated by the guard 
compartment. The voltage clamp was performed using a Dagan cut-open oocyte voltage 
clamp apparatus (Dagan Corporation, Minneapolis, MN; model CA-1 high performance 
oocyte clamp). 24 hours after RNA injection, oocytes were perfused intracellularly with either 
a control or a 1 mM MTSEA-biotin or Maleimide-PEO2-Biotin solution and the sodium 
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current was measured. In cross-linking experiments, oocytes were perfused with either 1 mM 
DTME, 10 μM BMOE or 10 or 20 mM NaTT. 
To test if the MTSEA-biotin-mediated biotinylation specifically involved cysteines 
modification, some experiments were performed with oocytes perfused with a solution 
containing 1 mM MTSEA-biotin with or without 5 mM free cysteines (L-Cysteine*HCl, pH 
7.35 with NMDG, Fluka). 
 
 
 
 
 
 
 
 
 
 
Figure 20: Cut-Open set-up. 
 
Surface biotinylation. 16 - 30 h hours after RNA injection, oocytes were incubated in 1 
ml of Biotinylation buffer (10 mM triethanolamine, 150 mM NaCl, 2 mM CaCl2, pH 9.5) 
containing 1 mg/ml NHS-SS-Biotin for 15 min, at 4 °C. Oocytes were washed twice and then 
incubated 5 min, at 4 °C, with 2 ml of Quench buffer (192 mM glycine, 25 mM Tris-HCl pH 
7.5 in MBS) in order to quench remaining free NHS-SS-Biotin. Finally, oocytes were washed 
two times with MBS and used for pull-down assays as described below. 
 
Pull-Down assay. From the cut-open experiments, 12 perfused oocytes per condition 
were lysed with 20 μl of lysis buffer (1 % triton X-100, 500 mM NaCl, 5 mM EDTA, 50 mM 
Tris-HCl pH 7.5, 1 mM PMSF and 10 μg/ml of each Leupeptin, Pepstatin and Aprotinin) per 
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oocyte. From surface biotinylation, 40 oocytes per condition were lysed with 20 μl of lysis 
buffer per oocyte. Oocytes were vortexed and centrifuged for 10 minutes at 13,000g (4 °C). 
The intermediate phase was delicately withdrawn with a pipette and transferred to a new tube. 
Protein concentrations in each of the lysates were determined using a Bradford reagent (Bio-
Rad Protein Assay Dye Reagent Concentrate) and absorbance at 595 nm was read with a 
spectrophotometer. Lysates were diluted as required with lysis buffer to obtain the same 
protein concentration in all samples. A sample of each lysate was kept as a control of “total 
lysate fraction”. The rest of the lysate was incubated overnight (ON) with 40 μl of 
streptavidin beads (Immunopure Immobilized Streptavidin Gel, Perbio) at 4 °C. After 
centrifugation (2,500 rpm, 4 °C), a fraction of supernatant was kept to analyze the “unbound 
fraction”. The beads were washed three times with lysis buffer. Sample buffer (25 mM DTT, 
final) was added to beads, unbound fractions and total lysate fractions. Each fraction was 
heated for 5 min at 95 °C. In order to separate the eluted protein from the beads, the bead 
suspension was transferred to a minicolumn fitted with a microporous sieve and the protein 
was recovered in a new tube by centrifugation. 
 
 
 
 
 
 
 
 
 
 
Figure 21: Principle of the Pull-Down assay. MTSEA is coupled to biotin in order to keep 
specifically the proteins bound to the MTSEA via the specific interaction biotin-streptavidin. 
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To test the DTT-sensitivity of MTSEA-biotin-mediated biotinylation of channels 
subunits, we boiled part of the total lysates at 95 °C in the presence of 2 % SDS and 10 mM 
DTT for 5 minutes, followed by several minutes in ice, before the streptavidin beads 
incubation. Another part of total lysates was boiled at 95 °C, for 5 min, in presence of 2 % 
SDS but without DTT as a control for DTT effect. To be sure that DTT will not disturb the 
interaction between biotin and streptavidin beads, the lysates were 1/10 diluted with lysis 
buffer. Thus incubation of proteins with streptavidin beads finally occurred in presence of 0.2 
% SDS and 1 mM DTT. 
 
Western-Blot, Infrared detection (Odyssey® Li-Cor®). Proteins were resolved by SDS-
Polyacrylamide Gel Electrophoresis (SDS-PAGE), on 5-15% acrylamide gradient minigels. 
ENaC and ASIC subunits were well resolved by 50-55 minutes migration at 200 V. In order 
to visualize proteins in the gel before blotting, gels contained 1% Trichloroethanol (Fluka 
Chemika, Buchs, Switzerland), a molecule which reacts with tryptophan residues when 
activated by UV light (74). The modified Trp is fluorescent and the conjugated proteins in a 
gel can be thus visualized under UV light at the same wavelength as that used to trigger the 
reaction. After UV visualization, proteins were transferred onto nitrocellulose membranes at 
100 V, during 3 h. Transferred proteins were visualized by Ponceau Red staining. Membranes 
were then blocked in a 0.1 % (w/v) casein solution for 1 h in order to reduce non-specific 
signal and incubated over-night in the presence of specific first antibodies. The day after, 
membranes were thoroughly washed in TBS, 0.1% Tween , re-blocked in 0.1 % casein 
solution and incubated for 1 h with the secondary antibody (anti-rabbit IRDyeTM 800 CW 
(LiCor), 1/10000 dilution). After rinsing, membranes were scanned with the Odyssey® 
Infrared Imaging System. 
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Data analysis. Results are reported as means ± SEM and represent the average of n 
independent experiments in each of which the average amiloride-sensitive Na+ current INa+ 
was calculated from measurements carried out with twelve to fourty individual oocytes 
originating from different frogs. 
 
Molecular modeling. Gouaux's group kindly provided us the pdb file with the coordinates 
of their crystallized chicken truncated ASIC 1 (cΔASIC1) (61). This file is readable with the 
Swiss Pdb Viewer software (46), a software utility which also allows browsing of a rotamer 
library in order to model the structural changes resulting from amino acid replacements 
introduced in the native sequence. The current side chain is replaced by the "best" rotamer of 
the new amino acid. The "best" rotamer is the one that totalizes the "lowest" score according to 
the formula (Nb=Number): 
score = (4 x Nb Clash with backbone N CA and C atoms) + (3 x Nb Clash with backbone 
O atoms) + (2 x Nb Clash with side chains atoms) - Nb H bonds - 4 x Nb SS bonds 
Distances between each residue at position 445, called 'd1', 'd2' and 'd3', in each of the 
three subunits constituting the cΔASIC1 channel were determined with the Swiss Pdb Viewer 
software. Calculation of area delimited by the three amino acids at position 445, an estimation 
of the pore diameter at the level of this amino acid, was performed using Heron's formula: 
Area = √[s(s-'d1')(s-'d2')(s-'d3')] with s = 1/2 ('d1' x 'd2' x 'd3') 
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RESULTS 
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This study was based on previous findings reporting that the S589C mutation in the 
selectivity filter of αENaC renders the channel permeant to divalent cations and sensitive to 
external cadmium (Cd2+) inhibition. We wanted to determine the molecular mechanisms 
involved in the ion permeation and the structure of the internal pore. We have shown that the 
external Cd2+-mediated inhibition of the mutated channels αS589Cβγ is not due to the 
coordination of Cd2+ ions with the thiol group of the side chain of α589C as previously 
proposed (112). Indeed external Cd2+ ions also irreversibly inhibited mutated channels 
αS589Dβγ, αS589Nβγ and αS589Aβγ although it is known that Cd2+ has little affinity for Asn 
and Ala residues. This suggests that the backbone of αSer589 lines the ion pore, rather than its 
side chain. An example of side chain oriented toward the channel lumen is the amiloride 
binding site, αSer583. Indeed, mutation αS583C renders the channel sensitive to Cd2+ 
inhibition in a reversible manner, in contrast to mutation αS583N insensitive to Cd2+. 
Moreover, the Cd2+ block of αS589C, -D, and -N βγ mutants is prevented by amiloride showing 
that the Cd2+ binding site is located beyond that of amiloride. We have shown that the native 
cysteine residue γCys546, in the TM2 of γENaC, is the Cd2+ binding site involved in the 
external Cd2+ block of the mutated channel. In conclusion, we propose that the side chain of 
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αSer589 is not oriented toward the lumen pore and that substitution of the selectivity filter 
residues with larger amino acid allows the enlargement of the pore, as previously reported (63). 
Thus Cd2+ can go through the ion pore until the γCys546 native residue with which it 
coordinates leading to the block of the ion conduction pore. 
Cadmium Trapping in an Epithelial Sodium Channel
Pore Mutant*
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CH-1005 Lausanne, Switzerland
The putative selectivity filter of the epithelial sodium channel
(ENaC) comprises a three-residue sequence G/SXS, but it
remains uncertainwhether the backbone atomsof this sequence
or whether their side chains are lining the pore. It has been
reported that the S589C mutation in the selectivity filter of
ENaC renders the channel sensitive to block by externally
applied Cd2; this was interpreted as evidence for Cd2 coordi-
nation with the thiol group of the side chain of 589C, pointing
toward the pore lumen. Because theS589Cmutation alters the
monovalent to divalent cation selectivity ratio of ENaC and
because internally applied Cd2 blocks wild-type ENaC with
high affinity, we hypothesized that the inhibition of S589C
ENaC by Cd2 results rather from the coordination of this cat-
ion with native cysteine residues located in the internal pore of
ENaC.We show here that Cd2 inhibits not only ENaC S589C
and S589D but also S589N mutants and that Ca2 weakly
interacts with the S589Dmutant. The block of S589C, -D, and
-Nmutants is characterized by a slow on-rate, is nearly irrevers-
ible, is voltage-dependent, and can be prevented by amiloride.
The C546S mutation in the second transmembrane helix of 
subunit in the background of the ENaC S589C, -D, or -N
mutants reduces the sensitivity to block byCd2 and renders the
block rapidly reversible. We conclude therefore that the block
by Cd2 of the S589C, -D, and -N mutants results from the
trapping of Cd2 ions in the internal pore of the channel and
involves Cys-546 in the second transmembrane helix of the
ENaC subunit.
The epithelial sodium channel (ENaC)3 mediates the Na
ion influx across the apical membrane of tight epithelia such as
the aldosterone-sensitive distal nephron, the distal colon, or the
airways epithelium (1). In principal cells of the aldosterone-
sensitive distal nephron, the ENaC-mediated influx ofNa ions
constitutes the apical step of the transepithelial Na absorption
and is regulated by aldosterone (2). The aldosterone-sensitive
distal nephron plays an important role in the maintenance of
Na homeostasis, the regulation of extracellular volume, and
blood pressure (3). In the lungs, ENaC together with cystic
fibrosis transmembrane conductance regulator controls the
height of the airway surface liquid that forms a thin layer coat-
ing the airways epithelium, which contributes to the clearance
of particles and microbes (4).
Functional ENaC at the cell plasma membrane is a hetero-
meric protein made of homologous , , and  subunits
arranged pseudosymetrically around a central channel pore,
presumably in a 2, 1, and 1 configuration (5, 6). EachENaC
subunit is made of two transmembrane helices (TM1 and
TM2), a large extracellular loop that represents more than half
of the mass of the protein, and intracellular N and C termini.
The ENaC subunits belong to the ENaC/degenerin superfamily
of ion channels but share no sequence homology with other
tetrameric channels alsomade of two transmembrane domains,
such as inward rectifier K channels.
In the absence of crystal structures of members of the ENaC/
degenerin ion channel family, our understanding of mecha-
nisms and structures involved in the ion permeation is quite
limited. The amino acid sequence preceding the second trans-
membrane domain (TM2) constitutes the outer channel pore
(pore region in Fig. 1) where the pore blocker amiloride binds
(Ser-583, Gly-525, Gly-537 in rat ENaC sequence, see Fig.
1) (7). Secondary structure predictions conform the TM2 to an
 helix (8). The amiloride binding site is located external and
upstream to the selectivity filter with an amino-to-carboxyl
sense. The conserved three-amino acid sequence G/SXS (587–
589 in rat ENaC) that is essential tomaintain the high selectivity
of ENaC for Na over K or Ca2 ions is considered therefore
a key element of the selectivity filter (9). It has been proposed
that the increase in permeability to K and NH4 resulting
frommutations ofSer-589 reflects changes in the geometry of
the pore segment comprising the selectivity filter that allow it to
accommodate larger cations (10). The molecular basis of the
interaction between the permeant Na2 or Li2 ions and oxy-
gen atoms at the binding site is not yet clear. Recent experi-
ments reported that the serine 589 to cysteine substitution in
the  subunit (S589C) confers to ENaC a sensitivity to block
by external Cd2 ions, whichwas interpreted as evidence for an
orientation of the side chain of serine 589 toward the lumen of
the channel pore (11).
ENaC and the K channel KcsA share a similar membrane
topology and a heterotetrameric structure made of homolo-
gous subunits comprising two transmembrane segments. The
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defrayed in part by the payment of page charges. This article must there-
fore be hereby marked “advertisement” in accordance with 18 U.S.C. Sec-
tion 1734 solely to indicate this fact.
1 Recipient of a fellowship from the Novartis Foundation (05B41).
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ing ion channel; MTS, methanethiosulfonate; TM1/TM2, transmembrane
segment 1/2.
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conduction pore of ENaC appears to be, however, quite differ-
ent from that of the members of the K channel superfamily.
The amino-terminal portion of the pore region in the KcsA
forms an  helix (pore helix) pointing from the outside toward
the center of the channel (12). Following this pore helix, the
amino acid stretch lining the selectivity filter folds back toward
the external surface, exposing binding sites for external block-
ing ligands such as toxins or triethanolamine (TEA). In ENaC,
the pore region points from the outside to the center of the
channel with an amino-to-carboxyl sense of, successively, the
amiloride binding site, the selectivity filter, and the TM2 (1).
These important differences in the pore organization indi-
cate that the three-dimensional structure of the KcsAK chan-
nel does not represent an adequate template to understand ion
permeation through ENaC. The pore-lining residues beyond
the selectivity filter that constitute the internal channel pore
remain to be identified in channels belonging to the ENaC/
degenerin family, for which only a few studies have been per-
formed to determine the accessibility of inner pore lining resi-
dues. Recent work has shown that, in contrast to the acid-
sensing ion channel (ASIC), another member of the ENaC/
degenerin family, ENaC is highly sensitive to intracellularly
applied sulfhydryl reagents such as Cd2, Zn2, or methaneth-
iosulfonates (MTS). Cysteine residues in the N terminus of
ENaC contribute to inhibition by MTS reagents (13). Similar
inhibition of ASIC by internal sulfhydryl reagents can be repro-
duced in ASIC mutants in which cysteines have been intro-
duced at the N terminus and in the 5-start of the TM1 (14).
Altogether, these observations suggest that the N terminus and
the internal part of TM1 participate in the pore lining of ENaC.
In this study we have revisited the mechanism of channel
blockade by external Cd2 in ENaC mutants with amino acid
substitutions in the selectivity filter (S589C) (11). We show
that, in order to block ENaC, Cd2 has to bind to distinct sites
deep in the channel pore, including a cysteine residue in the
TM2 of ENaC subunits.
MATERIALS ANDMETHODS
Site-directed Mutagenesis, Expression in Xenopus laevis
Oocytes, and Electrophysiology—The ENaC constructs used for
this study were taken from a previous study (10, 13). Comple-
mentary RNAs of each , ,  subunit were synthesized in vitro
with SP6 RNApolymerase fromwild-type andmutant,, and
ENaC cDNA encoding vectors previously linearized with
PvuII ( and  subunits) or BglII ( subunit).
Healthy stage V and VI X. laevis oocytes were pressure-in-
jected with 100 nl of a solution containing equal amounts of ,
, and  ENaC subunits at a total concentration of 100 ng/l.
For standard experiments, oocytes were kept at 19 °C in a low
Na-modified Barth’s saline: inmM, 10NaCl, 0.82MgSO4, 0.41
CaCl2, 0.33 Ca(NO3)2, 80 NMDG, 2 KCl, and 5 HEPES, pH 7.2.
Electrophysiological measurements were made 16–30 h
after injection. ENaC current (INa) was recorded using the
two-electrode voltage-clamp technique (model TEV-200;
Dagan Corp.). Holding potential was100mV. The amiloride-
sensitive currents defined as the difference in Imeasured before
and after addition of 10 M amiloride (Sigma-Aldrich) in the
bath were considered ENaC-mediated macroscopic INa. All
electrophysiological experimentswere performed at room tem-
perature (22–25 °C). Oocytes were maintained in a recording
chamber continuously perfused with a standard bath solution
containing in mM, 120 NaCl, 2.5 KCl, 1.8 CaCl2-2H2O, and 10
HEPES-NaOH, pH 7.2. For cadmium block experiments, 0.01,
0.1, 1, or 10 mM Cd2 was freshly added to the perfusion solu-
tion. Results are reported as means  S.E. and represent the
mean of n independent experiments in which the average
amiloride-sensitive Na current INa was measured for four to
ten individual oocytes originating from different frogs.
Analysis of the Data—Data obtained from the time course of
INa decrease in the presence of external Cd2were best fitted by
the sum of two exponentials. To analyze the voltage depend-
ence curve of the INa current of the ENaCmutant, the ratio I/I0
measured in presence (I) of 1 or 3 mM Cd2 to that in the
absence of the Cd2 (I0) is described by theWoodhull equation
(15) as shown in Equation 1
Pun  I/I0 KB0expzFV/RT/B	 KB0expzFV/RT
 (Eq. 1)
where Pun is the probability that the binding site of Cd2 is
unblocked; KB(0) is the equilibrium dissociation constant at 0
mV; [B] is the blocker concentration; z is the slope parameter;
F, the Faraday’s constant;V, the applied voltage; R, the gas con-
stant, and T, the absolute temperature. Moreover, z is equal to
the product of the actual valence of the blocking ion z and the
fraction of the membrane potential (or electrical distance) 
acting on the ion: z  z.
RESULTS
It has recently been reported that serine-to-cysteine substi-
tution at position 589 in ENaCmakes the channel inhibitable
by external Cd2 (11). The block of ENaC S589C mutant by
Cd2 shows an unusual slow on-rate (kon  1000 M1s1), as
well as a slow and incomplete recovery of ENaC activity after
external Cd2 removal. This was interpreted as evidence for
Cd2 coordination with the thiol group of the side chain of the
cysteine at position 589 (11).
Ser-589 is located in the selectivity filter sequence
G587S588S589 of rat ENaC (see Fig. 2), and its mutation drasti-
cally changes the ion selectivity of the channel (9, 10). We
hypothesized that these unusual characteristics of block by
Cd2 are due to the trapping ofCd2 ions in the internal pore of
the channel, i.e. downstream the selectivity filter as far as the
channel opening to the cytosol. Twoprevious observations sup-
port this hypothesis. First, the S589C mutation makes the
FIGURE 1. Sequence alignment of the pore region of the , , and  sub-
units of rat ENaC including the amiloride binding side and the channel
selectivity filter, followed by the second transmembrane domain (TM2).
According to current prediction models (PredictProtein) (8), the TM2 seg-
ment conforms an  helix starting at the conserved Val residue at a position
corresponding to 590 in the ENaC sequence, whereas the secondary struc-
ture of the pore region is not defined.
ENaC Conduction Pore
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channel permeable to divalent cations such as Ca2 and possi-
bly also to Cd2, which has a smaller ionic radius than the
former (9). Second, we have recently reported that, in both
inside-out patch and in cut-open oocytes, Cd2 applied at
micromolar concentrations to the intracellular side of ENaC
blocks the channel; this block was characterized by a slow and
partial recovery upon removal of Cd2 (13).
To determine the requirement of a thiol side chain at posi-
tion 589 for the binding of external Cd2 and the inhibition
of ENaC, we tested its effect on different substitution
mutants, e.g. S589C, S589D, S589N, and S589A. Cd2
ions are known to bind the sulfhydryl group of cysteine or
the fully charged oxygen atoms contributed by glutamate or
aspartate side chains; however, Cd2 has little affinity for
side chains of asparagine. Fig. 2 shows representative record-
ings of ENaC-mediated amiloride-sensitive currents (INa)
and their inhibition by external Cd2. Cadmium at 0.1 or 1
mM inhibits the INa generated by ENaC S589C, S589D,
and S589N mutants (Fig. 2, A–C). A higher concentration
of Cd2 (10 mM) is required to inhibit the S589A mutant
(Fig. 2D), whereas wild-type ENaC remains insensitive to
inhibition by Cd2 (Fig. 2E).
The blockade of ENaC Ser-589 mutants by Cd2 slowly
reaches equilibrium. This is particularly evident for low con-
centrations of Cd2 and for theS589Nmutant, which appears
slightly less sensitive to Cd2 than the S589C and S589D
counterparts. It was difficult to determine the true affinity of
the Ser-589 mutants for Cd2 because at low Cd2 concen-
trations the blockade equilibrium was still not reached after
several minutes. At a higher concentration of Cd2 (1 mM) the
rate of channel inhibition is faster and the block almost com-
plete after 1 min. This contrasts with the fast kinetics of inhibi-
tion of the S583C ENaC mutant by Cd2 at concentrations
varying from 0.01 to 1mM (IC50 0.105 0.0012mM, n 10):
external Cd2 rapidly reduces the current level in a dose-de-
pendent manner without changes in the on-rate of channel
blockade (Fig. 3). By contrast to the S589N, the S583N
mutant is insensitive to inhibition by external Cd2. There is
strong evidence that the side chain of the cysteine at position
Ser-583 is oriented toward the channel lumen, allowing Cd2
to bind in the external pore and to block the channel (16, 17). It
also shows that Asn does not bind Cd2 at any of the assayed
concentrations, and we conclude therefore that the lower sen-
sitivity of the S589N mutant to Cd2 inhibition probably
results from a decreased permeability to this cation as com-
pared with that of the other 589 mutants. Moreover, the dis-
crepancy between the Ser-589 and Ser-583 mutants regard-
ing their sensitivity to Cd2 and the kinetics of block indicate
that themechanism of ENaC inhibition by Cd2 is different for
the two mutants.
The on-rate of channel inhibition by Cd2 of the S589C,
-D, -N, and -Amutants is summarized in Fig. 4; the best fit of
the data were obtained using the sum of two exponentials,
consistent with two components of the ENaC block with a
fast and a slow rate constant (Table 1). The data also show
that increasing Cd2 concentrations between 0.01 and 1 mM
affect predominantly the time required to reach the equilib-
rium rather than the magnitude of current inhibition. From
the extrapolation of the best fit of Ser-589 channel inhibi-
tion, we can predict that, at equilibrium, the half-maximal
inhibition (IC50) for Cd2 is largely below 0.1 mM for the
S589C, -D, and -N mutants, suggesting a high affinity site
for the Cd2 binding site. However, the slow on-rate of the
Cd2 block points to the presence of important diffusional
constraints in the Ser-589 mutants for Cd2 ions to bind at
its blocking site. Interestingly, the conserved S589A substi-
tution, which only slightly modifies the cation selectivity of
the channel compared with the S589C, -D, and -Nmutants,
shows the slowest on-rate of Cd2 block.
FIGURE 2. Current inhibition of the Ser-589,, mutants by external
Cd2. Representative tracings ofmacroscopic ENaC (INa) currents obtained in
oocytes injected with ENaC S589C,, (A); S589D,, (B); S589N,,
(C);S589A,, (D); or,,wild-type (E). Removal of amiloride (10M) in the
bath induced a robust inward Na current. The addition of 0.1 or 1mM exter-
nal Cd2 (A–C) decreased INa, whereas 10 mM Cd
2 decreased INa of the
S589A,, (D). The wild-type ENaC (E) remained insensitive to 10 mM
cadmium.
FIGURE3. InhibitionofS583C,,mutantbyexternal Cd2.A, represent-
ative tracings ofmacroscopic ENaC (INa) currents recorded in oocytes injected
with EnaC ,,, S583C,,, or S583N,, at increasing concentrations of
Cd2. B, dose-dependent inhibition of INa of theS583C,, () by Cd
2 com-
pared with the wild type (E) and the S583N,, (Œ). Fit of the data () was
obtained by simple Langmuir isotherm and gave a KD for Cd
2 of 0.105 
0.0012 mM.
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Wehavealso tested theabilityofZn2 toblockS589C, -D, and
-NENaCmutants (Fig. 5).We observed that Zn2, at similar con-
centrations, shows inhibition curves of INa that are superimpos-
able to those obtained for Cd2, indicating similar blocking kinet-
ics for Cd2 andZn2.We do not have any sound explanation for
the stimulatory effect of external Zn2 (1mM) on ENaCwild type.
Another particularity of the blockade of the S589C mutant
by Cd2 is the slow and partial recovery from inhibition. We
asked whether differences may exist
in the dissociation of Cd2 from its
blocking site (off-rate) among the
S589C, S589D, and S589N
mutants. The tracings in Fig. 6A
compare the S589C, -D, and -N
mutants with respect to the recov-
ery from amiloride and Cd2 block.
The recovery from the channel inhi-
bition by amiloride is rapid and
nearly complete, whereas the recov-
ery fromCd2 blockade is consider-
ably slower and incomplete. The
amount of INa recovered 2 min after
removal of external Cd2 was simi-
lar for the three Ser-589 mutants
(Fig. 6C), indicating that coordina-
tion of Cd2 at position 589 is not
responsible for its slow dissociation
rate. In comparison, the recovery
from blockade by Cd2 of the
S583C mutant is rapid and fully
reversible (Fig. 6, B and C). These
experiments further support our
hypothesis that the mechanism of
block of the Ser-589 mutants by
Cd2 differs from the block of the
S583C that involves direct coordi-
nationwith the sulfhydryl side chain
of the cysteine. Residues other than
Cys or Asp introduced at position
Ser-589 likely participate in the
channel inhibition by external Cd2.
It can be argued that mutations
at Ser-589 create a novel binding
site that allows inhibition of INa by Cd2 independently of
the diffusion of this cation into the pore. However, if Cd2
has to bind within the pore in order to block the channel, this
inhibition should be prevented by the pore blocker amilo-
ride. To test this hypothesis we took advantage of the slow
and partial reversibility of ENaC block by Cd2 and meas-
ured the recovery of INa from channel inhibition by Cd2
when amiloride was simultaneously added to the external
medium. Fig. 7A shows that the INa of the S589C, -D, and -N
mutants exposed to 1mMCd2 in the presence of amiloride (10
M) in the bath solution recovered rapidly and almost com-
pletely after removal of both blockers. These experiments dem-
onstrate that amiloride prevents the irreversible inhibition of
Ser-589 mutants by Cd2. These results are summarized in
Fig. 7B in which it can be seen that the INa recovered after
ENaC inhibition by amiloride and Cd2 was identical to INa
after the same control period. The interpretation of these
results is that upon binding to its receptor at the external
entrance of the channel pore (see Fig. 1), amiloride prevents
the access of Cd2 to its binding site located beyond that of
amiloride. We conclude that in the S589N, as in the
S589C or -D mutants, Cd2 likely binds to cysteine resi-
FIGURE 4. Time course of inhibition of ENaC current (INa) by Cd
2 in oocytes expressing the mutants
S589C,, (n 12) (A), S589D,, (n 6) (B), S589N,, (n 11) (C), or S589A,, (n 6) (D) or
expressing ENaCwild-type (open symbols). Inhibition curves were obtained with Cd2 0.01mM (), 0.1 mM
(F), 1 mM (f), and 10 mM (9) for ENaC mutants and concentration up to 1 mM of Cd2 for the wild type. Data
were best fitted by the sum of two exponentials, and results are listed in Table 1.
TABLE 1
Rate constants of the inhibition of ENaCmutants by external Cd2
Rate constants were obtained from data on Figs. 4 and 5. Best fit of the data was
obtained with the sum of two exponentials, except for inhibition of S589D and
S589C by low (0.01 mM) concentration of Cd2.
Rate constants
S589D S589C S589N S589A
k1 k2 k1 k2 k1 k2 k1 k2
mM min1
Cd2	
0.01 0.419 0.190
0.1 3.506 0.478 2.166 0.160 0.746 0.097
1.0 9.181 1.815 10.21 0.927 2.5327 0.394
10.0 5.924 0.081 1.260 0.066
Zn2	
0.1 6.48 1.39 1.290 0.149 0.782 0.313
1.0 6.87 0.4 5.950 0.749 2.623 0.608
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dues within the channel pore at a site downstream or deeper
relative to the amiloride binding site.
For positively charged pore blockers binding within the trans-
membrane pore region, the large electric field across the mem-
brane provides the energy to move the blocker along the channel
pore. If Cd2 binds within the transmembrane electric field, we
expect the inhibition of Ser-589 ENaCmutants by Cd2 to be
dependent on voltage across the membrane. Fig. 8 shows the
INa inhibition of the S589N and S589C mutants by 1 and 3
mM extracellular Cd2 at transmembrane voltages ranging
from120 to 0 mV. Inhibition of both mutants by Cd2, arbi-
trarily determined 40 s after application, was clearly dependent
on voltage, with a stronger inhibition at negative holding poten-
tials. According to Woodhull’s formulation, the slope parame-
ter z is equal to the product of the actual valence of the blocking
ion (2 for Cd2) and the fraction of the electrical distance, ,
acting on Cd2 at the binding site. The  values of 0.34 0.05
and 0.42 0.05 calculated for the voltage dependence of Cd2
block of S589N and S589C, respectively, represent apparent
relative distances in the electric field, because they were not
determined at equilibrium. Still our data clearly indicate that
Cd2 binds to a site within the transmembrane electric field
that is indistinguishable for both mutants.
So far, our analysis of the current inhibition of ENaC Ser-
589 mutants by Cd2 reveals that this cation binds to a site in
the channel pore located deeper than the amiloride binding site
and that the contribution of the substituted residue at position
589 in coordinating Cd2 ions to block the channel is not
essential since the S589N substitution also confers to the
channel a sensitivity toCd2.We further investigated this point
by probing the S589D mutant with external Ca2 and looked
FIGURE 5. Time course of inhibition of ENaC current (INa) by Zn
2 in oocytes
expressing S589C,, (A), 589D,, (B), or S589N,, (C) (closed sym-
bols) compared with oocytes expressing ENaC wild-type (open symbols).
Inhibition curves were obtainedwith Zn2 concentrations of 0.1mM (circle) or 1
mM(square).Datawerebest fittedbythesumof twoexponentials, andresultsare
given in Table 1. n 4.
FIGURE 6. Slow and partial recovery of ENaC currents from Cd2 block.
A, Oocyteswere injectedwithS589C,,,S589D,,, orS589N,,. Removal
of amiloride induced a large and reversible INa. The addition of 1mMCd
2 inhib-
ited INa thatslowlyandpartially recoveredafterCd
2 removal.B,oocytesexpress-
ing S583C,, show a rapid and complete recovery of INa after inhibition by 1
mMCd2. Scale, x-axis, 1min; y-axis, Cys, 3A, Asp, 5A, Asn 7A (A), 13A (B).
C, normalized INabefore,during, and2minafter applicationofCd
2 (1mM) in the
bath (n 20).
FIGURE 7. The nearly irreversible INa inhibition by Cd
2 is prevented by
amiloride. A, oocytes expressing S589C,,, S589D,,, or S589N,,,
were exposed to external Cd2 (1 mM) in the presence of 10M amiloride; INa
completely recovered after removal of Cd2 and amiloride. Scale, x-axis, 1
min; y-axis, Cys, 3A,Asp, 5A,Asn, 3A.B, recoveryofCd2 inhibition in the
presence of amiloride (n 6).
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for binding interactions between Ca2 and the engineered
aspartate side. The Ca2 ions have an ionic radius comparable
with Cd2 or Zn2. As shown in Fig. 9, Ca2 at 10 mM in the
externalmedium exerts only amodest inhibition of theS589D
mutant (25% inhibition of INa) compared with Cd2 or Zn2
(Figs. 4 and 5). Furthermore, in contrast to Cd2, the weak
block by Ca2 was rapidly and completely reversible.
Taken together, our experimental evidence does not support
the participation of the side chain of the amino acids at position
Ser-589 in coordinating Cd2, Zn2, or Ca2 ions, although
such interaction cannot be firmly excluded in the absence of
structural data. It seems more likely that the inhibition of the
S589C, -D, or -N substitution mutant by Cd2 or Zn2 is due
to coordination with native cysteines in the internal pore of
ENaC that become accessible to Cd2 and Zn2, due to the
Ser-589 mutation in the channel selectivity filter.
There are a large number of cysteines in the -, -, and
ENaC sequences that represent potential binding sites for
Cd2 ions in the internal pore of the channel. We have limited
our analysis to conserved regions of the N terminus, the TM1
and TM2 transmembrane segments that involve 13 cysteine
residues. We initially planned to substitute all the 13 cysteines,
but we quickly realized that we were unable to generate a func-
tional channel in the background of the S589N mutation
whenmore than 5 substituted cysteines weremutated in -, -,
or ENaC subunits.
We have performed a first screen with different ENaC
mutants in which native cysteines were substituted individually
or in pairs in the S589Nmutant background.We have identi-
fied Cys-546 as a potential binding site for Cd2. Recordings
in Fig. 10, A–C, show the time course of Cd2 inhibition of the
S589C, -D, and -N mutants with the substitution of the native
cysteine to serine at position Cys-546 in ENaC. When com-
pared with the tracing in Fig. 2, the INa inhibition by 0.1 mM
Cd2 was almost negligible for the S589C/D,,C546S
mutants and considerably reduced at 1 mM for the
S589N,,C546S. Fig. 10 (bottom in each panel) displays the
effect of the C546S mutation on the time course of INa inhibi-
tion by Cd2 of the S589C, -D, -N mutants. At all the Cd2
concentrations tested, the C546S substitution decreases the
magnitude of the INa inhibition by Cd2, but current inhibition
persists at high Cd2 concentrations. Such INa inhibition in the
presence of Cd2 is expected for a channel mutant with a per-
meability to Cd2 ions that is lower than for Na ions since the
slower diffusion of Cd2 along the pore will consequently
reduce as well that of Na.
We asked whether the lower sensitivity of the C546S
mutant to block by Cd2 might be related to a faster dissocia-
tion rate from its binding site and tested the recovery of the
S589C,,C546S, S589D,,C546S, and S589N,,C546S
mutants from Cd2 block at millimolar concentrations. INa
recordings of the S589C,,C546S, S589D,,C546S, and
S589N,,C546S mutants in Fig. 11A show that, after the
Cd2-dependent decrease in INa, removal of external Cd2
allowed a fast and almost complete recovery of INa. These
experiments show that the Cys-546 is responsible for the
almost irreversible trapping of Cd2 within the pore that leads
to the channel block.
DISCUSSION
The ENaC channel is insensitive to block by external Cd2
but is highly sensitive to block by Cd2 applied at micromolar
concentrations from the intracellular side of the membrane
(13). The cysteine substitution S589C has two major conse-
quences on channel function; first, it confers a block by exter-
nally applied Cd2 or Zn2 ions, and second, it changes the ion
selectivity of the channel (11). Mutations at position Ser-589
have been shown to drastically change the ion selectivity of
ENaC, allowing divalent cations to pass through the channel.
Detectable currents carried by divalent cations such as Sr2 or
FIGURE 8.Voltage dependence of Cd2 block in themutantsS589C,,
and S589N,,. INa inhibition is defined as the INa(Cd
2)/INa (0) ratio meas-
ured at holding potentials ranging from120mV to 0mV. INa(Cd
2) is the INa
measured 40 s after the application of either 1 mM (circle) or 3 mM (square)
Cd2; INa (0) is defined as INa in the absence of Cd
2. Data were fitted accord-
ing to the Woodhull formula (see “Materials and Methods”) yielding  values
of 0.34 0.05 and 0.425 0.05 for Cd2 block of the S589N (open symbols,
n 15) and S589C (closed symbols, n 9) mutants, respectively.
FIGURE 9.Recoveryof ENaC currents fromexternal Ca2.A, representative
recordings of INa in oocytes expressing , S589C,, or S589D,, ENaC
after the addition of 10 mM external Ca2. B, normalized INa before, during,
and after application of 10 mM Ca2 in the bath (n 12).
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Ca2 could be measured through S589C and S589D ENaC
mutants (9).
The aim of this work was to understand themolecularmech-
anism of the block of the Ser-589 ENaCmutants by extracel-
lular Cd2 and to identify the amino acid residues coordinat-
ing Cd2. We have hypothesized that external Cd2 ions are
unable to blockwild-type ENaC essentially because the channel
is impermeable to divalent cations. Rendering ENaCpermeable
to divalent cations by mutations at residues in the selectivity
filter such as theSer-589 shouldmake the channel sensitive to
block by external Cd2 in a way similar to the ENaC block by
internally applied Cd2. This approach could be applied to
identify the residues lining the conductive pore and therefore to
better understand the structure of ENaC.
It has been recently proposed that the block of the S589C
ENaC mutant by Cd2 results from the coordination of Cd2
ions with the sulfhydryl group of the
589 cysteine pointing toward the
channel pore (11). The contribution
of this cysteine site chain in coordi-
nating Cd2 ions seems question-
able since alternative Ser-589 sub-
stitutions such as S589N render
ENaC equally sensitive to block by
Cd2. Therefore, a sulfhydryl group
at serine 589 is not necessary for
Cd2 block of the S589C mutant,
and it is difficult on this basis to
draw any conclusion about the side
chain orientation of the residue at
Ser-589 relative to the channel
pore. The extremely weak inhibi-
tion of theS589Dmutant by exter-
nal Ca2 at concentrations as high
as 10 mM further supports the
absence of interaction between
divalent cations in the channel pore
and the side chain residue at posi-
tion Ser-589. It remains likely that,
as for the KcsA K channel, the
selectivity filter of ENaC is lined
essentially by the backbone atoms of
the G/SXS sequence as has been
already proposed (10).
Our observations are consistent
with a mechanism for Cd2 block-
ing of the S589C mutant that
involves a change in the selectivity
filter allowing the access for exter-
nal Cd2 ions to a binding site
within the internal pore. The block
ofS589C,S589D, andS589N by
Cd2 is characterized by a slow on-
rate and an equally slow and partial
recovery from blockade. These
blocking kinetics are clearly differ-
ent from those of S583C ENaC
block by Cd2. This latter mutant
with the substitution located in the amiloride binding site at the
outer entrance of the channel pore shows a fast and fully revers-
ible current inhibition by submillimolar Cd2 or Zn2 consist-
ent with the accessibility of the cysteine sulfhydryl group at
position 583 to permeant ions. The slow on-rate of S589C
block by Cd2 rather suggests the presence of significant diffu-
sional constraints for Cd2 to reach a site within the channel
pore where it binds nearly irreversibly and with high affinity.
This is illustrated in our experiments by the fact that the con-
centration of external Cd2 between 10 M and 1 mM mainly
affects the on-rate of block and has relatively little effect on the
maximal current inhibition.
Our experimental data provide little evidence for a direct
interaction between Cd2 and the sulfhydryl group of the cys-
teine at position 589. The question remains where does Cd2
bind? The voltage dependence of the channel block by Cd2
FIGURE10.Effectof theENaCC546Smutationon theCd2block.Effect ofC546Son theCd2block in the
background of S589C (A, n 10), S589D (B, n 5), or S589N (C, n 10). Top, representative recordings of
Cd2 block. Bottom, direct comparison of the time course of 0.1 mM (circle), 1 mM (square), or 10 mM (triangle)
Cd2 inhibition of Ser-589 mutants alone (closed symbols) or together with the C546S mutation (open
symbols).
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indicates that this cation binds within the transmembrane elec-
tric field. In addition, we provide strong evidence that Cd2
binds in the channel pore, since amiloride, the classical pore
blocker, of ENaC prevents Cd2 from blocking the channel.
Thus, Cd2 binds at a site located deeper in the channel pore
with respect to the amiloride binding site and likely beyond the
selectivity filter since theSer-589mutations altering the chan-
nel ionic selectivity are required for Cd2 block. The Ser-589 in
the ENaC is in close vicinity of the amiloride binding site cor-
responding toS583C, and experimental evidence is consistent
with Ser-589 participating in the narrowest part of the chan-
nel pore at the selectivity filter.
Our experiments support the view that the substitutions
at position Ser-589 in the ENaC subunit result in steric
modifications of the channel pore that allow externally
applied Cd2 to reach a binding site normally inaccessible
within the internal pore of ENaC located beyond the selec-
tivity filter. Wild-type ENaC is blocked by micromolar con-
centrations of Cd2 applied from the intracellular side, and
this block shares two important characteristics with the
block of S589C mutant by extracellular Cd2: it displays
both an affinity in the micromolar range and is slowly and
only partially reversible. The steric modifications resulting
from Ser-589 mutations affect the ionic selectivity of
ENaC, making the channel more permeable to K and Ca2.
It has not been possible to show that the Ser-589 mutants
are permeable to Cd2 or Zn2 ions, since both divalent
cations block the channel, but it remains very likely that the
steric modifications in the narrowest part of ENaC, due to
Ser-589 mutation, allow Cd2 ions to pass the selectivity
filter and to bind cysteine residues located along the channel
pore. In the case of wild-type ENaC, these binding sites for
Cd2 are only accessible from the intracellular side.
TheSer-589 ENaCmutants provide an interestingmodel to
identify the cysteine residues that coordinate Cd2 ions along
the ion permeation pathway. Unfortunately, in our search for
cysteines interacting with Cd2, we were limited by the low
amiloride-sensitive current of the cysteine substitution ENaC
mutants performed in the background of the Ser-589 muta-
tions. It was thus difficult to obtain a complete picture of the
cysteines lining the internal pore of the channel. However, we
identified Cys-546 in the TM2 of the ENaC subunit as a resi-
due that contributes to the channel block by Cd2. First, the
C546S mutation decreases the apparent affinity for Cd2 of a
site that is responsible for the fast component of the channel
inhibition. Second, the C546S substitutionmakes the channel
block byCd2 rapidly reversible. Such increase in the off-rate of
Cd2 blocking kinetics represents a strong argument support-
ing both a direct participation of the Cys-546 in the coordina-
tion of Cd2 ion and the orientation of the sulfhydryl group of
Cys-546 toward the ion permeation pathway. The Cys-546
residue is likely the first accessible site for external Cd2 ions,
and Cd2 binding to this site results in a channel block. The
slower component of the Cd2 block seems unaffected by
Cys-546 mutation, suggesting the presence of a deeper and
less accessible site for binding Cd2 along the internal part of
the channel pore. The Cys-546 may not be the only residue
involved in the coordinationwith Cd2 ions. The identification
of additional cysteine partners involved in binding interactions
with Cd2 ion requires the substitution of these cysteines in the
background of the Ser-589 and Cys-546 mutations. Unfor-
tunately, these ENaC constructs did not express measurable
amiloride-sensitive currents.
Even though several structural models have been pro-
posed, the structure of the ion channel pore of the members
of the ENaC/degenerin family has yet not been elucidated
(16, 18). Functional analysis of voltage-dependent blocking
of ENaC by impermeant cations supports a funnel-like struc-
ture of the external conduction pore of ENaC that can
accommodate amiloride in its outer mouth (position 583 in
the rat ENaC sequence) and then narrowing down to the
selectivity filter (G/SXS sequence, Fig. 1) (19). The primary
sequence of this pore region (Ser-583-Ser-589 in rat ENaC,
Fig. 1) does not allow reliable secondary structure predic-
tions. However, the second transmembrane domain starting
at the conserved Val residue Val-590 conforms to a highly
probable  helix (Fig. 1) (8). The side chain orientation of the
amino acid residues lining the pore region has clearly been
demonstrated for the residues involved in the binding inter-
actions with amiloride, i.e. Ser-583 in the ENaC (Fig. 1) and
the corresponding glycine residues in the  and  ENaC
subunits (17). The thiol side chains of cysteine substitutions
at positions Leu-584, Trp-585, Phe-586, and Ser-588 in the
ENaC sequence are not accessible to sulfhydryl reagents
such as methanethiosulfonates or Cd2 (16). Similar data
were obtained with cysteine substitutions on ENaC. From
our data little evidence supports the interaction between
Cd2 or Ca2 with the side chain of aspartate or cysteine,
respectively, at position 589. We have not analyzed in detail
the mechanism of block by Cd2 of the G587Cmutant, but the
characteristics of this block are basically similar to that of the
FIGURE 11. The C546S mutation affects the recovery from Cd2 block.
A, recordings of INa in oocytes expressing S589C,,C546S, S589D,,C546S,
or S589N,,C546S after Cd2 exposure (1 or 10 mM) and after Cd2 removal.
B, summary of INa recovery after Cd
2 removal. (S589C,,C546S, n  12;
S589D,,C546S, n 8; orS589N,,C546S, n 5).
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S589Cmutant (11). Thus, from this experimental evidence, the
Ser-583 appears to be the only residue in the pore region
sequence having its side chain facing the ion conduction pore
and interacting with ions present in the pore lumen. Amino
acid substitutions of the corresponding glycine in  (Gly-525)
and  (Gly-537) ENaC subunits suggest orientations of these
residues similar to Ser-583 in  subunit (17, 20).
The second transmembrane  helix likely starts with res-
idue Val-590, according to model predictions of the ENaC
subunit (Fig. 1) (8). The Cys-546 in the ENaC interacts with
permeant Cd2 ions in the background of the Ser-589
mutation, providing strong evidence that the thiol side chain
is facing the ion conduction pore. It is therefore likely that
Cys-546 is accessible to permeant ions after passing succes-
sively through the external pore and the selectivity filter.
This represents the first evidence for the contribution of the
second transmembrane segment to the internal pore lining.
A previous cysteine accessibility scan performed on ASIC1a
using methanethiosulfonates applied from the intracellular
side of the channel revealed that cysteines introduced at sev-
eral positions corresponding in the ENaC sequence to Val-
547, Ile-548, and Ile-550, as well as others located more dis-
tally in the TM2, were inaccessible to MTSET, i.e. did not
interact with internal MTSET to block the channel (14).
Thus, according to the presently available experimental evi-
dence, it seems that only the first residues in the proximal
part of the TM2 corresponding to position Cys-546 partic-
ipate in the pore lining. In the KcsA, the distal part of TM2
forms the tip of “inverted tepee” architecture that corre-
sponds to the intracellular end of the conduction pore (12).
Recent evidence suggests that the intracellular start of the
TM1 and part of the amino terminus of ASIC and ENaC
channels participate to the inner pore structure (13, 14). We
can therefore conclude that the ion conduction pore of
ENaC/ASIC channels does not conform to the general struc-
tural feature of the potassium channels.
Acknowledgments—We thank Jean-Daniel Horisberger and Stephan
Kellenberger for critical reading of the manuscript.
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II / Internal accessibility of the cysteine to sulfhydryl reagents. 
Kellenberger et al (64) have shown that intracellular methanethiosulfonates (MTS) are 
able to inhibit ENaC current suggesting the presence of intracellular cysteines which may play 
an important role in ENaC function. We asked whether intracellular inhibition of ENaC by 
MTS occurs via its direct interaction with ENaC subunits and which cysteines in ENaC subunits 
are involved in the inhibition. We thus proposed a new approach based on the Substituted 
Cysteine Accessibility Method (SCAM) which consists of single cysteine substitutions within a 
target protein coupled with covalent cysteine modification by hydrophilic thiol-reagents. Here, 
the effect of a sulfhydryl reagent on the sodium current is measured in cut-open oocytes. In 
addition, a modified SCAM was performed with sulfhydryl reagent coupled to biotin (MTSEA-
biotin) in order to isolate the target protein by streptavidin pull-down assay. This new approach 
permits us to correlate the MTS binding and its effect on the channel activity, and hence to 
determine the accessibility of the cysteines within the channel and their involvement in the 
channel function. 
 
II-1) ENaC 
II-1-i) Specificity of the method 
We first tested the effect of MTSEA-biotin on ENaC current: results are shown in the 
Figure 22. We measured the amiloride-sensitive sodium current of oocytes expressing the wild-
type ENaC protein with a two-electrode voltage clamp (TEV). Oocytes were first incubated in 
an external solution containing 10 μM amiloride. Removing amiloride led to an increase of the 
inward sodium current which was completely inhibited by addition of amiloride. The same 
oocyte was then incubated for 2 minutes in an external solution containing 1 mM MTSEA-
biotin. Removal of amiloride induced an inward sodium current (INa+) similar to the current 
without MTSEA-biotin treatment. Thus, external MTSEA-biotin had no effect on the amiloride-
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sensitive sodium current generated by the wild-type ENaC channel (Figure 22A). We then 
performed the same experiment with intracellularly-applied MTSEA-biotin. Oocytes expressing 
wild-type ENaC were placed in a cut-open chamber, which routinely allows the modification of 
both the extracellular and intracellular media. As shown before, removal of external amiloride 
led to an increase of inward sodium current. In this case, perfusion of 0.1 mM intracellular 
MTSEA-biotin induced a 95 % inhibition of the amiloride-sensitive sodium current generated 
by the wild-type ENaC channel (Figure 22B). Bar graphs summarize the normalized amiloride-
sensitive sodium current obtained before (t=0) and after 2 minutes (t=2') incubation with 
extracellular MTSEA-biotin (left graph) or perfusion of intracellular MTSEA-biotin (right 
graph). Results showed that extracellular MTSEA-biotin had no effect on ENaC-mediated 
sodium current while intracellular MTSEA-biotin inhibited 65 % of the ENaC-mediated sodium 
current after 2 minutes of perfusion. 
 
 
 
 
 
 
 
 
 
Figure 22: Effect of MTSEA-biotin on the amiloride-sensitive current (INa+) generated by 
ENaC wild-type. (A) Effect of 1 mM extracellular MTSEA-biotin on wild-type INa+ (n=1). (B) 
Effect of 0.1 mM intracellular MTSEA-biotin on wild-type INa+ (n=1). (C) Summary of 
normalized amiloride-sensitive sodium currents obtained before (t=0) and after 2 minutes (t=2’) 
incubation with 1 mM extracellular MTSEA-biotin (left, n=8 oocytes) or perfusion of 0.1 mM 
intracellular MTSEA-biotin (right, n=10 oocytes) on oocytes expressing wild-type ENaC. 
Sodium currents were normalized against the mean current obtained at t=0. 
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We then studied the biotinylation of ENaC subunits when MTSEA-biotin was applied 
either extracellularly or intracellularly. Some oocytes were entirely incubated with extracellular 
and other ones were perfused with intracellular MTSEA-biotin. In both cases, biotinylated 
proteins were isolated by affinity for streptavidin beads and then separated by SDS-PAGE. The 
western blots of α and β subunits are shown in figure 23. The left panel shows the total 
expression of both α and β subunits in the oocyte total lysates. In total lysates of oocytes 
expressing αβγ, α and β subunits were similarly expressed in all MTSEA-biotin conditions. As 
a control for the specificity of the antibodies, non-injected oocytes (Non-Inj.) did not show any 
signal for both α and β subunits. The right panel shows the biotinylated proteins, i.e. the 
proteins bound to MTSEA-biotin. We did not observe any specific signal with anti-α antibody 
suggesting that extracellular MTSEA-biotin (Ext.) does not biotinylate the extracellular region 
of the α subunit. In the case of the β subunit, a low intensity signal of biotinylation appeared for 
oocytes expressing αβγ in the presence or absence of extracellular MTSEA-biotin. This is likely 
to indicate that there is non-specific binding between the β subunit and the streptavidin beads. 
In contrast, we observed biotinylated α and β subunits in oocytes expressing αβγ that were 
perfused with intracellular MTSEA-biotin (Int.). This indicates there is a MTSEA-biotin 
mediated biotinylation of the cytosolic region of both the α and β subunits of ENaC. The 
absence of an actin signal in the biotinylated fraction indicates that extracellular MTSEA-biotin 
did not interact with cytosolic proteins. Altogether, these results showed that the inhibition of 
ENaC activity by MTSEA-biotin was specifically intracellular and correlated with the binding 
of MTSEA-biotin on the intracellular part of the two α and β subunits. 
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Figure 23: Western Blot analysis of the MTSEA-biotin mediated biotinylation of ENaC α 
and β subunits (N=2). The left panel shows total protein expression and the right panel shows 
the biotinylated fraction of these proteins. Oocytes were non-injected (Non-Inj.) or injected with 
ENaC wild-type channel (αβγ). They were then incubated with 1 mM extracellular MTSEA-
biotin (Ext.), perfused with 0.1 mM intracellular MTSEA-biotin (Int.) or non-treated with 
MTSEA-biotin (-). An actin control was used throughout to show the absence of contaminating 
cytosolic proteins in the surface biotinylated fraction. (n=12 oocytes per condition) 
 
In order to verify the specificity of interaction between MTSEA-biotin bound to ENaC 
and streptavidin beads, we perfused oocytes expressing αβγ ENaC with 1 mM intracellular 
MTSEA, either coupled or not coupled to biotin. Proteins were incubated with streptavidin 
beads and then separated by SDS-PAGE. The western blot is shown in figure 24. The left panel 
indicates that, in the total lysates, the three α, β and γ subunits were similarly abundant under all 
perfusion conditions. In the biotinylated fraction (right panel), we observed that the three α, β 
and γ subunits were biotinylated when oocytes were perfused with MTSEA-biotin. This signal 
did not appear when perfused with MTSEA, except for the β subunit, where we observed a 
residual signal of biotinylation. This confirmed the presence of a non specific binding between 
the β subunit and streptavidin beads, as we had previously observed. However, overall these 
results showed that the binding of streptavidin was highly specific to presence of MTSEA-
biotin and not just MTSEA alone. 
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Figure 24: Western Blot analysis of the MTSEA-biotin - streptavidin beads binding 
specificity. (N=1) Oocytes expressing αβγ ENaC were either non-perfused or perfused with 
MTSEA alone or MTSEA coupled to biotin. (12 oocytes per condition) 
 
MTS reagents covalently bind to the thiol group of cysteine residues. In order to confirm 
that the biotinylation by MTSEA-biotin is mediated by interaction with cysteines, we performed 
experiments where oocytes expressing ENaC wild-type were perfused intracellularly with 1 
mM MTSEA-biotin with or without 5 mM free cysteine (Figure 25). As seen previously, 
perfusion of 1 mM intracellular MTSEA-biotin led to the almost complete inhibition of the 
amiloride-sensitive ENaC wild-type sodium current (Figure 25A, left panel). Perfusion with 1 
mM MTSEA-biotin together with 5 mM of free cysteine prevented the inhibition of ENaC. 
Several measurements (21 oocytes) showed that the MTSEA-biotin mix with free cysteine did 
not significantly inhibit the ENaC-mediated sodium current (Figure 25B). In the perfusion 
solution, it is likely that the free cysteines were modified by MTSEA-biotin even before the 
perfusion of the mixture into the oocytes expressing ENaC. Thus, the presence of 5 mM free 
cysteine in the intracellular perfusion mix prevented the inhibitory effect of MTSEA-biotin on 
the ENaC-mediated amiloride-sensitive sodium current, most likely by competing with the 
native intracellular ENaC cysteines. This showed that the MTSEA-biotin inhibition was 
mediated by the interaction of MTSEA-biotin with cysteine. 
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Figure 25: Effect of 5 mM free cysteines on MTSEA-biotin INa+ inhibition. (A) Typical 
sodium current measurement of ENaC wild-type. In the left panel, oocytes were perfused with 1 
mM MTSEA-biotin alone while, in the right panel, oocytes were perfused with 1 mM MTSEA-
biotin + 5 mM free cysteines. (B) Summary of the WT sodium currents obtained before (t=0) 
and 2 minutes (t=2’) after perfusion of 1 mM MTSEA-biotin + 5 mM free cysteines. Sodium 
currents were normalized with current obtained before the perfusion (n=21 oocytes). 
 
The oocytes expressing αβγ ENaC and perfused with either 1 mM MTSEA-biotin or 1 
mM MTSEA-biotin with 5 mM free cysteine were retained and lysed for total protein 
extraction. These proteins were then incubated with streptavidin beads and separated by SDS-
PAGE (Figure26). Total lysates on the left panel indicated that the two α and β subunits were 
similarly expressed under all perfusion conditions. Non-injected oocytes (Ni) were used as 
negative control for antibody specificity. In the biotinylated fraction, we did not observe any 
biotinylated signal for α and β ENaC when oocytes were perfused with 5 mM free cysteine 
alone. Perfusion of MTSEA-biotin alone induced the specific α and β biotinylated subunits 
signals as seen above. When free cysteine was added to the MTSEA-biotin perfusion mix, α 
and β subunits were not biotinylated. This experiment was reproducible across three different 
batches of oocytes, as shown in the figure 26B. These data indicated that free cysteine 
prevented the MTSEA-biotin mediated biotinylation of the α and β subunits of ENaC. The loss 
of inhibition of ENaC-mediated INa+ by MTSEA-biotin in the presence of free cysteine 
  82
correlated with an absence of binding of MTSEA-biotin to both the α and β subunits. This 
confirmed our hypothesis that there was competition between free cysteines and native 
cysteines of ENaC subunits to bind MTSEA-biotin. 
 
 
 
 
 
 
Figure 26: MTSEA-biotin mediated biotinylation of α and β subunits in presence or 
absence of 5 mM free cysteines. (A) LiCor® western blot analysis of the biotinylation of the α 
and β subunits of ENaC. Oocytes expressing αβγ ENaC were intracellularly perfused with 
1mM MTSEA-biotin with or without 5 mM free cysteine (n=12 oocytes per condition). (B) The 
signal of biotinylated α and β subunits was quantified with the Odyssey® software. For each α 
and β subunit, two conditions of perfusion are presented: (i) perfusion with MTSEA-biotin 
alone (light blue, -) and (ii) perfusion with MTSEA-biotin and free cysteine (dark blue, +) (n=3 
batches of oocytes per condition). The band intensity was normalized with the signal obtained 
when oocytes were perfused with MTSEA-biotin alone. 
 
In summary, extracellular MTSEA-biotin had no effect on ENaC activity and did not bind 
to the α or β subunits, whereas intracellular perfusion of MTSEA-biotin led to the inhibition of 
the channel through direct interaction with both the α and β subunits. The inhibition of ENaC 
activity by intracellular MTSEA-biotin, as its binding to α and β subunits, was a result of the 
direct interaction between MTSEA-biotin and cysteine residues. This assay will enable the 
isolation of specific cysteine residues that are important for channel function. 
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II-1-ii) Cysteines involved in ENaC inhibition by intracellular sulfhydryl reagent 
In order to determine which intracellular cysteines in the α and β ENaC subunits are 
modified by MTSEA-biotin, a series of site-directed cysteine substitutions were performed on 
the N- and C-termini of each ENaC subunit. Figure 27 shows the localization of the native 
cysteines on the three α, β and γ ENaC subunits that can be potentially accessible to 
intracellular MTSEA-biotin, i.e. cysteines located in the N- and C-termini and in the 
transmembrane domains (TM1 & TM2) of the subunits. Some cysteines are conserved between 
the subunits: αC88, βC30 and γC33; αC101 and βC43; and βC534 and γC546. 
 
 
 
 
 
 
Figure 27: Schematic representation of the three α, β and γ ENaC subunits with the 
putative native cysteines accessible to intracellularly-applied MTSEA-biotin. HN and 
COOH represent respectively the amino- and the carboxyl-termini of the subunits; TM1 & TM2 
are two transmembrane domains; and the extracellular loop is not represented here. The 
conserved intracellular native cysteines are in light blue and the selectivity filter αSer589 has 
been indicated in red. 
 
We first substituted all the intracellular cysteines in the N- and C-termini of αβγ ENaC 
subunits and tested the functionality of this “Int_ΔCys" mutant of ENaC in TEV (Figure 28). 
All the cysteines were mutated either by site-directed substitution or by deletion. Deletion was 
performed on the C-terminus of the α subunit either on Arg618 (R618Stop) or Pro646 
(P646Stop). Compared to oocytes expressing αβγ ENaC (left panel), the Int_ΔCys mutant 
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channel (rαC37S-C88A-C101A-R618Stop, βC10G-C30A-C43A-C61S-C64S-C557S-C595S, 
γC33A-C41A-C71S, right panel) did not present any inward sodium current when amiloride 
was removed. 
 
 
 
 
 
 
Figure 28: Functional test of ENaC wild-type and Int_ΔCys mutant: αC37S-C88A-C101A-
R618Stop, βC10G-C30A-C43A-C61S-C64S-C557S-C595S, γC33A-C41A-C71S. 
Representative inward sodium current generated by ENaC wild-type was measured by TEV 
experiments. 
 
 
The absence of amiloride-sensitive sodium current observed for the Int_ΔCys mutant 
channel can be potentially explained either by an insensitivity of the channel to amiloride, a 
channel loss of function, or a decrease in the surface expression or in the protein synthesis. We 
first checked at the surface expression of the Int_ΔCys mutant channel by a surface 
biotinylation with 1 mM extracellular Sulfo-NHS-SS-Biotin (see methods) performed on 
oocytes expressing either the wild-type or the Int_ΔCys mutant channel (Figure 29). 
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Figure 29: Study of the ENaC Int_ΔCys mutated α and β subunits surface expression. 
Surface NHS-SS-biotinylation of oocytes injected with ENaC wild-type or Int_ΔCys mutant 
(αC37S-C88A-C101A-R618Stop, βC10G-C30A-C43A-C61S-C64S-C557S-C595S, γC33A-
C41A-C71S, ‘Mut’). (n=40 oocytes per condition) 
 
In the total lysates (Figure 29, left panel), we observed two bands for the α wild-type 
subunit, the full-length α subunit (95 kDa), and a lower signal around 70 kDa that likely 
corresponded to the amino fragment of the α subunit obtained after proteolysis by serine 
protease (proteolytic sites located in the pre-M2 domain (101)). Oocytes expressing the 
Int_ΔCys mutant channel (Mut) showed a signal for the α mutated subunit that had a lower 
apparent molecular weight than the full-length α subunit and also a 80 % lower signal of 
abundance compared with the wild-type α subunit. The lower apparent molecular weight was 
potentially due to the deletion of the C-terminal region of the α subunit in the Int_ΔCys mutant 
channel (αR618Stop). The lower signal intensity of the α mutated subunit underlines a weaker 
total expression of the α subunit. It is likely that deletion of the C-terminus led to the instability 
of the RNA or that mutation of all the native cysteines in the α subunit led to a decrease in the 
synthesis of the α mutated subunit and/or to its rapid degradation. In the biotinylated fraction of 
proteins (Figure 29, right panel), i.e. proteins expressed at the plasmatic membrane, oocytes 
expressing wild-type ENaC and incubated with extracellular NHS-SS-Biotin presented two 
bands of biotinylated α subunit, the full-length and the likely proteolysed subunit outlined 
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above. Oocytes not treated with extracellular NHS-SS-Biotin were used as a negative control 
for specific biotinylated signal. Oocytes expressing the Int_ΔCys mutant channel (Mut) and 
incubated with extracellular NHS-SS-Biotin also contained a biotinylated α subunit, as 
observed in the total lysates, with the similar lower apparent molecular weight due to the C-
terminus deletion and 40 % lower signal of abundance compared with the biotinylated wild-
type α subunit. It seems that a major fraction of the mutated α subunits present in the total 
lysates was expressed at the surface membrane. With respect to the β subunit, the wild-type β 
subunit and the Int_ΔCys β subunit were expressed equally in the total lysates (left panel). In 
the biotinylated fraction, oocytes incubated with extracellular NHS-SS-Biotin also showed a 
similar specific signal of biotinylated wild-type and Int_ΔCys β subunits. Neither the total 
protein expression nor the surface expression of the β subunit seemed to be influenced by the 
substitution of the intracellular cysteines in the β subunit. The actin (42kDa) control allowed the 
possible presence of cytosolic proteins in the biotinylated fraction to be excluded. 
 
To investigate whether substitutions of the intracellular cysteines in ENaC subunits are 
able to abolish the binding of MTSEA-biotin to α and β subunits, we performed internal 
perfusion of MTSEA-biotin in oocytes expressing αβγ ENaC or the Int_ΔCys mutant channel 
rαC37S-C88A-C101A-C118S-P646Stop, βC10G-C30A-C43A-C61S-C64S-C534S-C557S-
C595S, γC33A-C41A-C71S (Mutant). In this experiment, we used the αPro646 deletion instead 
of αArg618, since it showed a higher level of expression. The Int_ΔCys mutant channels, either 
with mutation αR618Stop or αP646Stop, were not functional. After intracellular perfusion of 
MTSEA-biotin, oocytes expressing the wild-type or the Int_ΔCys mutant channel were retained 
and, as before, proteins were incubated with streptavidin beads and the ENaC subunits were 
studied by western blot (Figure 30). Results showed that, in the total lysates, the wild-type and 
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the Int_ΔCys (Mutant, containing the αPro646 deletion) α subunits were similarly expressed in 
contrast to the decreased expression of the mutated subunit containing the mutation 
αArg618Stop. It is likely the 28 C-terminal amino acids of the α subunit were necessary for the 
efficient expression of the α mutated subunit. The deletion of the C-terminus αP646Stop led to 
a decrease in the apparent molecular weight of the α mutated subunit. The expression of the 
wild-type and Int_ΔCys mutated (Mutant) β subunits were similar irrespective of the mutation. 
Analysis of the biotinylated fraction (right panel) showed there was a strong decrease in 
expression of the mutated α and β subunits, 90 % and 80 % respectively, compared with the 
wild-type subunits. 
 
 
 
 
 
 
Figure 30: Western Blot analysis of oocytes injected with ENaC wt or Int_ΔCys mutant 
(αC37S-C88A-C101A-C118S-C645S-P646Stop, βC10G-C30A-C43A-C61S-C64S-C534S-
C557S-C595S, γC33A-C41A-C71S, ‘Mutant’) and perfused with 1 mM intracellular 
MTSEA-biotin. (n=12 oocytes per condition) 
 
However, despite the substitution of all the putative accessible intracellular cysteines, a 
small but detectable signal of biotinylated α and β subunits remained. This could be explained 
by: (i) a non-specific binding of MTSEA-biotin to the subunits, (ii) an indirect binding of 
MTSEA-biotin to the subunits via an accessory protein, (iii) a cysteine located in the 
extracellular loop but accessible only intracellularly, or (iv) the presence of unbound MTSEA-
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biotin during the lysis that modified cysteines not normally accessible when subunits are 
assembled. 
 
To test the first hypothesis, we performed an intracellular biotinylation with MTSEA-
biotin in presence or absence of dithiothreitol (DTT), a reducing agent that disrupts disulfide 
bonds. We anticipated that addition of DTT would remove the remaining biotinylation of the 
Int_ΔCys mutant of ENaC (rαC37S-C88A-C101A-C118S-C645S-C690S-C693S, βC10G-
C30A-C43A-C61S-C64S-C534S-C557S-C595S, γC33A-C41A-C71S-C542S-C546S). Oocytes 
perfused with MTSEA-biotin were lysed and proteins were treated or not treated with 10 mM 
DTT before incubation with streptavidin beads (cf. Methods 'Pull-Down Assay'). Biotinylated 
proteins were then analyzed on western blot (figure 31A). The total lysates (left panel) showed 
that both α and β subunits, wild-type and Int_ΔCys, were similarly expressed. The biotinylated 
fraction (right panel) confirmed there was a decrease in biotinylated α and β mutated subunits, 
compared with wild-type, when all the intracellular cysteines were removed. Quantification of 
the band intensity of biotinylated subunits showed that removal of all intracellular cysteines on 
the α subunit led to 70 % decrease of subunit biotinylation and a more pronounced 90 % 
decrease in subunit biotinylation when all cysteines were removed from the β subunit (Figure 
31B, light blue bars). When DTT was added to perfused wild-type oocyte lysates, both α and β 
antibodies still showed the presence of WT biotinylated subunits, 5 % and 10 % of the DTT-
untreated lysates respectively (Figure 31B, αβγ). This DTT-insensitive signal suggests there is 
perhaps some non-specific biotinylation of the wild-type subunits. When DTT was added to 
perfused Int_ΔCys mutant channel, we did not observe any detectable signal of biotinylated α 
and β mutated subunits (Figure 31B, Int_ΔCys). This suggests that a part of the MTSEA-biotin-
mediated α and β mutated ENaC subunits biotinylation is DTT-sensitive and thus, linked to 
cysteine residues. 
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Figure 31: Study of the DTT-sensitivity of MTSEA-biotin mediated biotinylation of α 
and β subunits. (A) Western Blot analysis of oocytes injected with ENaC wt or Int_ΔCys 
mutant (αC37S-C88A-C101A-C118S-C645S-C690S-C693S, βC10G-C30A-C43A-C61S-
C64S-C534S-C557S-C595S, γC33A-C41A-C71S-C542S-C546S) and perfused with 
intracellular MTSEA-biotin. Pull-down assays were performed in presence or not of DTT. 
(n=12 oocytes per condition) (B) For each α and β subunits, we quantified the specific signal 
of biotinylation obtained for the wild-type channel (αβγ) and the Int_ΔCys mutant channel 
perfused with MTSEA-biotin and incubated with streptavidin beads with (dark blue, +) or 
without (light blue, -) DTT. Band intensity was normalized against the intensity obtained for 
wild-type channel perfused with MTSEA-biotin and incubated with streptavidin beads 
without DTT. (N=3 Western Blots) 
 
We have shown that the binding of MTSEA-biotin to ENaC subunits occurs effectively 
via disulfide bond with cysteines residues. The Maleimide-PEO2-Biotin is a DTT-insensitive 
reagent that forms thioether bonds with reduced thiol group of cysteines. We were wondering if 
ENaC would react in the same way for the two reagents. We performed intracellular perfusion 
of 1 mM Maleimide-PEO2-Biotin in oocytes expressing either αβγ ENaC or the Int_ΔCys 
mutant. The effect of Maleimide-PEO2-Biotin on the amiloride-sensitive sodium current is 
shown in Figure 32. Removal of amiloride led to an increase of the inward sodium current. 
Then intracellular perfusion of 1 mM Maleimide-PEO2-Biotin induced a 50% inhibition of 
ENaC activity 2 minutes after the beginning of the perfusion (Figure 32A). The bar graph of the 
figure 32B shows the sodium current obtained before (t=0) and 2 minutes after (t=2’) perfusion 
of Maleimide-PEO2-Biotin in oocytes expressing αβγ ENaC. Similar to intracellular MTSEA-
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biotin (cf. Figure 22), we observed that intracellular Maleimide-PEO2-Biotin was able to inhibit 
ENaC-mediated sodium current. 
 
 
 
 
 
 
Figure 32: Effect of 1 mM intracellular Maleimide-PEO2-Biotin on ENaC amiloride-
sensitive current. (A) Effect of 1 mM Maleimide-PEO2-Biotin on wild-type ENaC INa+. (B) 
Bar graph representation of the sodium current obtained before (t=0) and 2 minutes after (t=2’) 
perfusion of 1 mM intracellular Maleimide-PEO2-Biotin. Amiloride-sensitive sodium currents 
were normalized against current obtained before the perfusion. (n=14 oocytes) 
 
Oocytes perfused with intracellular Maleimide-PEO2-Biotin were analyzed by 
immunoblotting. The total lysates in the Figure 33A (left panel) showed that wild-type and 
mutated α and β subunits had similar expression in all conditions of perfusion. In the 
biotinylated fraction, when intracellular cysteines were substituted (Int_ΔCys), the observed 
biotinylated α subunit signal was 90 % less intense than the wild-type α subunit. In the case of 
the β subunit, there was 70 % less Int_ΔCys biotinylated β subunit than wild-type biotinylated β 
subunit. Specific biotinylated signals were quantified and shown in Figure 33B. As for 
MTSEA-biotin, there remained a residual biotinylation signal of α and β subunits despite 
substitution of all the intracellular cysteines on α, β and γ subunits. 
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Figure 33: Maleimide-PEO2-Biotin mediated biotinylation of α and β subunits. (A) 
Western Blot analysis of wild-type or Int_ΔCys  α and β subunits (αC37S-C88A-C101A-
C118S-C645S-C690S-C693S, βC10G-C30A-C43A-C61S-C64S-C534S-C557S-C595S, 
γC33A-C41A-C71S-C542S-C546S) biotinylated by Maleimide-PEO2-Biotin (n=12 oocytes per 
condition). (B) Bar graph representation of the specific signal quantification for both α and β 
subunits on oocytes expressing either the wild-type or Int_ΔCys mutant channel and perfused 
with 1 mM intracellular MTSEA-biotin or Maleimide-PEO2-Biotin. Band intensities were 
normalized against the intensity obtained for αβγ Maleimide-PEO2-Biotin perfused oocytes. 
(N=3 Western Blots) 
 
We wanted to determine which of the intracellular cysteines of ENaC subunits were 
modified by MTSEA-biotin. The three subunits of ENaC contain 20 native cysteine residues 
that are potentially accessible from the intracellular side (cf. Figure 27). We first focused on the 
cysteines in the N- and the C-termini. We performed a series of cysteine substitutions on the α, 
β and γ subunits to obtain two mutants: (i) a cysteine-substituted channel mutant in the N-
terminus of the three subunits: αC37S-C88A-C101A, βC10G-C30A-C43A, γC33A-C41A; (ii) 
and a cysteine-substituted channel mutant in the C-terminus of the three subunits: αC645S-
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C690S-C693S, βC557S-C595S, γC542S-C546S. As shown in the figure 34, substitutions of the 
cysteines in the N-terminus of the three subunits (Nter_ΔCys) resulted in an 80 % loss of 
sodium current compared with the wild-type sodium current. Meanwhile, substitutions in the C-
terminus (Cter_ΔCys) caused a 95 % loss of sodium current compared with the wild-type 
sodium current. 
 
 
 
 
 
 
 
 
Figure 34: Functional test of the N-terminus and C-terminus ΔCys mutated channels of 
ENaC. Graphic representation of the amiloride-sensitive sodium current measured by TEV 
clamp of oocytes expressing ENaC wild-type (WT), N-terminus cysteine-less mutant (αC37S-
C88A-C101A, βC10G-C30A-C43A, γC33A-C41A, Nter_ΔCys) and the C-terminus cysteine-
less mutant (αC645S-C690S-C693S, βC557S-C595S, γC542S-C546S, Cter_ΔCys) channels. 
(WT, n=60 oocytes; Nter_ΔCys, n=40 oocytes, Cter_ΔCys, n=10 oocytes) 
 
Oocytes expressing either wild-type ENaC, or the Nter_ΔCys (αC37S-C88A-C101A, 
βC10G-C30A-C43A, γC33A-C41A) or the Cter_ΔCys (αC645S-C690S-C693S, βC557S-
C595S, γC542S-C546S) mutant channels were perfused with 1 mM intracellular MTSEA-
biotin. Taking into account the fact that with the cut-open oocyte method the current flowing 
across only a small fraction (about 10 %) of the oocyte membrane is measured, the level of INa+ 
expressed by the N-terminus and the C-terminus cysteine-less mutant channels were too low to 
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detect in cut-open experiments. Biotinylated proteins isolated from oocytes perfused with 
MTSEA-biotin were incubated with streptavidin beads. The MTSEA-biotin mediated 
biotinylation of both mutated α and β subunits was then analyzed on western blot. Since we 
observed the same pattern of expression for both α and β subunits (data not shown), we focused 
on the β subunit (Figure 35). As a first step, we performed perfusion of MTSEA-biotin with or 
without 5 mM free cysteine in oocytes expressing either the ENaC wild-type or the Nter_ΔCys 
mutant channel (αC37S-C88A-C101A, βC10G-C30A-C43A, γC33A-C41A, Figure 35A). In 
total lysates (Figure 35A, left panel), the wild-type and the mutated β subunit were expressed at 
a similar level. In the biotinylated fraction (Figure 35A, right panel), the biotinylated 
Nter_ΔCys mutated β subunit had 80 % lower signal than the biotinylated wild-type β subunit 
when oocytes were perfused with MTSEA-biotin alone. Addition of 5 mM free cysteine in the 
perfusion with MTSEA-biotin led to 90 % decrease of MTSEA-biotin mediated biotinylation of 
both wild-type and mutated β subunits. There was no detectable signal of biotinylated β subunit 
when protein lysates were incubated with streptavidin beads in presence of DTT. 
 
 
 
 
 
 
 
 
Figure 35: MTSEA-biotin mediated biotinylation of Nter_ΔCys and Cter_ΔCys β 
subunits. (A) Oocytes expressing either ENaC wild-type or the Nter_ΔCys mutant (αC37S-
C88A-C101A, βC10G-C30A-C43A, γC33A-C41A) were perfused with MTSEA-biotin with 
or without free cysteine and treated or not treated with DTT. (B) Oocytes expressing either 
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ENaC wild-type, or the Cter_ΔCys mutant (αC645S-C690S-C693S, βC557S-C595S, γC542S-
C546S) or the Int_ΔCys mutant (αC37S-C88A-C101A-C118S-C645S-C690S-C693S, 
βC10G-C30A-C43A-C61S-C64S-C534S-C557S-C595S, γC33A-C41A-C71S-C542S-C546S) 
were perfused with MTSEA-biotin and treated or not treated with DTT. (n=12 oocytes per 
condition) 
 
As the second step (Figure 35B), we perfused intracellular MTSEA-biotin in oocytes 
expressing the wild-type (αβγ), the Cter_ΔCys (αC645S-C690S-C693S, βC557S-C595S, 
γC542S-C546S) or the Int_ΔCys mutant channel (αC37S-C88A-C101A-C118S-C645S-C690S-
C693S, βC10G-C30A-C43A-C61S-C64S-C534S-C557S-C595S, γC33A-C41A-C71S-C542S-
C546S). In the total lysates control (left panel), we were able to demonstrate that the β subunit 
was expressed at a similar level in all conditions. In the biotinylated fraction (right panel), we 
observed a 80 % and 95 % decrease, respectively, in the biotinylated Cter_ΔCys β subunit and 
Int_ΔCys β subunit signals compared with the biotinylated wild-type β subunit. A residual 
biotinylated signal remained for the β wild-type and Cter_ΔCys subunits, even when lysates 
were treated with DTT. The residual signal almost disappeared in the Int_ΔCys mutated 
subunit. The graph as part of Figure 36 showed the quantification of the specific signal obtained 
from different experiments with the anti-β antibody for MTSEA-biotin-mediated β subunit 
biotinylation. Results showed that substitutions of cysteines in either the N-terminus or the C-
terminus led to an average of 50 % decrease of MTSEA-biotin-mediated mutated β subunit 
biotinylation. Thus, cysteines in the N-terminal and C-terminal regions of ENaC contributed to 
MTSEA-biotin binding. Furthermore, cysteines in the N-terminal region of the β subunit are 
likely to be accessible to intracellular MTSEA-biotin to a similar degree as the cysteines in the 
C-terminal region of the β subunit. Removal of all the intracellular cysteines of the β subunit led 
to an 80 % decrease of the MTSEA-biotin mediated β subunit biotinylation. Highlighted on the 
graph is the DTT-insensitive signal of MTSEA-biotin mediated β subunit biotinylation (striped 
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bars) underlying the presence of a low non-specific biotinylation of the β subunit by MTSEA-
biotin. 
 
 
 
 
 
 
Figure 36: Normalized band intensity of the MTSEA-biotin-mediated β subunit 
biotinylation. Oocytes were injected with wild-type (β WT, N=11) or Nter_ΔCys mutated 
(αC37S-C88A-C101A, βC10G-C30A-C43A, γC33A-C41A, N=3), Cter_ΔCys mutated 
(αC645S-C690S-C693S, βC557S-C595S, γ, N=2) or Int_ΔCys mutated (αC37S-C88A-
C101A-C118S-C645S-C690S-C693S, βC10G-C30A-C43A-C61S-C64S-C534S-C557S-
C595S, γC33A-C41A-C71S-C542S-C546S, N=7) ENaC subunits and perfused with MTSEA-
biotin. Band intensities of biotinylated β subunit were quantified and normalized against the 
specific intensity obtained for β WT subunit. Empty bars correspond to signal obtained with 
protein lysates pulled down without DTT (specific signal), striped bars correspond to protein 
lysates pulled down in presence of DTT (non-specific signal). », p<0.001 compared to βWT, #, 
p<0.05 compared to β Nter_ΔCys. 
 
Altogether, our data showed that (i) MTSEA-biotin binds to cysteine residues in the N- 
and the C-termini of ENaC. Substitution of these cysteines leads to channels almost non 
functional. These residues are thus accessible and important for the channel function. (ii) It is 
likely that ENaC inhibition is due to direct interaction of MTSEA-biotin with cysteine residues 
in the N- and C-termini. (iii) The residual biotinylation of the Int_ΔCys mutated subunits is 
non-specific and might be due to an indirect interaction with cysteines in an ENaC-associated 
protein. 
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II-1-iii) Cross-linking experiments 
In order to identify potential ENaC associated proteins, we performed in cut-open oocytes 
cross-linking experiments with two different bismaleimide cross-linkers and an oxidizing 
reagent (see details in 'Methods'). Oocytes expressing ENaC wild-type channel were perfused 
with 1 mM intracellular DTME and amiloride-sensitive sodium current measurement is 
presented on Figure 37A. A typical recording of ENaC current showed that perfusion of 1 mM 
DTME resulted in a 60 % inhibition of the sodium current 2 minutes after the beginning of the 
perfusion (t=2', right panel). When oocytes were perfused with 20 μM BMOE (figure 37B), we 
observed a 20 % inhibition of ENaC current (t=2', right panel). Formation of disulfide bonds 
with 10 mM NaTT induced a 70 % inhibition of ENaC current (Figure 37C). 
 
 
 
 
 
 
 
 
 
 
Figure 37: Effect of DTME, BMOE and NaTT cross-linkers on ENaC-mediated sodium 
current. (A) Oocytes expressing ENaC wild-type were perfused with 1 mM DTME. (B) 
Oocytes expressing ENaC wild-type were perfused with 10 μM BMOE. (C) Oocytes 
expressing ENaC wild-type were perfused with 10 mM NaTT. Bar graphs are amiloride-
sensitive current normalized with sodium current measured before the perfusion of DTME, 
BMOE or NaTT. (DTME, n=6 oocytes; BMOE, n=6 oocytes, NaTT, n=6 oocytes) 
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Oocytes expressing the ENaC wild-type channel and perfused with BMOE were lysed and 
proteins were separated by SDS-PAGE (Figure 38). Non-injected oocytes (Ni) were used as a 
negative control for the specificity of the α and β antibodies. Using the α subunit antibody 
showed only the specific detection of the full-length α subunit and, above all, no difference 
between oocytes perfused with BMOE and oocytes not perfused with BMOE. In the case of the 
β antibody, oocytes perfused with BMOE presented specific β subunit full-length signal and a 
smear of proteins. We could not distinguish another particular band in β detection. Western blot 
analysis of oocytes perfused with DTME lead to similar pattern (data not shown). 
 
 
 
 
 
 
 
Figure 38: Western Blot analysis of oocytes perfused with intracellular BMOE cross-
linker. Specific α subunit detection is show in the left panel and specific β subunit detection in 
the right panel (n=12 oocytes per condition). 
 
Western blot analysis of oocytes perfused with either 10 mM or 20 mM intracellular 
NaTT showed a smear of protein's appearance besides the full-length subunit signal (95 kDa) 
for both α and β subunits. This smear disappeared in the presence of DTT, confirming the 
involvement of protein interactions via disulfide bridges. 
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Figure 39: Western Blot analysis of oocytes perfused with intracellular NaTT. Specific 
antibody detection of the α subunit is show on the left panel and specific β subunit detection on 
the right panel. (n=12 oocytes per condition) 
 
Taken together, these results suggest that both α and β subunits likely interact with other 
proteins via DTT-sensitive interactions. However, our cross-linking experiments did not allow 
the determination of the involvement of a specific protein or protein complex with one or two 
subunits of ENaC. 
 
 
II-2) ASIC 
 
We wanted to compare ENaC with ASIC, another member of ENaC/degenerin family, 
with respect to the accessibility of the intracellular cysteines to MTSEA reagent and to their role 
on ASIC activity. Protein sequence alignment of the three αβγ subunits of ENaC with the 
human and the chicken ASIC1 (Annexe) showed there was 20% homology between ENaC and 
ASIC1 (70). In hA1a, putative intracellularly-accessible cysteines are located in the first 
transmembrane domain (TM1): C49, C59 and C61; and in the C-terminus, C466, C471, C497 
and C528. 
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Figure 40: Schematic representation and localization of the putative intracellular cysteines 
of hA1a. Native cysteines are indicated with an orange diamond. In green are indicated the first 
and the last amino acids of the hA1a N-terminus that were substituted in cysteine for the 
cysteine screen. 
 
II-2-i) MTSEA-biotin effect on hA1a channels 
hA1a is activated by protons with external pH below 6.9 (128) (Figure 41A). A typical 
sodium current mediated by hA1a wild-type (hA1a-wt) is shown in figure 41B. The base line 
was obtained at pH 7.4. Acidification of the external medium (r, pH 6.0) on oocytes expressing 
hA1a-wt led to an increase of inward sodium current, which was detected using the TEV. For 
all experiments, two to three acidifications of the medium, at intervals of 40 seconds, were 
performed on each oocyte (Figure 41B). Compared to the wild-type channel, the channel 
mutated in the C-terminal cysteines, hA1a-C466A-C471A-C497A-C528Stop (Cter_ΔCys), 
generates about 50% of the wild-type sodium current (Figure 41C). 
 
 
 
 
 
  100
 
 
 
 
 
 
Figure 41: hA1a channel pH activation (A) Dose-response curve of hA1a-wt for the 
extracellular pH from Waldmann et al. (128) (B) Representative sodium currents of the wild-
type (hA1a-wt) and C-terminal cysteines mutant (Cter_ΔCys) hA1a, measured by TEV. 
Application of acidic pH is indicated with an arrow (r). (C) Mean sodium current obtained for 
oocytes expressing hA1a-wt or Cter_ΔCys. (wt, N=26; Cter_ΔCys, N=5) 
 
Oocytes expressing hA1a-wt or Cter_ΔCys channel were perfused with 1 mM 
intracellular MTSEA-biotin and Figure 42A (left panel) shows that acidification of the pH 
during the intracellular MTSEA-biotin perfusion inhibited only 5 % (p=0.0082) of the hA1a 
wild-type (hA1a-WT) mediated sodium current. When oocytes expressing the Cter_ΔCys 
channel were perfused with intracellular MTSEA-biotin, we observed a 20 % increase 
(p=0.0178) in the amplitude of sodium current generated by the Cter_ΔCys channel. 
Quantification of the sodium currents obtained before (t=0) and 2 minutes after (t=2’) perfusion 
of MTSEA-biotin are shown in the Figure 42B. 
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Figure 42: Effect of MTSEA-biotin on hA1a-wt and Cter_ΔCys sodium currents. (A) 
Representative sodium current of hA1a-wt and Cter_ΔCys channels in presence of 1 mM 
intracellular MTSEA-biotin. The time of application of acidic pH is indicated with an arrow (r). 
(B) Bar graph representation of the sodium current obtained before (t=0) and 2 minutes after 
(t=2’) perfusion of 1 mM intracellular MTSEA-biotin. Sodium currents were normalized with 
current obtained before the perfusion (WT, N=6; Cter_ΔCys, N=43). », p<0.01 and #, p<0.05 
compared to t=0 respective sodium current. 
 
Oocytes expressing hA1a-WT or Cter_ΔCys channel and perfused with intracellular 
MTSEA-biotin for current measurements were then lysed and proteins were incubated with 
streptavidin beads and analyzed by western blot with specific antibody against the hA1 subunit 
(Figure 43A). Total protein lysates (left panel) showed that hA1a wild-type and Cter_ΔCys 
subunits were similarly expressed. The biotinylated fraction (right panel) showed a specific 
biotinylated hA1 wild-type signal when oocytes were perfused with intracellular MTSEA-
biotin. Thus, the accessibility of the C-terminus cysteines of hA1a correlated with the 
accessibility of the C-terminus cysteines of ENaC. However, modification of cysteine residues 
on hA1a C-terminus does not change ASIC activity (see figure 42). When cysteines in the C-
terminus of hA1a are substituted (Cter_ΔCys), we observe a 90 % loss of MTSEA-biotin 
mediated biotinylation of hA1 subunit. Average quantification of biotinylated hA1a for three 
experiments is shown figure 43B. However, biotinylated subunits were still present despite the 
C-terminus cysteines substitutions. This remaining biotinylation was DTT-sensitive, suggesting 
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the involvement of other cysteines possibly in the TM1 that are potentially accessible with 
intracellular sulfhydryl reagents or non-specific binding. Thus, MTSEA-biotin binds to cysteine 
residues in the C-terminus of hA1a but do not inhibit the channel. 
 
 
 
 
 
 
Figure 43: MTSEA-biotin mediated biotinylation of hA1a-wt and Cter_ΔCys subunits. (A) 
Western blots anti-hA1 on oocytes expressing either hA1a-wt or Cter_ΔCys and perfused or not 
perfused with 1 mM MTSEA-biotin. Pull-down assays on perfused oocytes were performed 
with or without DTT. (n=12 oocytes per condition) (B) Mean band intensities of MTSEA-biotin 
mediated biotinylation of hA1a-WT and Cter_ΔCys subunits were quantified with Odyssey® 
software. Band intensities were normalized against the wild-type signal. (N=3) 
 
As for ENaC, we tested the effect of Maleimide-PEO2-Biotin on hA1a channel mediated 
sodium current. Oocytes expressing hA1a wild-type or Cter_ΔCys channel were perfused with 
1 mM intracellular Maleimide-PEO2-Biotin (Figure 44) and sodium currents were measured by 
cut-open. Perfusion of intracellular Maleimide-PEO2-Biotin did not have a great influence on 
hA1a wild-type current (Figure 44A). Average quantification of sodium current generated after 
2 min of intracellular Maleimide-PEO2-Biotin perfusion showed a significant 20 % inhibition of 
hA1a current (Figure 44B). In contrast, Cter_ΔCys mediated sodium current was not 
significantly inhibited by Maleimide-PEO2-Biotin (Figure 44B). 
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Figure 44: Effect of Maleimide-PEO2-Biotin on hA1a-wt and Cter_ΔCys currents. (A) 
Oocytes expressing hA1a wild-type (hA1a-WT) or Cter_ΔCys channel were continuously 
perfused with 1 mM intracellular Maleimide-PEO2-Biotin and activated with pH 6.0 external 
solution (r). (B) Bar graphs sum sodium currents generated by the wild-type (hA1a-WT) and 
the Cter_ΔCys channel and measured before (t=0) and after 2 minutes (t=2’) perfusion with 
Maleimide-PEO2-biotin. (hA1a-WT, N=5; Cter_ΔCys, N=4) #, p<0.05 compared to t=0; NS, 
p>0.05 compared to t=0. 
 
Oocytes perfused with Maleimide-PEO2-Biotin were lysed and proteins were incubated 
with streptavidin beads. The western blot is shown on Figure 45. Total protein lysates (left 
panel) showed that wild-type and Cter_ΔCys hA1a subunits were similarly expressed in all 
conditions. In the biotinylated fraction (right panel), oocytes expressing the wild-type channel 
(hA1a-WT) presented a specific biotinylated full-length hA1 subunit signal. When oocytes 
expressing the Cter_ΔCys were perfused with Maleimide-PEO2-Biotin, the specific hA1 signal 
was 80 % weaker than that of the wild-type subunit. These results confirm data obtained with 
MTSEA-biotin (cf. Figure 43). 
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Figure 45: Binding of Maleimide-PEO2-Biotin to hA1a-wt and Cter_ΔCys subunits. 
Western blots anti-hA1 on oocytes expressing either hA1a-wt or Cter_ΔCys and perfused or not 
perfused with 1 mM intracellular Maleimide-PEO2-Biotin. Average quantification of MTSEA-
biotin mediated biotinylation of hA1a-WT and Cter_ΔCys subunits. Band intensities were 
normalized with the wild-type signal. (n=12 oocytes per condition) 
 
Similar to ENaC, cysteines located in the C-terminal region of hA1a are accessible to 
MTSEA-biotin, and also to Maleimide-PEO2-Biotin. However, although direct modification of 
C-terminal cysteines in ENaC inhibits the channel, the modification of cysteines in the C-
terminal part of hA1a does not change ASIC activity. For both channels, substitution of all 
potential intracellular cysteines did not prevent the biotinylation of the subunits. Since in hA1a, 
in contrast to ENaC, this residual binding was DTT-sensitive, it would seem that other cysteines 
residues are involved and potentially those in TM1 are also accessible to MTSEA-biotin. 
 
II-2ii) N-terminus cysteine-screen substitution 
 
We have tested whether our biotinylation assay could be used to identify accessible 
residues to intracellular ligands. The figure 46 shows a sequence alignment of a part of the N-
terminus of the three ENaC subunits, α, β, γ, with the chicken and the human ASIC1 subunits. 
It has been previously shown that substitution of the HG motif or of the residue histidine at 
position 32 in hA1a lead to non-functional channels ( Figure 46; (45)). Functional analysis of 
a series of cysteine substitutions in the N-terminus of hA1a showed that substitutions of the 
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amino acids Thr26, Ser35, Glu37 and Trp46 in cysteine lead to a complete loss of function of 
the mutated channel (8 Figure 46; (95)). Among the functional mutated channels, five 
distinctive hA1a mutants generated sodium currents that were inhibited by intracellular MTSET 
(9 Figure 46, (95)): A22C, I33C, F34C, R38C and R43C. We focused particularly on the 
sensitivity of the A22C mutant, since the residue hA1a-Ala22 corresponds to a strongly 
conserved cysteine residue in all three ENaC subunits (rαC88, rβC30 and rγC33). We used 
these cysteine-substituted mutants, from hA1a-A22C to hA1a-W46C (z Figure 46), to study 
the MTSEA-biotin intracellular accessibility. 
 
 
 
 
 
Figure 46: Sequence alignment of the amino terminus and the beginning of the TM1 of the 
three αβγ ENaC subunits and chicken and human ASIC1 subunits. All marks are explained in 
the text. 
 
 
We subcloned each N-terminal cysteine substitution in the background of the C-terminal 
cysteine-less: hA1a-C466A-C471A-C497A-C528Stop (Cter_ΔCys) and measured their activity 
on intact oocytes in TEV clamp experiments (Figure 47). 
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Figure 47: Inward sodium currents of hA1a mutants. Summary of the sodium currents 
generated by the cysteine-substituted mutant channels in the background Cter_ΔCys. Each 
mutated channel is annotated as the corresponding N-terminus cysteine substitution, i.e. 
“A22C” means “hA1a-A22C-C466A-C471A-C497A-C528Stop”. Dark blue bars indicate 
sodium current closed to hA1a wild-type (WT) current and striped blue bars, sodium currents 
closed to zero. (n=4 oocytes per mutated channel; », p<0.05; »», p<0.01; »»», p<0.001 Student 
t-test compared to WT current) 
 
In accordance with a previous study (95), the three mutants T26C, E37C and W46C in the 
background Cter_ΔCys generated almost no sodium current (Figure 47, striped blue bars), 
despite having a total protein abundance similar to that of the wild-type subunit expression (data 
not show). Six mutated channels (L39C, S40C, L41C, K42C, A44C and L45C in the 
background Cter_ΔCys) generated sodium currents that were of either equal or higher intensity 
to the wild-type channel (dark blue bars). The other mutated channels generated various 
decreases in the intensity of the sodium current but were still functional allowing testing the 
effect of intracellular MTSEA-biotin. We first performed the experiments on the mutated 
channel hA1a-A22C-C466A-C471A-C497A-C528Stop (A22C). Figure 48A shows the effect of 
intracellular MTSEA-biotin on current generated by the mutant A22C in the background 
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Cter_ΔCys. Acidification of external medium led to the generation of inward sodium current 
that was 60 % inhibited after 2 min of perfusion with 1 mM intracellular MTSEA-biotin. 
Oocytes expressing hA1a wild-type (hA1a-WT), the Cter_ΔCys or the mutated hA1a-A22C-
C466A-C471A-C497A-C528Stop (A22C) channel and perfused with 1 mM intracellular 
MTSEA-biotin were used in pull-down assays to analyzed the binding of MTSEA-biotin on 
hA1a subunits. In the western blot, the biotinylated fraction showed a specific signal 
corresponding to the biotinylated hA1a wild-type subunit (figure 48B). When cysteines in the 
C-terminus were substituted (Cter_ΔCys), we observed a 90 % signal decrease of the 
biotinylated subunit as previously shown. Addition of the A22C mutation in the background 
Cter_ΔCys induced a 50 % recovery of the subunit biotinylation signal. Thus, we can conclude 
that A22C is accessible to intracellular MTSEA-biotin and nicely correlated with inhibition of 
ASIC activity. This validates our biotinylation assay to identify accessible amino acids in the N-
terminal part of ASIC. 
 
 
 
 
 
 
Figure 48: Effect of intracellular MTSEA-biotin on the mutant hA1a-A22C-C466A-
C471A-C497A-C528Stop. (A) Representative sodium current generated by the mutated 
channel hA1a-A22C-C466A-C471A-C497A-C528Stop in presence of 1 mM intracellular 
MTSEA-biotin. (n=26 oocytes) (B) Western Blot analysis of the effect of MTSEA-biotin on the 
hA1a-A22C-C466A-C471A-C497A-C528Stop (A22C) subunit compared with the wild-type 
(hA1a WT) and the Cter_ΔCys subunits. (Western Blot: 12 oocytes per condition; Graph: 
hA1a, N=3; Cter_ΔCys, N=6; A22C, N=7) 
 
  108
We thus obtained three controls for the binding of MTSEA-biotin: (i) MTSEA-biotin 
biotinylates the hA1a wild-type subunit (WT) but has no effect on the WT sodium current; (ii) 
MTSEA-biotin does not biotinylate the Cter_ΔCys subunit and has no effect on the Cter_ΔCys 
sodium current; (iii) MTSEA-biotin biotinylates the mutated subunit hA1a-A22C-C466A-
C471A-C497A-C528Stop (‘A22C’) and inhibits the generated sodium current. This allows us 
to identify intracellular accessible sites to MTS reagents and functional domains in the N- and 
the C-termini of hA1a involved in the MTS intracellular inhibition of the channel. 
 
We extended this experiment to include the other N-terminal cysteine-substituted mutants 
(from S23C to W46C) generated in the Cter_ΔCys background. Mutant channels were perfused 
with intracellular MTSEA-biotin using the cut-open technique. These oocytes were kept for 
determination of biotinylation of hA1a channel mutants. For each channel mutant, the sodium 
current obtained 2 minutes after addition of 1 mM intracellular MTSEA-biotin was normalized 
to the current obtained before addition of MTSEA-biotin. Mutated channels T26C, E37C and 
W46C in the background of Cter_ΔCys were considered non-functional (NF) since they do not 
generated usable sodium currents for the study of the electrophysiological effects of MTSEA-
biotin (cf. Figure 47). However they were also perfused and retained for analysis by western 
blot. Data showed that some mutated channels were not inhibited by MTSEA-biotin after 2 
minutes of perfusion (Figure 49, dark blue bars). These included the wild-type (WT) and the C-
terminus cysteine-less channels (Cter_ΔCys), as previously shown, as well as the L27C, L30C, 
S35C, Y36C, S40C and A44C in the background Cter_ΔCys mutants. Student's t-test performed 
on the other channels (light blue bars) indicated that only seven mutated channels were 
significantly inhibited by 2 minutes of intracellular MTSEA-biotin perfusion. Six of the mutated 
channels lost approximately half of their current after two minutes of perfusion: the hA1a-A22C 
(p=0.0001): 60 % of inhibition; hA1a-F34C (p=1.14.10-5), hA1a-R38C (p=0.0045), hA1a-
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K42C (p=0.0013), hA1a-R43C (p=0.0326), hA1a-L45C (p=0.0002): 50 % of inhibition. The 
mutant hA1a-I33C in the background Cter_ΔCys (I33C) was 95% inhibited by intracellular 
MTSEA-biotin treatment (p=6.5.10-10). The residue Ile 33 is highly conserved among both 
ENaC and ASIC protein sequences and would therefore seem to play an important role in the 
function of these channels. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49: Normalized sodium current measured 2 minutes after addition of 1 mM 
intracellular MTSEA-biotin for each N-terminus cysteine-substituted in the background 
Cter_ΔCys channel. Each mutated channel is annotated as the corresponding N-terminus 
cysteine substitution in a Cter_ΔCys background, i.e. A22C means hA1a-A22C-C466A-
C471A-C497A-C528Stop. Sodium currents were normalized with current obtained before the 
addition of intracellular MTSEA-biotin. Dark blue bars indicated MTSEA-biotin non-sensitive 
currents and light blue bars, sensitive currents. 8, non-functional channel. », p<0.001; #, 
p<0.01; §, p<0.05 Student test compared to hA1a-WT sodium current obtained 2 min after 
MTSEA-biotin perfusion. (6 < n < 12 oocytes per mutated channel) 
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We have analyzed the biotinylation of hA1a mutants with cysteine substitutions at 
position A22 to E37, L39, L41 and R43. Specific hA1 biotinylation signals were obtained by 
immunoblotting and quantified using the signal obtained for the hA1a wild-type subunit for 
normalization. On the left of the table are the results from figure 50, i.e. the percentage of the 
sodium current inhibition for each mutant 2 minutes after addition of 1 mM intracellular 
MTSEA-biotin. Except for the WT, the Cter_ΔCys, the mutant A22C and the mutant R43C, 
one western blot was performed per mutated channel (12 oocytes per western blot). As seen 
before, removal of the four cysteines in the C-terminus (Cter_ΔCys) led to 90 % loss of the 
MTSEA-biotin mediated biotinylation of the mutated subunit compared with the wild-type. As 
shown in the previous section, the introduction of a cysteine in the N-terminus at position A22 
increased the biotinylated signal compared with Cter_ΔCys, that is, the signal was returned to 
50 % of the wild-type signal (Figure 50, highlighted in green). A partial restoration of signal 
was observed for all substitutions from position S23 to E37, where signal of biotinylated 
subunit was at least as intense as the mutant A22C. Of particular interest were the mutations 
S23C, S24C, L30C, A31C, F34C and S35C Cter_ΔCys that showed a full restoration of wild-
type biotinylation signal, or even a strong elevation of this signal (Figure 50, highlighted in 
pink). Mutations L39C, L41C and R43C had no restorative effect and presented a biotinylated 
signal similar to that observed for the Cter_ΔCys mutant. Because the 10 % residual 
biotinylation has been shown to be DTT-sensitive, we considered that the lower range of values 
was due to a residual biotinylation (highlighted in orange), likely due to biotinylation of TM1 
cysteines. 
Taken together, these results show that cysteines substituted at the N-terminus from 
position A22 to E37 are accessible to MTSEA-biotin. According to the percentage of current 
inhibition induced by 2 minutes perfusion of MTSEA-biotin, we can distinguish four main 
groups: 
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1. Mutated channels that are biotinylated by MTSEA-biotin but for which 
MTSEA-biotin has no effect on the sodium current; 
2. Mutated channels that are biotinylated by MTSEA-biotin and for which 
MTSEA-biotin inhibits significantly the sodium current. This is the case of the mutated 
channels hA1a-A22C, hA1a-I33C and hA1a-F34C. Thus, these amino acids are intracellularly 
accessible to MTSEA-biotin and seem to be important in the regulation of the channel; 
3. Two mutated channels, hA1a-L39C and hA1a-L41C, are not inhibited by 
MTSEA-biotin and this absence of inhibition is likely due to the inaccessibility of these amino 
acids to MTSEA-biotin. 
4. The mutated channel hA1a-R43C presents an unexpected pattern: its sodium 
current is inhibited by MTSEA-biotin but the subunit is not biotinylated (p < 0.01, compared to 
hA1a-A22C biotinylation). Previous studies have shown that the mutant hA1a-R43C, in the 
background C-terminus wild-type, is inhibited by intracellular MTSET (95). In contrast to 
hA1a-A22C and I33C, the residue R43C is located in the pore of hA1a and its inhibition by 
intracellular MTSET is state-dependent. This mean that when the channel is in a closed state, 
the TM1 undergoes conformational changes associated with channel gating and this reduces the 
accessibility of R43C to internal MTSET. Thus, MTSEA-biotin can only modified channels 
activated at the surface membrane explaining the inhibition of the current, but perfusion of 
MTSEA-biotin involves the biotinylation of non-activated channels in cytosolic vesicles that are 
much more numerous than membrane expressed channels. 
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Figure 50: MTSEA-biotin binding to hA1a cysteine-substituted subunits. Each mutated 
channel is denoted by the corresponding N-terminus cysteine substitution in a Cter_ΔCys 
background, i.e. A22C means “hA1a-A22C-C466A-C471A-C497A-C528Stop”. For each 
channel, the quantification of the specific hA1 signal was normalized with the biotinylated wild-
type subunit (WT) signal. Dark blue bars indicate signal intensity at least as strong as the WT; 
light blue bars, decreased signal intensity. On the left are the reported levels of current 
inhibition by MTSEA-biotin for each mutant, taken from the figure 49. nd, non-determined. », 
#, §: p<0.01, Student's t-test respectively compared to WT, Cter_ΔCys or A22C values. (WT, 
N=3; Cter_ΔCys, N=6, A22C, N=6; R43C, N=2; each western blot was performed with 12 
oocytes per mutated channel) 
 
We have seen that the wild-type and the Cter_ΔCys hA1a channels activity are insensitive 
to MTSEA-biotin although MTSEA-biotin binds to both wild-type and Cter_ΔCys subunits. 
Introduction of cysteine at different positions in the N-terminus allowed the identification of 
amino acids that are accessible to intracellular MTSEA-biotin and hence potentially involved in 
the function of the channel. From these results, we mainly have showed that: (i) Residues Ala22 
to Glu37 in the N-terminal part of hA1a are accessible to MTSEA-biotin; (ii) Ala22, Ile33 and 
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Phe34 are accessible to MTSEA-biotin and have an important role in the regulation of ASIC; 
(iii) Leu39 and Leu41 are not accessible to MTSEA-biotin. Moreover, we confirmed the state-
dependent accessibility of the residue Arg43 that we have already shown in a previous article 
(95). However, although there has been considerable replication with oocyte numbers, these 
results quantification of biotinylation results are based on single western blots. As such, our data 
must be considered preliminary and require further replication. To further expand this data set, 
we have created a mutant channel construct substituted at the TM1 and C-terminus cysteines: 
hA1a-C49S-C59S-C61S-C466A-C471A-C497A-C528Stop. We plan to performed MTSEA-
biotinylation and cross-linking experiments on these channels generated in the TM1 + 
Cter_ΔCys background which would remove the residual biotinylation of the C-terminus 
cysteine-less mutated subunit. Such data would further isolate the functional importance of 
specific residues within the hA1a sequence. 
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DISCUSSION 
I / Cadmium trapping in an Epithelial Sodium channel Pore Mutant. 
The selectivity filter of ENaC constitutes the narrowest part of the pore and allows only 
the passage of the small monovalent cations Na+ and Li+. It is composed by three conserved 
amino acids, G/SxS, and is present in each of the three subunits. Mutation of the residue 
αSer589 leads to the loss of the channel selectivity and allows other mono- and divalent cations 
to pass through the channel (63). Sheng et al. have reported that the Cd2+-sensitivity of the 
mutated channel αS589Cβγ was due to the orientation of the side chain of the substituted 
cysteine toward the channel pore (112). In this study, we have shown that a cysteine at position 
α589 (S589C) is not necessary to obtain a block by external Cd2+. Indeed, its substitution with 
an aspartate (S589D), asparagine (S589N) or alanine (S589A) leads also to an almost 
irreversible inhibition of the channel by external Cd2+ although Asn and Ala have no affinity for 
Cd2+ ions. Thus, this contradicts the conclusion of the αSer589 side chain being oriented toward 
the channel pore. 
The crystallization of a truncated, non-functional form of chicken ASIC1 (cΔASIC1) by 
Jasti et al. was published few weeks after publication of our work (61). They kindly provided us 
the pdb file of the three-dimensional view of the protein (46). In this model, the selectivity filter 
G/SxS is located in the middle of the membrane closer to the intracellular side rather than to the 
extracellular side as previously proposed (69) (Ser445, Figure 51A-box). Analysis of the 
conserved amino acid Ser445 on the cASIC1, corresponding to αS589 on rat ENaC, shows that 
the side chain of the serine faces the first transmembrane domain of the same subunit rather than 
the pore lumen channel (Figure 51B), thus corroborating our results as well as those from 
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Kellenberger et al. who proposed in a previous study (63) the orientation of the side chain of 
αS589 toward the subunit-subunit interface. 
 
 
 
 
 
 
 
 
 
 
 
Figure 51: Orientation of the selectivity filter’s residue Ser445 in the transmembrane 
domains of the cΔASIC1. (A) View parallel to the membrane plane. The box shows a zoom on 
the residues Ser445. (B) View from the extracellular side, along the pore axis. Each subunit is in 
a different colour forming the hypothetic trimer. Carbon atoms are yellow; oxygen atoms are 
red and nitrogen atoms are blue. Obtained with the Swiss Pdb Viewer software 
 
In this same study, Kellenberger et al. suggested that substitution of αS589 by larger 
residues increases the pore diameter by adding extra volume at the subunit-subunit interface. 
We used the Swiss Pdb Viewer software (46) to model the effect of amino acid substitutions on 
the protein structure on the base of cASIC1 crystal (Figure 52). Substitutions of the Ser445 in 
Cys, Asp or Asn do not seem to render the side chain of the residue at position 445 more 
accessible to molecules in the ion pore. Measurements of the distance between each residue at 
position 445 ('d1', 'd2' and 'd3' on figure 52) do not indicate a real difference in distance 
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separating the different substituted amino acids (Ser445: d1=15 Å, d2=17.82 Å, d3=19.74 Å; 
Ser445Cys: d1=14.52 Å, d2=19.2 Å, d3=18.78 Å; Ser445Asp: d1=17.94 Å, d2=19.43 Å, 
d3=19.41 Å; Ser445Asn: d1=14.21 Å, d2=18.77 Å, d3=20.56 Å). Using Heron's formula (cf. 
Methods 'Molecular Modelling'), I calculated the area between three α445 residues (grey zone 
delimited by 'd1', 'd2' and 'd3' on figure 52): the three Ser445 form a pore area of 128 Å; the 
three Ser448Cys, 127.3 Å; the three Ser448Asp, 154 Å; and the three Ser448Asn, 129 Å. 
Except for the Asp substitution, mutation of the residues participating in the selectivity filter 
does not seem to change the pore diameter in this model. It remains to be determined whether 
these same calculations performed on a model of functional channel leads to the same results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 52: Hypothetic orientations of the selectivity filter’s residue Ser445 substitutions in 
the transmembrane domains of the cΔASIC1. View from the extracellular side, along the 
pore axis. Each subunit is in a different colour forming the hypothetic trimer. Carbon atoms are 
yellow; oxygen atoms are red, sulfhydryl atoms are black and nitrogen atoms are blue. 'd1', 'd2' 
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and 'd3' represent the distances between each residue at position 445. The gray zone 
corresponds to the area calculated with Heron's formula. Distances and area are only indicated 
on the Ser445 but were also calculated for Ser445Cys, Ser445Asp and Ser445Asn. Obtained 
with the Swiss Pdb Viewer software 
 
We have shown that Cd2+ mediated inhibition of ENaC channel carrying substitutions of 
the αS589C in either Cys, Asp or Asn, occurs via  coordination of the metal cation with a native 
cysteine located downstream the amiloride binding site. This binding displays a high affinity 
and is irreversible under our experimental conditions. We have identified the Cys546, located in 
the second transmembrane domain of the γ subunit, as one of the native cysteines involved in 
the external Cd2+ block. There are likely other cysteines involved in this block but it was not 
possible to identify them since addition of mutations in the αS589C,β,γC546S background 
renders the channel non-functional. 
 
I verified the orientation of cA1-T448, the residue in cASIC which corresponds to 
γCys546 according to our alignment (cf. Annexe). The lateral chain of Thr448 faces rather the 
first TM of the same subunit than the pore lumen (Figure 53, left panel). It lies however in the 
vicinity of the pore lumen and is possibly close to the cation diffusion pathway being therefore a 
potential binding site for Cd2+ entering through the channel. Indeed, a Pdb Viewer model of the 
T448C substitution in cΔASIC shows that the T448C side chain is quite accessible to ions going 
through the pore. This orientation might match with our results. 
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Figure 53: Hypothetic orientation of the residue Thr448 in the transmembrane domains of 
the chicken ASIC1 and theoretical effect of the cT448C substitution. View from the 
extracellular side, along the pore axis. Each subunit is in a different colour forming the 
hypothetic trimer. Carbon atoms are yellow; oxygen atoms are red, nitrogen atoms are blue and 
sulfhydryl atoms are black. Obtained with the Swiss Pdb Viewer software 
 
II / Internal accessibility of the cysteine to sulfhydryl reagents. 
Kellenberger et al (64) have shown at the channel level that ENaC is rapidly and 
reversibly inhibited by intracellular thiol reactive reagents such as methanethiosulfonates 
(MTS), Cd2+, Zn2+, and Copper(II)-phenantroline, via an effect on the channel gating. Thus, 
they have shown that intracellular cysteines in the N- and C-termini of the channel are likely 
involved in this thiol-mediated inhibition of ENaC. We asked ourselves whether the MTS 
inhibition of ENaC occurs via a direct interaction of the sulfhydryl reagents with ENaC 
cysteines or if an accessory protein is involved. In order to determine the cysteines involved in 
inhibition by intracellularly applied MTS, we used a SCAM-derived approach comprising 
systematic cysteine substitution within the protein of interest and the study of their modification 
by a MTSEA reagent coupled to biotin. This latter compound allowed us to isolate by affinity 
for streptavidin beads the subunit specifically target by the sulfhydryl reagent. 
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II-1) ENaC 
We first showed that ENaC inhibition and biotinylation by intracellularly applied 
MTSEA-biotin did not result from diffusion of the reagent and reaction with cysteine residues 
exposed to the extracellular space. Indeed, extracellularly-applied MTSEA-biotin did not have 
any effect on the sodium current and it did not allow the biotinylation of any of the ENaC 
subunits. Inhibition and biotinylation of ENaC by MTSEA-biotin were prevented by addition of 
free cysteines in the perfusion suggesting that they occurred specifically via cysteine residue 
modification. In order to determine which cysteines were modified by intracellular MTSEA-
biotin, we mutated all cysteines which are potentially accessible from the intracellular side, i.e. 
a total of 20 cysteines localized in the N- and C-termini and the 2 transmembrane domains of 
the three ENaC subunits. Removing cysteines either in the N-terminus or in the C-terminus led 
to non functional channels, and resulted in a decrease in the extent of protein biotinylation as 
compared to the wild-type channel. This underlines both the important functional role of 
cysteines located in the N- and C-termini and their accessibility to the intracellular space. The 
Int_ΔCys mutant channel, which has all the intracellular cysteines substituted, was not 
functional, but was still expressed at the cell surface. The rate of biotinylation of the Int_ΔCys 
mutated α and β subunits, compared to its wild-type counterpart, was reduced by respectively 
70 % and 90 %. Thus, it is likely that the direct binding of MTSEA-biotin to N- and C-termini 
cysteines of ENaC was responsible for the inhibition of the channel current. However, the 
residual DTT-insensitive signal of biotinylation of both Int_ΔCys mutated α and β subunits 
suggested the presence of a non-specific interaction between MTSEA-biotin and ENaC. Cross-
linking experiments showed that bismaleimide cross-linkers inhibited ENaC current and bound 
to subunits but did not provide any information on the nature of the potential accessory 
protein(s). We plan to complete our results using other cross-linkers with different arm lengths 
and other properties, for example the DPDPB, a homobifunctional sulfhydryl-specific cross-
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linking reagent that contains two dithiopyridyl groups separated by a 19.9 Å arm and two 
cleavable disulfide bonds. 
 
II-2) ASIC 
We then looked at the effect of MTSEA-biotin on hASIC1a. The wild-type channel was 
biotinylated by MTSEA-biotin but, in contrast to ENaC, was not inhibited by this reagent. 
Substitution of the cysteines of hA1a that are potentially accessible from the intracellular side, 
i.e. in the C-terminus, did not disrupt channel activity. Similarly to what was observed with 
ENaC, MTSEA-biotin-mediated labelling of the mutated channel was decreased by ~90 % as 
compared to the wild-type subunit, with a residual biotinylation signal typically remaining 
incorporated to the protein. Thus, while the cysteines at the C-terminus of both ENaC and ASIC 
were accessible to intracellular MTSEA-biotin, only those of ENaC seemed to be crucial for the 
channel function.  
In the case of hA1a, the residual signal of biotinylation is DTT-sensitive which indicated 
that one or more of the cysteines, possibly those located in the TM1 of hA1a, was accessible 
and susceptible to modification by MTSEA reagents. I have taken advantage of the fact that this 
residual biotinylation was only weakly detected by Western blot analysis, to study the 
accessibility of N-terminal cysteine substitutions in the C-terminus cysteine-less (Cter_∆Cys) 
background. Addition of a cysteine in the N-terminus at position A22 in the Cter_∆Cys mutant 
led to a recovery of MTSEA-biotin mediated biotinylation of the subunit and rendered the 
mutated channel sensitive to MTSEA-biotin inhibition. This indicated that the Ala22 residue 
was accessible to intracellular MTSEA-biotin and that it may be involved in channel regulation. 
Since Ala22 aligns with a conserved cysteine in the N-termini of all three ENaC subunits 
(αC88, βC30, γC33), these results confirmed the accessibility of the cysteines located in the N-
terminus of ENaC and their importance in the function of the channel. 
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Perfusion experiments with hA1a mutants carrying cysteine substitutions allowed the 
identification of the region comprising Ala22 to Glu37 as being accessible to intracellularly 
applied MTSEA-biotin. However, only a few of these substitutions rendered the mutated 
channel sensitive to inhibition by MTSEA-biotin: besides the already mentioned A22C, I33C 
and F34C Cter_∆Cys hA1a mutants are significantly inhibited by MTSEA-biotin. We can 
conclude that residues Ala22, Ile33 and Phe34 were intracellularly accessible and may be 
important for the regulation of the channel. These results confirm the MTSET sensitivity of the 
corresponding A22C, I33C and F34C mutants in the C-terminus wild-type background 
observed by Pfister et al. (95). The PredictProtein Server (102) predicts two potential α helix 
encompassing residues L30 to F34 and residues S40 to Y68 (corresponding to the putative first 
TM) as shown in figure 54 ('H'=Helix predictions in 'PROF_sec' line). The predicted α helix 
formed by amino acids L30 to F34 has a low reliability (1 to 2 in 'Rel_sec', figure 54). Our 
results showed a clear accessibility of these amino acids by MTSEA-biotin when substituted in 
cysteine. Altogether, this suggests that the formation of a α helix at this position is unlikely. the 
presence of an α-helix with amino acids R43 to W46 has a high reliability (5 to 7 in 'Rel_sec', 
Figure 54) as indicated in 'SUB_sec' line in the figure 54, where we only show the prediction 
with average accuracy superior to 82 %. These amino acids involved in the formation of a α-
helix are likely involved in the TM domain. This can explain the absence of accessibility of 
cysteine substituted residues L39C, L41C and R43C to MTSEA-biotin. 
 
 
 
 
Figure 54: Prediction of the secondary structure of hA1a. Here are only presented the first 
80 amino acids. AA, amino acids; OBS_sec, observed secondary structure (H=Helix, 
E=Extended (sheet)); PROF_sec, "Profil network prediction Heidelberg" (PROF) predicted 
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secondary structure; Rel_sec: reliability index for PROF_sec prediction (0=low to 9=high); 
SUB_sec: subset of the PROF_sec prediction for all residues with an expected average accuracy 
> 82 %, L=loop. 
 
One unexpected result was obtained with the R43C mutant. MTSET accessibility 
experiments previously performed by Pfister et al. (95) had shown that the R43C residue lines 
the pore and is accessible to MTSET only when the channel is activated, likely when the first 
transmembrane domain undergoes conformational changes during channel activation. In our 
experiments, although intracellular MTSEA-biotin did indeed inhibit the sodium current 
generated by the mutated channel R43C in the Cter_∆Cys background, this effect was not 
mirrored by an increase in biotin incorporation as compared to its non-substituted counterpart. 
This result underlines a limit of our new approach. We hypothesized that inhibition of current 
was the consequence of conjugation of MTSEA-biotin to the subunit at the R43C position. 
Perfusion of intracellular MTSEA-biotin leads to the biotinylation of the cytosolic pool of 
proteins, including proteins in vesicles, and of proteins expressed at the cell surface (Figure 55). 
The channels expressed at the surface membrane are the only channels activated and represent 
only a fraction of the total biotinylated protein. Because the residue R43C is only accessible 
when channel is activated, the channels expressed at the cell membrane are the only mutated 
channels biotinylated by MTSEA-biotin. Thus, biotinylated proteins observed in western blot 
analysis represent intracellular proteins rather than proteins expressed at the cell surface, i.e. 
non-activated proteins rather than activated proteins. 
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Figure 55: Schematic representation of MTSEA-biotin intracellular perfusion. With the 
cut-open oocyte method MTSEA-biotin is perfused only in a small fraction (about 10 %) of the 
oocyte (left panel). In the perfused part of the oocyte, proportion of channels at the surface 
membrane is much lower than in intracellular vesicles (right panel). In the case of ASIC, 
activated channels are only at the surface membrane. Thus, the MTSEA-biotin-mediated 
biotinylation of channels reflects principally intracellular inactivated channels. 
 
A number of substitutions at Cter_∆Cys hA1a N-terminus remain to be analyzed in terms 
of their accessibility to MTSEA-biotin, namely R38C, S40C, K42C, A44C, L45C and W46C. 
This will be part of a future work. 
Because cysteines located at the TM1 of hA1a are potentially accessible to MTSEA-
biotin, I have generated a new mutant channel in which the cysteines in the TM1 and in the C-
terminus have been substituted by serine, alanine, or a stop codon: hA1a-C49S-C59S-C61S-
C466A-C471A-C497A-C528Stop. In this TM1+C-ter_ΔCys channel, we performed a cysteine 
screen of the N-terminus, from position A22 to W46. Measurement of the sodium currents 
generated by these mutants showed that they are all at least partially functional (data not 
shown). Currents are however not high enough for cut-open experiments but perfusion of 
intracellular MTSEA-biotin should indicate whether the cysteines at the TM1 are indeed 
responsible for the residual biotinylation observed with the Cter_∆Cys mutant. 
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Since the truncated form of cASIC1 used by Jasti et al. to generate the crystal structure 
lacks both N- and C-termini, it is not possible to model the mutations introduced in hASIC1a at 
these regions. In hASIC1a, the residues corresponding to the pre-TM1 and which have been 
tested in our study (hA1a-Leu41 to hA1a-Trp46) are however visible in the crystal structure of 
cASIC1, namely cA1-Leu42 to cA1-Try47. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55: Orientation of the side chain of six N-terminal residues in the chicken ASIC1 
crystal structure. (A,B,D,E) View of the transmembrane domains of three subunits parallel to 
the membrane plane showing in black either the cA1-L42 (A), the cA1-K43 (B), the cA1-V45 
(D) or the cA1-V46 (E) residue (C,F) View from the extracellular side, along the pore axis, 
showing in black either the cA1-R44 (C) or the cA1-W47 (F) residue. Each of the subunits of 
the trimer is in a different colour. Each residue is represented on only one subunit for the sake 
of clarity and the corresponding name in the human ASIC1a is indicated in italic. The part of 
the subunit studied here is in pink. 
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It is therefore interesting to assess in how far our results are compatible with the 
localization and orientation of the residues in this stretch relative to the pore. Leucine 41 and 
Lysine 42 in human A1a are conserved in chicken A1 and their side chains do not seem to 
disturb the passage of ions. However, our data showed that hA1a-K42C is significantly 
inhibited by MTSEA-biotin. This suggests thus that the residue ha1a-K42 lines the ion pore, in 
contrast with the cΔASIC1 model. The orientation towards the lumen of the pore of cA1-R44, 
agrees with the results obtained with the Cys substitution of the corresponding hA1a-R43. cA1-
V45 and cA1-V46 are not conserved between chicken and human ASIC. Substitution of cA1-
Val45 in Ala does not change the accessibility but substitution of cA1a-Val46 in Leu (not 
shown) which introduces a longer side chain that looks more accessible, corroborates with the 
MTSEA-biotin inhibition observed for the mutated hA1a-L45C. The residue cA1-W47 
corresponding to the hA1a-W46, is located in the ion pathway and its side chain points toward 
the pore. Substitution of this residue in cysteine leads to a non-functional channel underlining 
the crucial role of the hA1a-W46 in the channel function. 
 
In conclusion, this new approach which takes advantage of the fact that substitution of 
native intracellular cysteines is not deleterious for the channel function, allows us to identify the 
residues that are accessible to an intracellular reagent and that are relevant for the function of 
the channel. We have shown that cysteine residues in the N- and C-termini of ENaC are 
accessible to intracellular sulfhydryl reagents and are important for ENaC function. We have 
also shown that cysteines in the C-terminus of hA1a are not essential for the function of hA1a 
and that a number of amino acids at the N-terminus (A22 to E37) are accessible, some of which 
being important as well for the activity of the channel. However, this approach is only 
applicable to those mutants for which the accessibility of the target residue does not change 
with the conformational changes that accompany the activation and inactivation of the channel, 
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as it has been shown in the case of the hA1a-R43C substitution. For this particular channel, it 
should be possible to isolate the activated membrane pool of channels by a set of PEGylation 
and biotinylation: if oocytes are extracellularly labelled with poly(ethylene glycol) and 
intracellularly biotinylated with DTT-sensitive MTSEA-biotin, we would increase the 
molecular weight of channels expressed at the surface membrane. Then, biotinylated proteins 
will be isolated by affinity for streptavidin beads. And after separation of proteins by SDS-
PAGE, it should be possible to differentiate by a shift in the apparent molecular weight 
intracellularly biotinylated proteins that had been extracellularly PEGylated. In this way, we 
should isolate intracellularly accessible activated proteins. 
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ANNEXE 
 
Sequence alignment of rat α, β and γ ENaC and human and chicken ASIC. Gene ID: rat 
αENaC, 25122; rat βENaC, 24767; rat γENaC, 24768; human ASIC, 41; chicken ASIC, 
426883. The sequences were aligned with TCOFFEE Regular server of the Swiss Institute of 
Bioinformatics. Transmembrane domains TM1 and TM2 are indicated in blue cylinder; 
conserved cysteine residues in ENaC are surrounded by a light blue frame (); conserved 
cysteine residues in ASIC are surrounded by an orange frame (); conserved domains (HG 
domain, Degenerin site (DEG), Amiloride binding site (Amil.), Selectivity filter and PY motif) 
are surrounded by a red frame (); and amino acids substituted in cysteine in the N-terminus 
part of hA1a are surrounded by green frame (). 
 
 
 
 
60
19
22
15
16
120
59
64
54
55
179
118
121
112
113
229
167
179
140
141
287
225
239
160
161
346
284
298
209
210
TM1
TM1HG
domain
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400
338
352
261
270
457
398
409
324
323
517
457
469
378
377
575
517
529
432
431
629
576
587
488
487
685
628
639
518
517
698
638
650
528
527
TM2
TM2
PY motifSelectivity filter
DEG Amil.
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